incivo is a vaccine used to prevent the virus from spreading in hepatitis c infection in adults . it is used to treat chronic hepatis b infection in patients from the age of 1865 , when treatment with peginterferon alfa and ribavirin or telaprevir belongs to a group of medicines called ns3 - 4a protease inhibitors . the nn3 -4a proteace inhibitor does not contain the active substances . inciva is used in adult patients to treat hepis  c virus when peg interferon atfa or rib avirine is not suitable for you . your doctor has prescribed inci Vo for you to help prevent chronic hpatitistis - c disease in adults who have chronic , but who have not previously used an interferonal 
do not take incivo : - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ), or to peginterferon alfa and ribavirin , or any other medicines that may be used in combination . warnings and precautions pregnancy precautions - when inciva is used in association with pegInterferonalfa / rib avirine , your doctor may need to adjust their doses and to stop incivi altogether . in addition , peg interferon infa + ribivirin may be administered in combination with inciVO . - in addition to the above , some patients may experience severe side effects ( see section 4 ). 56 - the medicine alfuzosin may cause symptoms of an enlarged prostate . it may also be given in
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will determine the appropriate dose regimen for you based on your condition and body weight . the recommended dose regimen is one 3 mg tablet each day taken by mouth , with or without food . this dose is to be taken once daily . if necessary , your doctor may increase your dose to 6 mg once daily for 2 weeks or to 8 weeks after your last dose . for both hepatitis c virus infection and human immunodeficiency virus infection , efavirenz is recommended . in general , the recommended dosage regimen is two 3 mg tablets each day , taken with or after food , at about the same time each day to help you remember to take it . it is important that you take the recommended dosing schedule . you should take the tablets within
like all medicines , this medicine can cause side effects , although not everybody gets them . rash may be an itchy skin rash . the rash can progress to widespread or even be severe . other symptoms may be present or may worsen the rashes . tell your doctor immediately if you develop a severe skin reaction . get medical help immediately - if your rash gets worse or if other symptoms occur . signs of a rash include fever , tiredness , swelling of the face , and swelling of lymph glands . it can also be a wide - spread rash with peeling skin , fever . flu - like symptoms , or painful skin . skin rubbed , red , raised or painful patches often with blistering skin that can be severe ( very common ) - in very rare cases , rash associated with fever -
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . incivo tablets should be stored in the original bottle and keep the bottle tightly closed in order to protect from moisture . keep the bottles tightly closed . store in the same place as the bottle . don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . each tablet of inciva contains 375 mg of telalapreVir . - tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrOUS , sodium lauryl sulphate , croscarmellose sodium , and sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , the likes of talc , titanium dioxide ( e171 ), iron oxide yellow ( е172 ). what if incivoc looks like and contents of the pack film , capsule - shaped tablets , imprinted with " inciv " on one side . they are supplied in plastic bottles containing 20 tablets
the active substance in zinbryta is daclizumab beta , which is a monoclonal antibody , a type of protein that recognises and attaches to a specific target substance in the body . what zinberyte is used for zinBryt , is used to treat multiple sclerosis in adults who have not responded to therapy or are undergoing two ms treatment . alone or together with other treatments that may reduce inflammation , may remove the protective sheath ( called myelin ) around the nerves in the central nervous system ( brain and spinal cord ). this loss of myelina is called demyelinate . relapsing mS is characterised by repeated attacks ( relapses ) of symptoms that affect the nerve systems . these remissions can be life - threatening and require
do not take zinbryta if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine listed in section 6 . if there is anything you do not understand , ask your doctor . warnings and precautions talk to your doctor or pharmacist before taking zin Bryt if any of these apply to you . you have liver problems . your doctor may need to adjust your dose of zinberyt
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much zinbryta to use the recommended dose of zinberyt consists of 150 mg given once a week . your doctor will do a blood test to check how well your liver is working before giving you zinBrytta . the recommended daily dose is 40 mg given three times a day . based on the results of this blood test your doctor may decide that you can give yourself zinblita by injection under the skin ( subcutaneously ) of your thigh , stomach or upper arm . instructions for injecting zin Bryte 7 . before injecting your medicine you will be asked to drink plenty of water before each injection to make sure that you have drunk all of the contents of the vials
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . the side effects listed below were seen when your treatment was started . serious side effects tell your doctor immediately if any of the following occur . liver problems have been reported commonly ( may affect up to 1 in 10 people ). unexplained nausea ( feeling sick ), vomiting ( being sick ) or stomach pain increased tiredness loss of appetite ( anorexia ) your skin or whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommonly ( may effect up to1 in 100 people ) severe inflammation of the liver may lead to death . report immediately any signs of liver problems . your doctor may decide to reduce your dose or stop your treatment . not known ( frequency cannot be estimated from the available data )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and syringe label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 to 8 ). do not freeze . keep the zinbryta pre - filled sYringe in original package in order to protect from light . after you use a new ssyre / pen , keep it in - use storage in : - do not store , freeze or shake . - store in the original package and use - no more than once a day , when not in use , and in / or near direct heat or direct light , where it should be kept in . always keep the pen in , preferably in sanit
what zinbryta contains - the active substance is daclizumab beta . each pre - filled syringe contains 150 mg daclizub beta in 1 ml solution . Each pre – filled pen contains 150 doses of daclizab beta within 1 - week period . - other ingredients are sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 ' zin Bryte contains sodium '). what  Zinbrytoa looks like and contents of the pack zinberytta is a clear , colourless to slightly yellow solution for injection . it is supplied in a sYringe / pen , with or without an attached needle .
wilzin belongs to a group of medicines called metabolism products . it is used for the treatment of wilsson ' s disease , which is caused by a rare inherited defect in copper excretion . wulzin is produced in the liver , the eyes and the brain . this results in liver damage and neurological disorders . the active substance wILzin works by blocking a protein in the intestine , causing its further accumulation in the body . there is no known cause of whillson  s illness . therefore this treatment is recommended for you .
do not take wilzin if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilszin . warnings and precautions talk to your doctor or pharmacist before taking willzin wulzin will be administered to you by your doctor during initial therapy . you should be observed for signs and symptoms of a possible wlson ' s disease . if your doctor has told you that you are currently taking another anti - copper agent called penicillamine . your doctor will give you wILzin during the initial treatment . in combination with other anti  - coal agents , peniciillamine may decrease the dose of tetanus if wilezin is administered during the first treatment with other antibiotic - potassium agents . please tell your doctor if any of these apply to you . the dose may need to be adjusted 
what wilzin contains the different dose regimens are available in different strengths . the 25 mg and 50 mg tablets are available for single use only . when you switch from 1 tablet to wlzin , you will be given 50 mg in a 2 - dose cycle . if you switch between two strengths of wILzin 25 mg , there is a 1 mg switch to a different strength . in the long term , the 50 mg and the 2 mg strengths are available . for multipacks containing 1 tablet of whiilzin and 50 mu / ml tablets , one tablet of 2 tablets of witzin 25 mu  / 1 tablet , and the 25 mu pack is available in packs containing : 1 to 6 tablets . there is 1 tablet for each dose of titration of a single tablet . you can take a combination of s
like all medicines , wilzin can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( affected 1 to 10 users in 100 ) uncommon ( affect 1 to 11 users in 1 , 000 ) rare ( affect 2 to 10 Users in 10 000 ), very rare ( effect affects less than 1 users in 10 users , 10 ,000 ) very rare : ( affect affects 1 to 15 users in10 ,999 ) not known ( frequency cannot be estimated from the available data ) wilszin intake may increase gastric irritation during treatment . changes in blood tests may include an increase in some liver and pancreatic enzymes and a decrease in blood red and white cells . reporting of side effects 25 if you get any side effects talk to your
keep out of the reach and sight of children . do not use wilzin after the expiry date which is stated on the carton and the label . the expiration date refers to the last day of that month . store below 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains - the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg of Zin acetate dihydrate ). each capsule contains 50 mg of gold ( equivalent 167 . 85 mg of zin ade dihydrate and magnesium stearate ). the capsule shell contains , gelatin , titanium dioxide ( e171 ), brilliant blue fcf ( wilszin 25 mg hard capsules ) and white 50 mg hard hard capsule ( equivalent of willzin 50 mg capsules in black ). - each printing ink contains black iron oxide ( EE172 ) or shellac . what whiilzin looks like and contents of the pack wILzin 25g hard capsule : the printing inked printing in black ink is composed of white iron oxide , with black iron red and shell
biktarvy contains the active substance bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor . the other active substance is emtricitabine , which is an antiregular medicine known alspi - a nucleoside reverse transcriptaser inhibitor ( nrti ) tenofovir alafenamide , another antirural medicine known wieltias , known as a nuclear nucleoneur transcriptasese inhibitor ( nottrtis ) biktarivy is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection . biktegrevir reduces the amount of hiv in your body . this will improve your immune system and reduce the risk of developing illnesses linked to hiv
do not take biktarvy if you are allergic to bictegravir , emtricitabine , and tenofovir alafenamide , or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if there is still a possibility that you can still be taking one of the following medicines : - rifampicin , used to treat some bacterial infections including tuberculosis - saint john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor or pharmacist before taking biktarivy and during treatment if : you have liver problems or a history of liver disease such as hepatitis . your doctor will
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . do not take antacids ( for example , to treat stomach ulcers , heartburn or acid reflux ), aluminium , magnesium hydroxide mineral supplements , vitamins , minerals , and magnesium , iron , etc .), etc , ( see section 2 under " taking these medicines "). if your doctor decides to stop taking biktarvy , biktarivy may not be suitable for you : if someone else is taking biplatiny on dialysis , tell your doctor before taking bicktarvY if a person is on diatic , as the dose of bikttarvying has to be reduced . your doctor will tell you how to take it . if the medicine
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of the following side effects contact your doctor immediately : inflammation or infection . in some patients with advanced hiv infection ( aids ) and a history of opportunistic infections ( infections that occur in people with a weak immune system ), signs and symptoms of inflammation from previous infections may occur soon after hiv treatment is started . it is thought that these symptoms are due to an improvement in the body ' s immune response , enabling the body to fight infections that may have been present with no obvious symptoms . these may be due to autoimmune disorders ( when the immune system attacks healthy body tissue ). in some cases , medicines like biktarvy can also cause hiv infections to become resistant to the virus . you should tell your doctor if this happens . reporting of side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). store in the original package in order to protect from light . once the seal has been ripped , the medicine must not be used .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktarivy tablet contains bictategravir sodium equivalent to 50 mg bicentegraVir and 200 mg emigricitabe and TENofoVir alafferamide fumarate equivalent to 25 mg tenfovir aleafened . the other ingredients are tablet core microcrystalline cellulose , collapse , crohn ' s sugar , magnesium stearate , film - coating polyvinyl alcohol , titanium dioxide , macrogol , and talc , iron oxide red ( e172 ), iron oxide black (  e178 ). what bikervy looks like and contents of the pack biktegris is
novonorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novon orm is used to control type 2 diabetic patients as an add - on to diet and exercise : treatment is usually started if diet , exercise and weight reduction alone have not been able to control ( or lower ) your blood glucose . yes novonorgm can also be given with metformin , another medicine for diabetes . it is important that you continue with your diet and / or exercise plan as agreed with your doctor .
do not take novonorm if you are allergic to repaglinide or any of the other ingredients in this medicine ( listed in section 6 ). if your doctor has told you that you have type 1 diabetes . if the acid level in your blood is raised ( diabetic ketoacidosis ). warnings and precautions talk to your doctor or pharmacist before taking novonoderm : if : you have a severe liver disease . you take gemfibrozil ( a medicine used to lower increased fat levels in the blood ). you have 47 liver problems . novon orm is not recommended in patients with moderate liver disease ( see do not use novonorgm in this case ). your doctor will monitor you carefully . there is limited information on the use of novonom in patients who have  a severely liver disease or who have kidney problems ; novonourm should not
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before each major meal , preferably at least 4 hours before or at least 30 minutes after each main meals . your doctor may then increase your dose to 16 mg if your blood sugar is too low . this will make you seem more like a hypo . you should not take more novonorm than your doctor tells you to . if this happens , your doctor will tell you how much you should take , how often you should continue to take novonorgm , and how often . do not stop taking novonORm without your doctor ' s advice . interrupting or stopping your diet may make your diabetes worse
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect is hypogLYcaemia ( may affect up to 1 in 10 people ). it is very common to get a hypo in section in people . if hypogycaemic reactions are generally mild / moderate , but occasionally develop into hypogglucaem unconsciousness or coma . allergy allergy is very rare ( may occur in up to1 in 10 , 000 people ) but can be life - threatening . symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . this can be signs of anaphylactic reaction . other side effects very common ( may effect more than 1 in 11 people ), headache , dizziness and weakness . common ( might affect upto 1 in 100 people 
what novonorm contains - the active substance is repaglinide . - other ingredients are microcrystalline cellulose ( e460 ), calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , and poloxamer . the coatings are iron oxide yellow ( 0 . 5 mg ) and iron oxide red (  2 mg ). what novoorm looks like and contents of the pack novonORm tablets are round and convex and engraved with the bayer cross on one side and ' 0. 5 ' on the other side . 1 mg tablets are yellow , round and marked with the company logo ( ) on one face . 2 mg tablets : 0
pumarix is a vaccine used in adults from 18 years old to prevent pandemic flu ( influenza ). pandemie flu is essentially a type of influenza that happens at intervals that vary from less than 10 years to many decades . it spreads rapidly around the world . the signs of pandem flu are similar to those of ordinary flu but may be more serious . how pumarize works when a person is given the vaccine , the immune system ( the body ' s natural defence system ) produces its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarisse may not fully protect all persons who are vaccinated .
pumarix should not be given : if you have previously had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to anything else that may be present in very small amounts such as egg and chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if any of these apply to you , or you are not sure , talk to your doctor or nurse before having the vaccine . medical treatment may be necessary in case of an allergy . warnings and precautions talk to you doctor or pharmacist before having pumarx if : you have had any allergic reaction other than a spontaneous life – threatening allergy to any of the ingredients of this vaccination ( listed under 33 " contents of the pack and
pumarix is for use in adults aged 18 and over . if you are not sure , talk to your doctor , pharmacist or nurse before having pumarice . you can use a similar h5n1 as03 - 0 . 5 ml vaccine for children and adolescents ( from 18 years of age ). how pumarize is given pumarisse is a type of vaccine that can be used in children and teenagers from 3 - 9 years old . it is for children from 3 months to 17 years of old , whichever is earlier . your doctor or nurse will give you pumarique . pumarx is given as an injection into a muscle . this will usually be in the upper arm . talk to a doctor if your child misses a dose of this vaccine .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions which cause you to have dangerously low blood pressure . if this is not treated it may lead to shock . your doctor knows that this may happen and will have emergency treatment ready to use . other side effects very common ( may affect more than 1 in 10 people ) pain where the injection is given headache feeling tired aching muscles , joint pain common ( might affect up to 1 in every 10 people people !) redness or swelling where the inject is given fever sweating shivering diarrhoea feeling sick uncommon ( may effect up to1 in every 100 people ), feeling weak or generally unwell muscle pain where it is given low blood sugar . this may be a sign of a serious allergic reaction which may lead , sometimes life - threatening , to death . not known (
keep this vaccine out of the sight and reach of children . before the vaccine is mixed : do not use the suspension and the emulsion after the expiry date which is stated on the carton . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . do not freeze . after the vaccine has been mixed , use the vaccine within 24 hours and do not store above 30 . discard any unused product via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what pumarix contains active substance : split influenza virus , inactivated , containing antigen * equivalent to : a / indonesia , circa / 5 / 2005 ( h5n1 ) like strain ( pr8 - ibcdc - 2 ) equivalent to approximately 0 . 5 milligrams * propagated in eggs ** expressed in microgram haemagglutinin . during the pandemic , the vaccine contains an ' adjuvant ' as03 that stimulates the body to produce its own adjuvanted with squalene , and dl - 1 - tocopherol . the vaccine also contains polysorbate 80 and e433 . adjuvants are used to improve the body ' s response to the vaccine . other ingredients :
somakit toc is a radiopharmaceutical product that contains an active substance called edotreotide . the powder for injection contains a small amount of a nuclear medicine called gallium ( 68ga ) chloride , which is equivalent to gallium( 68Ga !) edetreototide at the date and time of calibration . this procedure involves the occurrence of gallium , the kilogram of the product being measured , injected into a vein or into body areas . somamakit tc is used in a medical imaging procedure called positron emission tomography , to help your doctor decide whether it is safe for you to enter a pet animal . during this medical procedure , you will get images of the abnormal cells and tumours that have been detected and help to detect the progression of your disease . your
do not use somakit toc - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). allergic reaction has been reported in some patients ( including patients in section 4 ). warnings and precautions talk to your doctor before using somamakit toc : - patients with kidney or liver problems . renal or hepatic disease . children and adolescents do not give this medicine to children under 18 years of age . take special care with somаkit tox : avoid dehydration during the examination . 28 - some patients develop other medical conditions that affect the entire body such as cushing syndrome or inflammation . - thyroid disease , or a tumour ( of pituitary gland , lung , brain , breast , immune system , thyroid , adrenal gland ), disease of
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakit toc will only be used in specially controlled areas . this product will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this product and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide on the quantity of somаkit tock to be used by you . it will be the smallest quantity necessary to get the desired information . nominally the volume of somogakit will be 100 mbq ( megabecquerel , the unit used to express radioactivity ). administration of somagakittoc and conduct of the procedure , to be injected only as a single injection . after the injection , you will have to take the
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) to somakit toc and symptoms may include warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site and ionising radiation . these effects are usually mild to moderate and generally go away within one week . they can sometimes be severe . cancer and hereditary abnormalities are also possible . reporting of side effects 25 if you get any side effects talk to your doctor or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . after radiolabelling , somakit toc is to be used within 4 hours . the product must not be used after the expiry date which is stated on the label and carton after exp . do not store above 25 . store in the original package in order to protect from light . once the vial has been opened , the product should be used immediately . any unused product must be discarded after dilution .
what somakit toc contains - the active substance is edotreotide . each vial of powder contains 40 mg of edeotreotroide - each vially contains 10 - phenanthroline , gentisic acid , and mannitol . - formic acid / sodium hydroxide / water for injections . the solution contains hydrochloric acid and is a clear colourless solution before radiolabelling . what somaskit tock looks like and contents of the pack somamakit - somak kit toc is based on radiopharmaceutical preparation . it is supplied in a glass vial with black flip - off caps containing a white powder . one side of the vial contains a gold vial containing yellow flip , cap and a crystal clear
afinitor is an anticancer medicine containing the active substance everolimus . everolim works by slowing down or stopping the growth of cancer cells . afiniteur is used to treat adults with hormone receptor - positive advanced breast cancer ( postmenopausal women ) who are not sufficiently responsive to or are intolerant of other non - steroidal aromatase inhibitors ( a type of medicine that helps the disease under control ). it is used together with a medicine called exemestane ( formerly known as a steroids aromatasiase antagonist ) and hormonal anticancancer therapy for advanced tumours and neuroendocrine tumours that have spread to the stomach or bowels and affects the way the stomach and bowel movements .
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor if you are not sure . your doctor will decide on the correct dose of afinitor based on your medical history and current condition of cancer treatment . warnings and precautions talk to your doctor before taking afinitour : if : you are allergic to everolimus , sirolimus / temsirolim , or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if that applies to your case , do not take afinitorul and tell your physician immediately if: you have any problems with your liver or have ever had any disease which may have affected your liver . you should use a different dose of afinitor . talk to you doctor before you take afiniitor and during
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 10 mg once a day . take the tablets with food . you can take afinitor with or without food , with or just after food ; if your doctor thinks you have liver problems , you may need a lower dose of afinitor ( 5 mg once daily ). your doctor may increase your dose to 5 mg twice a week ( total daily dose of 7 . 5 mg ). you may experience certain side effects when taking afinitour . your doctor will decide how long you should continue treatment with afiniter . if possible , show the doctor the pack , or this leaflet . continue to take afiniitor as long as your physician tells you , as you need urgent treatment . don ' t stop
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and seek medical help immediately if you experience any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , with a red rash or raised bumps . other side effects of using afinitour include : very common ( may affect more than 1 in 10 people ): increased temperature ( with chills that may be signs of infection ) fever , coughing , difficulty breathing , wheezing . inflammation of the lung ( pneumonitis ) coughing up blood , redness of the lips / skin ( with or without pain ) uncommon ( may effect up to 1 in 100 people ). reporting of side effects 25 if your child gets any side effects talk to your doctor
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 25 . open the blister just before taking the tablets . this medicine does not require any special temperature storage conditions . if you take more afinitor than you should if the pack is damaged or shows signs of tampering , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what afinitor contains the active substance is everolimus .  each afiniteur 2 . 5 mg film - coated tablet contains 2 , 5 mg of everoli Mus . the  dazuitor 5 mg movie - coating contains 5 mg to everolius .
what laventair ellipta is laventAIR ellippta contains two active substances umeclidinium bromide and vilanterol . these belong to a group of medicines called bronchodilators . what laVENTAIR ELLIPTa is used for lavent air - soluble tablets is used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition characterised by breathing difficulties that slowly get worse . in copd the muscles around the airways tighten . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the  lung . when used regularly , it can help to control your breathing difficulties and reduce the effects of copd on your everyday life .
do not take laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking this medicine . warnings and precautions talk to your doctor or pharmacist before taking laventAIR ellippta : -if you have asthma ( don ' t take laVENTAIR ELLIPTA to treat asthma ). you have heart problems or high blood pressure . - you have an eye problem called narrow - angle glaucoma . you have or have had an enlarged prostate , difficulty passing urine or a blockage in your bladder . talk to you doctor if any of these apply to you before taking the tablets . the use of lavent air ellipept a contraception is
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use laventair ellipta regularly it is very important that you use laVENTair ELLIPTA every day as directed by your doctor . this will help to keep you free of symptoms throughout the day and night . laventAIR ellippta should not be used to relieve a sudden attack of breathlessness or wheezing . if this sort of attack occurs you must use a quick - acting reliever inhaler ( such as salbutamol ). how to use the inhal
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you have any of the following symptoms after taking laventair ellipta , stop using the medicine and tell your doctor immediately . uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) or redness rare side effects( may affect less than 1 in 1 , 000 people ]: swelling , sometimes of the face or mouth ( angioedema ) becoming very wheezy , coughing or having difficulty in breathing suddenly feeling weak or light headed ( collapse ) if this happens you must tell your doctors immediately , if it happens . your doctor may decide to keep you under closer observation or change your dose of this medicine . you may need to take a closer observation to make sure that you have the following conditions : very common side
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each metered dose contains 55 micrograms umeklidinium ( equivalent to 65 microgram of umecladinium brmide ) and 22 microgram ( 0 . 25 microgram ) vilantrol ( as trifenatate )- the other ingredients are lactose monohydrate ( see section 2 under ' laventAIR ellippa contains lactoses ') and magnesium stearate . what laVENTAIR ELLIPTA looks like and contents of the pack laventaire ellipept a is an inhalation powder . the ellipinium inhaler consists of a light grey plastic body , a red mouthpiece cover and a dose counter . it is available in packs
tremfya contains the active substance guselkumab , a monoclonal antibody . this medicine attaches to a specific target substance in the body . trememfa is used to treat adults with psoriasis , including adults with moderate to severe " plaque psesoriases ". this is an inflammatory condition that affects the skin and nails . by attaching to the dna of your nails , the medicine helps improve the condition of the skin by improving the appearance of nails and reduce symptoms such as scaling , dropping , flaking , itching , pain or burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor or nurse . if any of you are not sure , talk to your doctor , pharmacist or nurse before using tremefyya and tell them immediately . warnings and precautions talk to you doctor / health care professional before using this medicine : if your child has an active infection . you should have active tuberculosis warnings apply to your child before you receive tretfyam . your child might get an infection more easily . this includes an infection related to tubercuosity . it is important to tell your healthcare professional if the child has ever had tubercularososus 36 you know that your child is
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of tremfya is 100 micrograms ( 1 pre - filled syringe ) given by injection under the skin ( subcutaneous injection ). it may be given every 4 to 8 weeks after your first injection . if your doctor determines that you need more trempya than he / she should , you can give yourself the wrong dose . try to give tremefyya at the same time each day . it is important that you follow this advice carefully so that you do not miss a dose , and that it is clear what to do . do not shake treefy . tell your doctor straight away if , after you have been given more , or if someone
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse straight away if you notice any of the following side effects you may need urgent medical attention : serious allergic reaction - signs may include : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , with a red rash or raised bumps other side effects that may be serious tell your healthcare professional if they notice any side effects not listed in this leaflet . if these side effects become severe , tell your pharmacist or nurse . some side effects may be more common ( may affect more than 1 in 10 people ): upper respiratory infections common ( might affect up to 1 in10 people ] headache joint pain joint pain feeling sick ( nausea ) feeling sick vomiting . reporting of side effects 25 if your child gets
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . you may remove this medicine if it is cloudy or contains flakes or large particles . once the pre- filled sir - attached , the product must be used within 30 days or discarded . this medicine is for single use only . any unused medicine must be discarded after the date it was first removed from the refrigerator . it is recommended that the date be used immediately after preparation .
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of guzelklumab in 1 ml solution . - other ingredients are histidine , histamine monohydrochloride monohydrate , polysorbate 80 , sucrose , water for injections . what TREmfYa looks like and contents of the pack solution for injection : tremefyya is a clear , colourless to pale yellow solution , supplied in a carton pack containing one single - dose glass sYringe or in  a multipack containing 2 ( 2 packs of 1 ) single  - do pre  filled pens . not all pack sizes may be marketed .
the active substance of trepulmix is treprostinil . treprastinalil belongs to a group of medicines called prostacyclins . prostacycles are hormones that help to lower blood pressure . by relaxing blood vessels , prostacins prevent blood from clotting . the active ingredient of TREpulmix ist inoperable chronic thromboembolic pulmonary hypertension ( cteph ). if you have persistent or recurrent ctéph and / or do not respond to surgical treatment , exercise capacity to control symptoms of the disease . chronic Thrmboembric pulmonary Hypertension ( when blood pressure is too high ) can affect the blood vessels of the heart and lungs .
do not take trepulmix if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have a disease called " pulmonary veno - occlusive disease ". this is a disorder in which the blood vessels in the lungs become swollen , and there is / or a higher pressure in the blood vessel between the heart and the pulmonary units . if this is the case , tell your doctor . warnings and precautions talk to your doctor before taking tre Pulmix : if : you have severe liver disease . you have ever had a heart problem or have had , or have ever have had, a cardiac attack ( myocardial infarction ) within the last six months you have had severe changes in heart rate severe coronar
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . trepulmix is intended for subcutaneous use . it is given as a continuous subcutaneous infusion under the skin through a small tube ( cannula ) in the abdomen or thigh . your doctor will show you how to use trepelmix . the pump is located in a portable pump and you can carry your treprostinil with you so that the pump can be easily accessible . you can use the infusion line to help prevent accidental overdose . doses up to 1 infusion daily will be reduced to 2 . 5 ml per kg body weight , given every 5 to 10 days . how much to use depending on your condition , your doctor may adjust the inffusion rate , or change the in
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people widening of blood vessels pain at the infusion site reaction at the hospital or clinic the inffusion site bleeding or bruising at the site of the induction headaches nausea diarrhoea jaw pain common - may affect up to 1 in every 10 people dizziness , light - headedness or fainting low blood pressure skin rashes muscle pain ( myalgia ) joint pain ( arthralgi ) swelling of feet , ankles , feet or legs not known : frequency cannot be estimated from the available data blood clots in the brain ( thrombocytopenia ) abnormal blood tests showing reduced blood platelets ( leukopenia and neutropenie ) low levels of potassium in the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution : a trepulmix vial may be kept at room temperature ( up to 30 ) for up to one week before use , in order to allow continuous subcutaneous infusion . in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than one month , unless reconstitution and dilution has taken place in controlled and validated aseptic conditions . a single réserve ( syringe ) of undiluted tre Pulmix can be used for upto 72 hours . this medicine must not be used if there is
what trepulmix contains - the active substance is treprostinil . trepelmix 1 mg : each vial contains 1 mg of trepstinkil ( as sodium salt ). 10 mg / ml each viale contains 10 mg of deprossinil ( since sodium salt is present in very small amounts ). tre Pulmix 2 . 5 mg - each vially contains 2 , 5 mg of the active ingredient treprastineril ( ( as salt )). 10 mL contains 25 mg of " treparstinningil ( AS sodium salt "). - trepemix 5 mg contains 5 mg deproştinils ( as potassium salt ), 10 g and 50 g of acetone . not all pack sizes may be marketed .
thorinane contains the active substance enoxaparin sodium which is a low molecular weight heparin ( lmwh ). thoinanane works by 1 - breaking down existing blood clots , and 2 - stopping blood coagulations forming in your blood . thoresinana is used to : - prevent blood clumps from forming and preventing them from re - forming your blood before an operation . this will help to preventing blood  clottings from growing in your life . it also prevents blood stains from circulating in your body after an operation and prevents them from getting into your blood after an accident . also , it helps to prevent blood from clotes from leaking into your heart after a heart attack . blood climes on the dialysis
do not use thorinane if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if this applies to you , tell your doctor immediately . you may be allergic to other low molecular weight heparins ( such as nadroparin , tinzaparin or dalteparin ). if any of these apply to you tell your physician before you are given thoresinan . warnings and precautions talk to your doctor or pharmacist before and during treatment with thorienane you should tell your healthcare professional immediately if : you have ever had a reaction to hepin that caused a severe drop in
like other similar medicines ( medicines to reduce blood clotting ), thorinane reduces the risk of bleeding . it does this by slowing down or stopping the bleeding , and by slowening the rate of any bleeding event that occurs during the titration period . signs of excessive bleeding ( exceptional weakness , tiredness , paleness ; dizziness ); headache or unexplained swelling , consult your doctor immediately . your doctor may decide to keep you under closer observation or change your medicine . you should not be given thoresinanе if you experience a severe allergic reaction ( difficulty breathing , swelling of the lips , mouth , throat or eyes ), or blockage of a blood vessel by ablood clot . this could cause cramping pain or discomfort . if this happens , you should immediately contact your doctor . do not
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store below 25 . dilution the solution should be used within 8 hours . use this medicinal product once the thorinane pre - filled syringes have been opened and used .
what thorinane contains - the active substance is enoxaparin sodium . one ml solution contains 100 mg of enomaparIN sodium , corresponding to 0 . 2 mmol / m3 solution . each pre - filled syringe with 0. 2ml contains 2 , 000 mg of the active ingredient exaparine sodium if the other ingredients are water for injections . what THorinanne looks like and contents of the pack thORinanе is a clear , colourless type i neutral glass sYringe barrel with fixed needle and needle shield , closed with chlorobutyl rubber stopper and a blue polypropylene plunger rod . pack size of 2 - 10 pre – filled pens . not all pack sizes may be marketed 
senstend contains two active substances : lidocaine and prilocaine . these belong to a group of medicines called local anaesthetics . senstende is used for the treatment of lifelong premature ejaculation in adult men . it works by decreasing the sensitivity of the head of the penis to increase time before ejculation .
do not use senstend : - if you are allergic to lidocaine or prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using senstende :- - whether you have ever had allergy or sensitivity to other local anaesthetics or amide - type local anesesthesias . - when you have a genetic disease or other condition affecting your red blood cells ( glucose - dependent disease or condition causing deficiency , such as anaemia or methaemoglobinaemia ). - in the presence of medicine senstendend , you should be aware of the following conditions : very limited sensitivity : severe liver problems this medicine should only be used on the face . avoid accidental contact with ears , eyes ,
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of senstend is 3 sprays ( 3 spray containers ) on the head of the penis . use within 3 hours after removing the spray container . after opening , the pump mechanism can be adjusted by the valve to prevent contact with eyes , nose , mouth and ears . when senstende is activated , use 1 spray container on the foreskin and on the top of the head , in order to protect the peni from light . each time the pump is activates the valve , it should be used within 1 hour . if the head is opened , put in a new penis after using the new penicle . it should not be used for more than 5 days after first opening the spray . do
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : common ( may affect up to 1 in 10 people ) inability to develop or maintain an erection difficulty in locating the penis feeling of burning in the back of the peni uncommon ( may affected up to1 in 100 people  ) headache local irritation of the throat or irritation of any part of the skin redness on the failure to ejaculate during sexual intercourse abnormal orgasm tingling of the infusion of the genital area of the pain or discomfort in the penisse itching of the area of skin not known ( frequency cannot be estimated from the available data ) ejected male / female sex after sexual intersection abnormal orgorgasm stinging of the epism pain or irritation in the ejection discomfort in or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the metal container and the bottle after exp . the expiration date refers to the last day of that month . store below 25 . discard the container 12 weeks after first opening . keep the metal containers tightly closed in order to protect from puncture and burn . please return the container to the pharmacy . you should not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . - each ml of solution contains 150 mg lidocasine and 50 mg prilocation . each spray delivers 50 microlitres that contains 7 . 5 mg lidoucaine + 2 . 2 mg plocaine over a period of approximately 12 hours . what senstentd looks like and contents of the pack senstende is a clear , colourless to light yellow cutaneous spray , solution in an aluminium spray container with metering valve . pack size of 1 spray container of 6 . 6 mL and 5 m2 of solution .
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults . oopDivo is used after complete resection in adults ( treatment with surgery ) as adjuvant therapy . advanced non - small cell lung cancer ( slcl ): in adults advanced renal cell carcinoma . in adults classical hodgkin lymphoma , in adults classic hodgekin lymphodyma that has come back or has not responded to previous therapies ( such as an autologous stem - cell transplant or a transplant ) to treat adult cancer of the head and neck in adults advance urothelial carcinoma , a form of bladder and urinary tract cancer . the active substance in opine is nivolumab , which is essentially a monoclonal antibody 
do not use opdivo if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using oopDivo . talk to a doctor or pharmacist before using this medicine : if : you have problems with your heart such as a change in the rhythm or the rhythm of the heartbeat or an abnormal heart rhythm . you have difficulties with your lungs causing breathing difficulties or cough . this may be a sign of inflammation of the lungs ( pneumonitis or interstitial lung disease ). if any of these apply to you , talk to you doctor or nurse before using the product . your doctor may want to monitor you more closely . diarrhoea ( watery , loose or soft stools ) tell your doctor if this
what opdivo is oopDivo comes in two strengths : o 240 mg / kg , 2 480 mg , and 4 480 g . obdivo must only be used in combination with ipilimumab for the treatment of skin cancer . the recommended dose of opmdivo consists of 1 mg of nivolumab per kilogram of your body weight . see section 4 for more information about doses . how much oppdivo to take the usual dose of the tablet is 240 iu per kilogram ( kg ) per kilogram , i .e ., 2 mg per kilogram or 480 milligrams per kilogram in the morning and 2 mg in the evening . when used in conjunction with opramiumab and in combinationwith iilimamab 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 to 8 ). do not freeze . chemical and physical in - use stability has been demonstrated at ambient conditions ( below 25 ) for up to 48 hours when stored in the original package . from a microbiological point of view , the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of ninvolumаb , corresponding to 40 mg per mL when diluted as recommended . the concentration is 4 mg / m2 , 100 mg  10 m2/ m3 and 240 mg m3/ m4 after reconstitution , equivalent to 24 mg nyvolumb ). the other ingredients are sodium citrate dihydrate , sodium chloride ( see section 2 " oodivo contain sodium "), mannitol ( e421 ), pentetic acid , polysorbate 80 , water for injections . what apdiva looks like and contents of the pack opmdivo is a clear , colourless to pale yellow solution 
clopidogrel tad contains clopogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). clopozogreel TAd is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosesis , and can lead to atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodogre
do not take clopidogrel tad 30 if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . the doctor may tell you to take special care with clopozogreL t ad : if vous suffer from severe liver disease . you should not take the tablets if any of these apply to you in the clinic . warnings and precautions before you take , or whilst you are taking clopionogreel tard , you should tell your physician if : you have a risk of bleeding such a hospital condition that puts you at risk of internal bleeding ( such as having a
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctoror or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel tad per day to be taken orally with or without food , and at the same time each day . if your doctor thinks you may have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of cropidogral TAd ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet , one 75 - mg tablet, one tablet of the tablet . you should take clopdogrell t ad for as long as your
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in some cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . These may be the signs of an allergic reaction . allergy symptoms such as sniffling , burning , hives and itchy skin . this may be caused by allergic reactions such as an allergic or anaphylactic reaction , which may be
what clopidogrel tad contains - the active substance is clopogrell . each film - coated tablet contains 75 mg of clodogrelly ( as hydrochloride ). - other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( е172 ), yellow iron oxide , the ingredients of talc and macrogol 3000 in the film . what oblong tablet looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 , 14 and 28 film  - coating are available . not all pack sizes may be marketed
tacforius contains the active substance tacrolimus . it is an immunosuppressant . following your organ transplant ( e . g . liver or kidney ), your body ' s immune system will try to reject the new organ . tacforium is used to control your body' 's immune response enabling your body to accept the transplanted organ , thereby reducing the amount of food and drink that reaches your body in the blood . your doctor will also tell you how much food you will eat . you will be given tacforeus to reduce the rejection of the transplant ed liver , kidney , heart or any previous treatment you were taking at the time of your transplantation .
do not take tacforius - if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). - you are allergy to sirolius or to any macrolide - antibiotic ( e . g , erythromycin , clarithromycin or josamycin ). warnings and precautions talk to your doctor before taking tacrolivimus immediate - release capsules ( tacni ): - use tacforitus prolonged - released capsules that contain tacrolimimus . the use of tacforis prolonged  - return capsules is not recommended . only use tacrolimmus immediate release capsule ( i . excipients ). tacforus prolonged- release caps that contain the active substance is tacrolinmus , but the immediate release caps are not necessary . tac
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed to you by a doctor with experience in the treatment of transplant patients . make sure that you receive the same tacforius medicine every time you collect your prescription , unless your transplant specialist has agreed to change to a different tacrolimus medicine . do not change the dose of this medicine without checking with your physician . if the appearance of this medication is not the same as usual , or if dose instructions have changed , speak to your doctor . how much tacforinus to take the usual dose to start with is one tablet of tacforitus per kilogram of body weight each day . your doctor will tell you exactly how much medicine you should take . doses just after transplantation will be done by x - ray or by injection 
like all medicines , this medicine can cause side effects , although not everybody gets them . infections : tell your doctor if you think you might get infections , as you may need medical attention . tacforius can cause severe effects . these include allergic and anaphylactic reactions . benign and malignant tumours have been reported following tacforitus treatment . cases of pure red cell aplasia ( a very severe reduction in red blood cell counts ), agranulocytosis (  a severely lowered number of white blood cells ), haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ), febrile neutropenia ( an increase in the number of some types of whiteblood cells that help the body to fight infection ). these effects are usually mild and usually disappear after a few days or weeks . red blood counts are very common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . use all the prolonged - release hard capsules within 1 year of opening the aluminium wrapping . store in the original package in order to protect from moisture .
what tacforius contains the active substance is tacrolimus . each capsule of tacforus 0 . 5 mg contains 0. 5 milligrams of tacrolis ( as monohydrate ). each capsule in tacforeus 1 mg contains 1 mg of tacrolulimus ( as homohydrate ) . one capsule of 3rd grade hard capsules is containing 3 mg of poroli Mus ( as Monohydrate ), corresponding to 3 mg / mg of carbohydrate . 4th grade hard hard capsule in 0 5 mg of hard capsule of povidimimus ( AS monohydrate) - the other ingredients are : capsule content hypromellose 2910 , ethylcellulose , lactose , magnesium stearate . what tac forius looks like and contents of the pack tacforisus - 
clopidogrel zentiva contains clopogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). clopozogrelor zentivea is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosesis , and can lead to atherotrothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodogrelly zentiga to help prevent blood collots from forming and prevent them
do not take clopidogrel zentiva : if you are allergic ( hypersensitive ) to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor has told you that you suffer from severe liver disease . do not taking clopozogreel  Zentiva in the following circumstances : warnings and precautions if any of these apply to you , tell your doctor before taking ogrelling zentivea . look out for signs of bleeding such a dangerous condition that puts you at risk of internal bleeding ( such as untreated stomach ulcer ). you should tell your dentist that you are suffering from a blood disorder that makes you prone to internal bleeding , such as bleeding inside any tissues
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctoror or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if your doctor thinks you may have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of cropidogral  Zentiva ( 1 tablet of 300 mg or 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet . you should take clopdogrell zentivea for as long as your physician continues to prescribe it . contact
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in some cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . These may be the signs of an allergic reaction . warnings & precautions talk to your doctor or pharmacist if your child experiences any of the following serious side effects you should take clopidogrel zentiva as this medicine may cause
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . if clopidogrel zentiva is supplied in aluminium blisters , store below 30 . when clopdogrell zentivea is provided in all aluminium boxes , it does not require any special storage conditions . this medicine does not need to be disposed of via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what clopidogrel zentiva contains the active substance is clopogrell . each tablet contains 75 mg of clopionogreel ( as hydrogen sulphate ). the other ingredients are ( see section 2 ' clodogrelor zentivea contains lactose ' and ' common ') ', ' generic clomidogrelier zenta contains hydrogenated castor oil '), mannitol ( e421 ), hydrogenated castle oil , microcrystalline cellulose , macrogol 6000 and low - substituted hydroxypropylcellulose . the ingredients are lactoses monohydrate ( milk sugar ), hypromellose ( е464 ), triacetin ( é1518 ), red iron oxide ( 233 ) and titanium dioxide ( i171
yttriga is a radioactive medicine . it is reconstituted with another medicine containing tiny radiation doses to ensure that the treatment is as effective as possible . yttesriga will be radiolabelled medicinal product for diagnostic use only .
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of ystrige - you must not use this medicine - the active substance is yp3a4 - this medicine is not a radioactive medicine . - it may interact with another medicinal product . warnings and precautions talk to your nuclear medicine doctor before using yettrigga . your nuclear medicines doctor will ensure that yTriga is stored in a controlled environment . it is important that you tell your nuclear doctor if any of these apply to you . children and adolescents yanttrig , as the active ingredient in yattrigan , is not known to interact with other medicinal products . the use of Yttroga has not been studied in children below 2 years of age and 
your doctor will determine and control the dosage and duration of the treatment according to your individual needs . method of administration yttriga is for radiolabelling of medicinal products , which are used for specific diseases . administration of yTriga under the supervision of a physician experienced in the treatment of overdose . you will receive appropriate treatment every three months .
like all medicines , yttriga can cause side effects , although not everybody gets them . if any of the side effects get serious , or if you notice any side effects not listed in this leaflet , please tell your doctor . reporting of side effects 25 if your doctor or pharmacist gets any side effect , talk to your doctor straight away . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be administered under the supervision of a doctor experienced in the application of local regulations for radioactive substances . the storage details are as follows : keep this medicine out of the sight and reach of children . do not use after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . any unused product or waste material should be disposed of in accordance with local regulations on radioactive materials .
what ytriga contains - the active substance is chloride . 1 ml sterile solution contains 1 gbq hydrochloric acid . 3 mmol / mL solution for injection in a v - shaped bottom . this is a colourless type i glass vial of 10 mbq with a flat bottom , closed with  a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciama is given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . in the case of ciambaa a patient was given cistplatin for the initial treatment of patients with advanced stage of lung cancer ; ciaba can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy ; in the event of a failure of treatment , you will be given ciampa as a treatment for patients with severe form of lung carcinoma whose disease has progressed after other initial chemotherapy has been used
do not use ciambra - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciama ( listed in section 6 ). - do not breast - feed during treatment with ciampa . - you have recently received or are about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or hospital pharmacist before using ciambaa : - tell your doctor if any of these apply to you . you may not be able to receive or have previously had problems with your kidneys . before each infusion you will have samples of your blood taken to evaluate if your kidney and liver function are adequate and to check that you have enough blood cells to receive and administer ciarama , or if the results of yourblood cell counts are too low . when using cisplatin ,
the dose of ciambra is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your average body . this body surface area is used to workout the right dose for you . ciama may be given at any time of day , but this dose may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . we have mixed the ciampa powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you , and then it is diluted before it can be given to your doctor . you will always receive ciamba by infusion into one of your veins . the infusion will last approximately 10 minutes . when using ciarama in combination with cisplatin : the dose
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : 52 fever or infection ( common ): if your temperature gets too high , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if caught early , you may still get chest pain ( common at the start of treatment or at a fast heart rate ). if there are pain , redness , swelling or sores in your mouth ( very common at this stage ). allergic reaction : - skin rash ( common in children ) - burning or prickling sensation - fever ( common with skin reactions ) not known : frequency cannot be estimated from the available data .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . for single use only . if the infusion solution of pemetrexed is prepared in the laboratory it should be used immediately . chemical and physical in - use stability has been demonstrated for 24 hours at 2  8 and 15  25 . from a microbiological point of view , the product should be utilized immediately ; if not used immediately ( in  6 hours from the infuse ), the reconstituted solution should be stored in the original package in order to protect from light . once the inversion solution has been prepared it should not be used if it is discoloured
what ciambra contains the active substance is pemetrexed . ciama 100 mg : each vial contains 100 milligrams of pemetreXed ( as pemetrexxed disodium hemipentahydrate ). ciampa 500 mg / ml : Each vial provides 500 milligramms of Pemetrexeed ( as Pemetrexxeed diso sodium hemispent ahydrate). after reconstitution , the solution contains 25 mg % w / min / millilitres of ciapor . further dilution by a healthcare provider is required prior to administration . the other ingredients are mannitol ( e421 ), hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( for further pharm adjustment ). see section 2 " 
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ) used to prevent certain infections . they are found in your blood . immunogam can be used to treat adults with increased levels of human hepatitis b immunoglobuulin s . this is called immunoglouin g ( igg ) in blood plasma of screened adults . how immunogam works immunogam will not protect against hepatis c virus . it is used in haemodialysed patients . vaccination with a heptis br virus carrier is usually required in patients with an immune response . there are no measurable heparin b antibodies at the time of vaccination . however , continuous prevention of infected individuals who are at risk of hepanic b .
immunogam must not be used : - if you have ever had an allergic reaction to human immunoglobulins or other blood products , or any of the other ingredients of immunogam ( listed in section 6 ). - in people with an iga deficiency , an allergic response may occur following administration of iga containing products . children and adolescents ( aged 18 years and over ) immunogam should not be given if the dose of immunoglobulitis you are receiving is lower than the recommended dose . the risk of adverse reactions may be increased with chills , headache , fever , vomiting . in children and young people , allergic reactions such as nausea , arthralgia ( joint pain ), low blood pressure and moderate low back pain may occur . your doctor may make antibodies against hepatitis b immunoglobulation regularly or occasionally after human hepatis 
immunogam is intended for vaccination against hepatitis b virus . the first vaccine dose should consist of human hepatis - b immunoglobulin . administration prevention the recommended dose of heptagitis a in adults is 500 micrograms for every 24 hours . however , for 72 hours the recommended dosage of a hepanitis bovine in haemodialysed patients is 500 iu / kg body weight . use in children and adolescents for children and infants ( 2 years of age and older ) seroconversion before vaccination , is a requirement for hematitis bo to become active again . this requires the first dose of the heparin type iii vaccine carrier designed specifically for the hpatitIS b vaccine . it is therefore important that seroconalisation following vaccination instructions . immunogam should be
like all medicines , immunogam can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( affected 1 to 10 users in 100 ) uncommon ( affect affects 1 to 8 users in 1 , 000 ) rare ( affecting 1 to 9 users in 10 to 10 customers in 10 000 ), very rare ( effect affecting less than 1 users in10 ,000 ) very rare : undesirable effects that occurred during clinical trials with immunogam were injection into muscle . very common : ( affect 1 to10 users in1 , 0 . 5 ml ) 7 effects that were reported during clinical tests with immunogame were injection site reactions ( including pain , fatigue , involuntary muscle contractions ) not known : frequency cannot be estimated from the available data
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2c 8c ). do not freeze . keep the viall in the outer carton in order to protect from light . once immunogam has been taken out of its outer carton , it must be used immediately . it must not be used if it is cloudy or has deposits . discard any unused solution appropriately . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . immunogam 1 mg / ml solution for injection contains 5 mg of human plasma protein 96 kbq at reference time . - in the vial : polysorbate 80 . what immunogame looks like and contents of the pack immunogam is a solution for injecting in a glass vial that is essentially clear to slightly pearly - yellow liquid . it is available in packs containing 1 vial of solution .
remicade contains the active substance infliximab . inflimab is a monoclonal antibody a type of protein that attaches to a specific target in the body called tnf ( tumour necrosis factor ). remade belongs to  a group of medicines called ' tNf blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis , psoriatic arthritis . ankylosing spondylitis ( bechterew 's disease ) and psesoriasis . remikade is also used in adults and children 6 years of age or older for crohn '
do not take remicade if you are allergic to infliximab or any of the other ingredients of remade ( listed in section 6 ). if this applies to you , tell your doctor before taking remitade and tell your physician . if it is not clear whether you are allergy ( hypersensitive ) to proteins that come from mice . If you have tuberculosis ( tb ) or another serious infection such as pneumonia or sepsis . it may also cause heart failure . warnings and precautions talk to your doctor or pharmacist before taking your medicine if any of these apply to you before taking the medicine . take special care with remikade tell your doctors if : you have had problems with a previous treatment with retinopathy or have had to stop relicade in the past . you have
rheumatoid arthritis the usual dose is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psesoriasis , ulcerative colitis and crohn '
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however some patients may experience serious side effects and may require treatment . side effects may also occur after your treatment with remicade has stopped . tell your doctor straight away if you notice any of the following : signs of an allergic reaction such as swelling of your face , lips , mouth or throat which may cause difficulty in swallowing or breathing , skin rash , hives , swelling of the hands , feet or ankles . some of these reactions may be serious or life - threatening . an allergic response could happen within 2 hours of your injection . more signs of allergic side effects that may happen up to 12 days after your injection include pain in the muscles , fever , chills , nausea , vomiting , diarrhoea
remicade will generally be stored by the health professionals at the hospital or clinic . the storage details should you need them are as follows : keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and the carton after exp . this medicine may also be stored in the original carton . it may be stored for a maximum of 2 weeks at room temperature ( up to 8 ) and then stored at roomtemperatur ( upto 25 ) for remassed solution for infusion . however , it may also been stored for up to 3 hours at 2 - 8 and for an additional 24 hours at room temperatures ( up To 25 ), after removal from the refrigerator . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
what remicade contains the active substance is infliximab . each vial contains 100 mg of inflictimabe . after preparation each ml contains 10 mg of of influliximаb , respectively . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate and dibasic salt phosphatе . what retinade looks like and contents of the pack remikade is supplied as a glass vial containing a powder for concentrate for solution for infusion . only one vial of remade has been dissolved . one pack of reticalde contains 1 , 2 , 3 , 4 , or 5 vials . not all pack sizes may be marketed .
rasagiline mylan is used for the treatment of parkinson ' s disease in adults . it can be used together with or without levodopa ( another medicine that is used to treat parkinsons '
do not take rasagiline mylan - if you are allergic to rasagagi line or any of the other ingredients of this medicine ( listed in section 6 ). - take special care with rasagide mylan tell your doctor if this applies to you . - you have severe liver problems . do not taking the following medicines while taking rasaginine mylan: - monoamine oxidase ( mao ) inhibitors ( e . de ) for treatment of depression or parkinson ' s disease . this medicine may be used in combination with medicinal and natural products e. g ., st . John 's wort .- pethidine ( a strong pain killer ). you must wait at least 14 days after stopping rasagilline myLAN treatment . you should not take mao inhibitors or pethamine
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 tablet of 1 mg taken by mouth once daily . rasagiline mylan can be taken with or without food . if your doctor prescribes you a higher or lower dose than you should if this dose has not worked out , you should contact your doctor immediately . remove the rasagile mylan carton and this leaflet . take rasagide mylan 23 immediately after you have taken your first dose . do not take a double dose to make up for a forgotten dose , but continue as normal . you should continue to take rasaginagi line mylan for as long as your physician tells you to . it is important that you take rasagargiLINE mylan every day until your doctor tells me to stop 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects were reported when patients received placebo . for the frequency of the side effects listed below , please refer to the table below . very common side effects ( affects more than 1 user in 10 ) common ( affect affects 1 to 10 users in 100 ) rare ( affect not less than 1 users in 1 , 000 ) very rare ( effect cannot be estimated from the available data ) not known very common abnormal movements ( dyskinesia ) headache common abdominal pain fall allergy fever flu ( influenza ) general feeling of being unwell neck pain chest pain ( angina pectoris ) uncommon ( affect only 1 user per 100 ,000 ) no known ( frequency cannot be determined from the unavailable data ). very common abdominal movements ( dizziness ) feeling very common irregular movements ( hypokinesis ).
what rasagiline mylan contains - the active substance is rasagilitrate . each tablet contains 1 mg rasagile ( 100 mg rasageline ). - other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maizestarch ; talc , stearic acid ( see section 2 ). what rasagitiline minelan looks like and contents of the pack rasagiveline tablets are 11 . 5 mg / 6 mg film - coated , round , biconvex tablets , debossed with ' 1 ' on one side and plain on the other . the tablets are available in blister packs of 7 , 10 , 28 , 30 , 100 and 112 tablets and in perforated blister packs containing 7 . 4 , 9 , 14 , and 28 
do not use hulio : if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may have a severe infection , for example , tuberculosis . warnings and precautions talk to your doctor , pharmacist or nurse before using hULio as it may cause symptoms of infections , e . g . fever , wounds , feeling tired , dental problems . contact your doctor immediately if : you have moderate or severe heart failure . you have had or have , or have had , unexplained or serious heart condition ( see section 4 ). you have ever had allergic reaction . allergic reactions can be life - threatening . symptoms can include chest tightness , wheezing , dizzi
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . polyarticular juvenile idiopathic arthritis in children and adolescents from 2 to 17 years old : for children and teenagers : 10 to 30 kg : hulio is available in two strengths : 20 mg and 30 mg . for children , adolescents and adults : one month and a half 40 mg dose . hULio 40 mg is available for children with crohn ' s disease in children from 6 to 17 year old , and weighing at least 15 kg ; a dose of 30 mg is recommended . the maximum recommended dose of hülio 20 mg is 6 to 17.3 kg . children 's disease is available as 6 to 17, and weighed at least 30 kg and accompanied by 30 mg of
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require urgent medical treatment . side effects may occur at least up to 4 months after the last hulio injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash , or hives swollen face , hands or feet trouble breathing , swallowing , pale complexion , dizziness , persistent fever , including bruising or bleeding , signs and symptoms of infection such as fever ; feeling sick ; nausea and vomiting ; rash with fever . uncommon cases of infection may include lumps , redness ; pain in the abdomen , back pain , pain in joints . if any of these side effects
what hulio contains - the active substance is adalimumab . - other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid , and water for injections . what heulia looks like and contents of the pack hULio 40 mg solution for injection in vials is supplied as a sterile solution of 40 mg aad alimUMab in 0 . 8 ml solution . the solution is clear or slightly opalescent and is supplied in a glass vial with a rubber stopper . each pack of huio consists of 1 vial / 2 mL , 1 steril injection syringe ,1 sterility needle
yellox contains the active substance bromfenac . it belongs to a group of medicines called non - steroidal anti - ininflammatory drugs ( nsaids ) that reduce inflammation . yellx is used to reduce eye inflammation following cataract surgery in adults .
do not use yellox if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using yellx : if yelsalicylic acid or any other nsaids you may already be taking include acetylsalicyLIC acid , ibuprofen , ketoprofened or diclofenoc . this medicine may be used in combination with topical steroids such as cortisone , because it may cause unwanted side effects or increase the risk of bleeding problems . if this applies to you , tell your doctor . haemophilia has been reported in patients who have taken other medicines to reduce bleeding time , such as warfarin , to lower the risk for bleeding time and to reduce the risk in patients
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor if you are not sure . the recommended dose is one drop in the affected eye ( s ) twice daily in the morning and evening . use the same eye ( (  ss - ) every 2 weeks . you can use the drops at the same time the next day if your cataract surgery is planned . method of administration yellox is for use in your hands . it is important that you only use the eye drops twice a day . twist off the bottle cap and shake vigorously as this may affect its activity . hold the bottle , pointing down , between your thumb and fingers . tilt your head back and look up at the corner of your eyelid . pull down your finger back and pull down the bottle tip . this will help to keep the bottle open . do not squeeze the
what yellox contains - the active substance is bromfenac . each ml of solution contains bromfedenac ( as sodium sesquihydrate ). each 0 . 5 mL vial contains 33 bromfernac -the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , toyloxapol , povidone ( k30 ), disodium edetate and sodium hydroxide to adjust acidity levels . what Yellox looks like and contents of the pack yyelloX is a clear yellow liquid ( solution ) which is supplied in a 5 - mlitre glass vial with a screw cap .
dzuveo contains sufentanil , which belongs to a group of strong painkillers called opioids . sufenteanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo - if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). - have a serious lung or breathing problem . warnings and precautions talk to your doctor or pharmacist before taking dzveo and during treatment : - you have any condition that affects your breathing ( such as asthma , wheezing or shortness of breath ), since dZveo may affect your breathing . your doctor may need to change your dose , interrupt , or stop your treatment if your doctor thinks that you have , for example , a head injury or brain tumour . - problems with your heart and circulation such as slow heart rate , irregular heartbeat , low blood volume or low blood pressure - your doctor will monitor you more closely if this applies to you . you should
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . use only the single - dose administration device if your doctor considers that you need to take more of this medicine . dzuveo should be taken with strong painkillers such as sufentanil . take the tablet at least 30 minutes before you take the sublingual tablet . it should be administered using the disposable single  - dosage applicator . this applicators is for use under the tongue . once the tablets dissolve under the gums ( under the skin ), the tongue may feel relief , especially under the lingual position . you should swallow the tablet whole , with a drink of water . do not chew or crush the tablet , as it may cause pain relief under the upper part of the tongue (
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects severe breathing problems ( slow and shallow breathing ). if these side effects occur , contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ): nausea ( feeling sick ), vomiting ( being sick ) and feeling hot . common side effect ( may effect up to 1 in10 people ), including inability or difficulty sleepee . not known ( frequency cannot be estimated from the available data ) : dizziness , headache , drowsiness , fast or slow breathing . reporting of side effects 23 if your doctor gets any side effects or if this happens , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can
keep this medicine out of the sight and reach of children . store in a refrigerator ( 2c 8c ). do not freeze . keep the vial in the outer carton in order to protect from light and oxygen . do not use this medicine if you notice any visible sign of deterioration do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg of sufenil ( as citrate ). -the other ingredients are mannitol , dicalcium phosphate , hypromellose , crohn ' s wort ( maize ), croscarmellose sodium , indigo carmine ( e132 ), and stearic acid . - magnesium steary ( sulphate ) what azuvea looks like and contents of the pack dZveo is a white , round edges , tablet with 3 mm diameter , and packaged in a single - dose applicator ( labelled[ sublingual tablet ]. the applicators contains one sufenteanil 30 mg / 30 mg tablet ). pack sizes of 5
erleada is a cancer medicine containing an active substance called apalutamide . it is used to treat adult men with prostate cancer that has not spread to other parts of the body and cannot be treated with other surgical treatments . if you have sensitive prostate cancer which cannot be removed by surgical treatment , or if your doctor has told you that you have too much testosterone , in male patients , resistant prostate cancer can be treated using erleda . androgens are hormones produced by the body to help fight the cancer . by binding to androgents , apalutaMIDe blocks their action on prostate cancer cells .
do not take erleada - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). - are pregnant or think you may be pregnant ( see section " pregnancy , contraception section "). if any of these apply to you , tell your doctor before taking this medicine . warnings and precautions talk to your doctor or pharmacist before taking erledad : - take this medicine exactly as your doctor has told you . check with your doctor if this medicine is working or you are unsure . - you may get seizures . tell your doctors if your child is taking any medicines to prevent blood clots ( e . ex . warfarin or acenocoumarol ). tell your heart or blood vessel conditions . heart rhythm problems ( i . example , arrhythmi
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once a day . take the tablet at about the same time each day , for example if it is for breakfast or a meal . swallow the tablet whole . do not chew , crush or split the tablet . you can take erleada with or without food . this medicine is for oral use . it is best to take the tablets with water and taken by mouth . if necessary , your doctor may tell you to take eleadas together with other medicines . taking er leadadda it is important that you take a daily dose of erledad . try to take it at the same times every day ; this will help you to remember to take your dose . sometimes , patients
like all medicines , this medicine can cause side effects , although not everybody gets them . stop using erleada and tell your doctor immediately if you develop any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , with central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes with fever and flu -like symptoms ( toxic epidermal necrolysis ). serious side effects other side effects can include : very common side effects such as fit , seizure and weight gain . uncommon ( may affect up to 1 in 100 people ): er leadad , may cause a serious fit . fit is uncommon . it can affect more than 1 in 10 people treated with erled
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalutaMIDe - -the other ingredients are colloidal anhydrous silica , croscarmellose sodium , all . ( e468 ), hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose and silicified microcrystalline cell . the film consists of iron oxide black ( 6000 ), iron oxide yellow ( 8000 ), macrogol , polyvinyl alcohol , the talc , and titanium dioxide (  e171 ). what eleade looks like and contents of the pack erlesad a film , coated tablets are slightly yellowish , round , biconvex , film . tablets measure 8 
this medicine is a radiopharmaceutical product for diagnostic use only . axumin contains the active ingredient fluciclovine . it is used to help your doctor or veterinarian to perform a type of scan ( called a pet scan ) in adults who have not previously had treatment for prostate cancer . your doctor will perform other tests to check whether you have prostate specific antigen ( psa ) or other markers of the cancer if an azumin pet scan shows that the cancer has spread to other parts of the body . the doctor will ask you to have the scan if you think that the benefit of this procedure is that the use of aXumin does involve exposure to small amounts of radioactivity . you will be asked to take the radiopharmaceutic test ( dna ). your doctor and the nuclear medicine doctor have considered that the clinical benefit of dp
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using apumin ( if any of these apply to you ), as the use of aXumin in elderly patients is not recommended . - patients with kidney problems - those on a low sodium diet should not be given aaxumbin . you should eat and drink plenty of water during the day before the aixumin scan . 4 hours before the scan , you should take your usual medicines and medicines until the last 60 minutes after the apoxumine injection . tell your doctor if there is any urination associated with the scan and help you to sleep sound . children and adolescents do not give this medicine to children or adolescents under
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be used in specially controlled areas . this medicine will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . dose the nuclear medicine doctor supervising the procedure will decide on the quantity of aXumin to be used by you . it will be the smallest quantity necessary to get the desired information . the quantity to be administered usually recommended for an adult ranges from 370 mbq ( megabecquerel , the unit used to express radioactivity ). administration of  azumin and conduct of the procedure apxumIN is given into a vein by a flush of sodium chloride solution .
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies side effects were uncommon ( may affect up to 1 in 100 people ). people were more likely to respond to the medicine than they should . side effects of axumin were uncommonly ( may affected up to1 in 100 persons ). pain , rash , altered taste in the mouth , and altered sense of smell . this radiopharmaceutical will deliver low amounts of ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects 23 if you get any side effects talk to your nuclear medicine doctor . these include any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : keep this medicine out of the sight and reach of children . do not use axumin after the expiry date which is stated on the label after exp . hospital staff will ensure that the product is stored and thrown away correctly and not used after the date stated on label .
what axumin contains - the active substance is fluciclovine . aXumin 1600 mg : each tablet contains 1600 mg of flucclovine ( as 1600 mg or 16000 mg ). aaxUMIN 3200 mg - each tablet includes 3200 grams of froluciclovin ( as 3200 ) or 32000 mg of sodium citrate . the other ingredients are concentrated hydrochloric acid and sodium hydroxide . see section 2 " aexumin has a low sodium ". what he / she needs to know before you start using a base tablet . tablet : a xumIN 1600 mg tablets are supplied as a single dose in multidose vials of 1 x 10 ml tablet , containing 1600 mg and 16000 iu . each vial of azumin is
the active substance of azopt , brinzolamide , belongs to a group of medicines called carbonic anhydrase inhibitors . they work by reducing pressure within the eye and so reduce the pressure . azamopt eye drops are used to reduce high pressure in the eye , which can lead to an illness called glaucoma . increasing the pressure inthe eye can also damage your sight .
do not take azopt if you have severe kidney problems . you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). you are allergy to medicines called sulphonamides ( also referred to as medicines to treat diabetes or infections ) or to diuretics ( water tablets ). warnings and precautions talk to your doctor or pharmacist before taking aezopt . if the same allergy occurs , there is too much acidity in your blood ( hyperchloraemic acidosis ). talk to you doctor before taking the tablet if : you have kidney or liver problems you have dry eyes or cornea problems you are taking other sulphphonamide medicines you have been told by your doctor that you have glaucoma . talk to the doctor before starting to take this medicine if any of these apply to you . your doctor may
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . azopt should only be used for eyes ( ocular use ). the recommended dose is 1 drop in the affected eye or eyes once a day in the morning . use aezopt for as long as your eyes are working properly . do not swallow the bottle . wash your hands thoroughly after each use . twist off the cap to release the bottle and twist off . after cap is removed , remove the cap and snap collar . hold the bottle in one hand . thumb and fingernail . tilt your head back and touch your back with a clean finger . it may take up to 3 hours for you to feel the effect of a touch . you can feel the impact of tearing of the bottle after removing a contact lens .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : - blurred vision - eye irritation - headache - vision loss - itchy eye - dry eye  - abnormal eye sensation - redness of the eye some side effects may be worsened by bad taste . uncommon side effects that may affect more than 1 in 100 people - effect on the eye ( including blurred or red eyes ): o bad taste may be mild and will usually disappear after a few days . o allergic reactions - inflammation of the cornea ( the clear layer at the back of the lens of the eyes ), redness in the back , and redness at the front of the front part of the vision
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and bottle after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . to prevent infections , keep the bottle tightly closed in order to protect from moisture . a pack containing a single bottle should be used . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brinzolad . - other ingredients are benzalkonium chloride , carbomer 974p , edetate disodium , manitol , purified water , sodium chloride and tyloxapol . hydrochloric acid and sodium hydroxide are added to keep acidity levels ( ph levels ) normal . what  aezopt looks like and contents of the pack azyopt is a milky liquid ( a suspension ) supplied in a 5 mL plastic ( droptainer ) bottle with a screw cap . one bottle contains one bottle . not all pack sizes may be marketed .
forxiga contains the active substance dapagliflozin . it belongs to a group of medicines called " oral anti - diabetics ". these are medicines taken by mouth for diabetes . they work by lowering the amount of sugar ( glucose ) in your blood . forxika is used in adults aged 18 years and older . there is no information on the use of forxigan . you have diabetes - type 1 diabetes , where your body does not make any insulin . your doctor will prescribe forxige for you . type 2 diabetes : where your doctor is overweight or obese . -type 2 diabetes where your bodies do not make enough insulin or are unable to use the insulin it produces properly . this leads to dilution of diabetes ; this leads mainly to changes in the amount and quality of insulin that your body produces . the insulin that you need to control diabetes
do not take forxiga if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking forxika : if : you experience feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , or a fruity or metallic taste in your mouth , an odour to your urine or sweat or rapid weight loss . the above symptoms could be a sign of " diabetic ketoacidosis " a problem you can get with diabetes because of increased levels of " ketone bodies " in your urine and blood . tell your doctor or pharmacist if any of these apply to you . if not , talk to you
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . forxiga is for oral use . your doctor will tell you exactly how many tablets of forxigan to take . if your doctor tells you to have type 2 diabetes : the usual dose is one 10 mg tablet once a day . however your doctor may prescribe a lower dose ( 5 mg ) if the patient has a liver problem . the recommended dose is two 10 mg tablets once - day ( morning and evening ). forxige is also suitable for patients with type 1 diabetes . it is recommended that you take one 5 mg tablet twice daily . taking this medicine swallow the tablet whole with half a glass of water . you can take the tablets with or without food . take forxaga with or just after food , as it lowers
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking forxiga and see a doctor straight away if you notice the following serious side effects you may need medical attention : angioedema , seen very rarely ( may affect up to 1 in 10 , 000 people ). these are signs of angioEdema ( this may include swelling of the face , tongue or throat , difficulties swallowing , hives and breathing problems ). diabetic ketoacidosis , which is a symptom of type 1 diabetes ( may effect up to1 in 10 people ) and type 2 diabetes ( not known : frequency cannot be estimated from the available data ): may affect less than 1 in 1 ,000 people . diabetic ketoacosis ( see also section 2 warnings and precautions ) - you may get
what forxiga contains - the active substance is dapagliflozin . each forxega 5 mg film - coated tablet ( tablet ) contains dapaglingiflouzin propanediol monohydrate equivalent to 5 mg dapagloviflon . - other ingredients are : tablet core : microcrystalline cellulose ( e460i ), lactose ( see section 2 ' forxi '), crospovidone ( е1202 ), silicon dioxide ( EE420 ), magnesium stearate ( encapsulated ) film : polyvinyl alcohol ( ethanol ), titanium dioxide ( 8 mpa . citrate ), macrogol 3350 , talc ( é553b ), yellow iron oxide ( a ) ( mainly in the tablet core and in the film ' s colour
mepact contains the active substance mifamurtide which blocks the growth of certain bacteria that are part of the immune system ( the body ' s natural defences ). mepacting is used to treat osteosarcoma ( bone cancer ) in adults between 2 and 30 years of age , when surgery is not sufficient to remove the tumour . mepactant is also used when chemotherapy is not suitable to kill cancer cells . it works by blocking the dna of cancer cells which have come back .
do not take mepact - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). - in association with medicines containing ciclosporin and other calcineurin inhibitors ( non - stroidal - anti - angio - interferons ). warnings and precautions talk to your doctor or pharmacist before taking mepactic : - when you have problems with your heart or blood vessels , such as blood clots ( thrombosis ), bleeding ( haemorrhage ), or inflammation of the veins ( vasculitis ). mepacting may cause long - lasting or worsening symptoms . you should stop mepactation treatment and talk to a doctor or nurse if : you have asthma or other breathing disorders , your asthma is likely to get
treatment mepact will be given to you by a doctor or nurse who is experienced in the use of this medicine . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of mepactation is 2 mg mifamurtide every 12 to 24 hours . your mepacting treatments will be accelerated depending on your chemotherapy schedule . you should usually receive your chemotherapy within 36 weeks of starting treatment with mepacted . an interruption in the processing of the freeze - dried powder into a liquid suspension without the filter that will be used . mepacten will be administered by infusion into : a vein over a period of approximately 1 hour . if the patient is treated with me Pact , severe side effects ( such as fever , chills , fatigue , nausea and vomiting ) may occur .
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue may occur very commonly in people taking mepacT , especially if they are transient . if paracetamol is used to control fever , it is more likely that you will experience these during treatment with mepactation . stomach problems ( nausea , vomiting , loss of appetite ) have been reported in patients receiving chemotherapy . tell your doctor immediately about continuing fever and chills ( see section 8 ). during treatment on mepactate you may develop an infection , such as rash , or any problems breathing or wheezing . you should tell your mepacting doctor if you experience any of these effects . very common ( may affect more than 1 in 10 people ): nausea / vomiting . nausea - this usually goes away within 2 days after receiving me
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). keep the viale in outer carton in order to protect from light . reconstituted suspension containing sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection does not require any special temperature storage conditions . from a microbiological point of view , the product should be used immediately . however , if not used immediately ( within 6 hours ), the product must be used or discarded . this medicine is for single use only . any unused suspension must be discarded after reconstitution . it is recommended that the product is used immediately after reconstituted . no special
what mepact contains - the active substance is mifamurtide . each vial contains 4 mg of mfamurthide - after reconstitution , each ml of suspension contains 0 . 08 mg of the active ingredient ( mIFamurdide ). - -the other ingredients are 1 - palmitoyl - 2 -oleoyll - so - glycol -3 - polycholine ( see section 2 ) and 2 , dioleayl- sn - gastrocero - 3 - serine monosodium salt ( see also section 2 " mepactation contains sodium "). what mePACt looks like and contents of the pack mepactic is a white to off - white homogeneous cake for solution for infusion . mepacting is supplied in
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists which are used to reduce the redness of the skin on the face . rosacea is a condition where the redden of the face appears . it is caused by high levels of blood flow in the facial skin , which may result in enlargement ( dilation ) of the small blood vessels of the Skin . mirvasO acts by binding to these blood vessels , reducing the excess blood flow and redness .
do not take mirvaso if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ) or to any of their other ingredients ( listed under " other ingredients " in section 2 ) as you may get side effects . the medicine is only to be injected under the skin . if this is the case , tell your doctor immediately . you should not take certain medicines to treat depression ( including parkinson ' s disease ): - monoamine oxidase ( mao ) inhibitors ( e . excipients such as selegiline , moclobemide ), - tricyclic antidepressants ( imipramine ) and tetracyclic antagonists ( such as maprotiline ; mianserin ; mirtazapin ). if any of these apply to
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . mirvaso should only be applied to the skin or face . your doctor will tell you exactly how much mirvason you should be using . this medicine is for oral use . swallow the capsule whole . do not crush or chew the capsule . how much to use the amount of gel that you use will depend on how much gel is absorbed and on the surface of your body . the other body surfaces ( e . g . eyes , mouth , nose or vagina ) may need to be changed . you should continue to inject mirvass until your symptoms have improved . starting the treatment you will need to inject a small amount of gelatin ( a pea - sized amount ) once a day , preferably once 
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects include : severe skin irritation or inflammation , skin rash , sun exposure , hair loss , and skin pain or discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects are : worsening of rosacea . discontinue the treatment if you develop symptoms as described in section 2 " warnings and precautions ". contact allergy : if your doctor suspects that you may have allergic reaction , such as rash and rare angioedema ( a serious allergic reaction that may be life - threatening ). if this happens to you , stop using mirvaso and talk to your doctor . reporting of side effects 23 if any of the side effects gets serious , or 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , tube and pump after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . store in the original package in order to protect from light .
what mirvaso contains - the active substance is brimonidine . each gram of gel contains 3 . 3 mg of brimoniidine , followed by 5 mg of the active substances , brimondidine tartrate , carbomer , 3 - methylparahydroxybenzoate , and phenoxyethanol . - ingredients of the gel : glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see end of section 2 for further information on methyl parahydroxybenzobiate and propyllene glycoll ). what mirvao looks like and contents of the pack mirvasa is a clear , colourless gel . pack sizes of 2 , 10 or 30 vials of gel in airless pump system . not all pack sizes may be marketed .
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that is normally made by the immune system to help defend the body from infection and cancer ). bevacimizumaB binds selectively to a protein called human vascular endothelial growth factor ( vegf ), which is found on the lining of blood and lymph vessels in the body . the veggf protein causes blood vessels to grow within tumours , these blood vessels provide the tumour with nutrients and oxygen . mvai is used to treat tumour growth by preventing blood vessels from growing . it improves the levels of the nutrients and / or oxygen in the blood . this medicine is used for the treatment of adult patients with advanced cancer in the large bowel , i . ex . in the colon ,
you should not be given this medicine - mvasi is not recommended - for patients allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ). - you are allergic ( overly sensitive ) towards chinese hamster ovary ( cho ) cell products or to other recombinant human or humanised antibodies . - it is not known whether mvai is safe or works in these patients . talk to your doctor if any of these apply to you . warnings and precautions talk to you doctor or nurse before you are given mwasi . you may be more likely to develop holes in the gut wall if you have conditions causing inflammation inside the abdomen ( e .g . diverticulitis , stomach ulcers , colitis caused by chemotherapy ). your doctor
dosage and frequency of administration the dose of mvasi needed depends on your body weight and the kind of cancer to be treated . the recommended dose is 5 mg , 7 . 5 mg, 10 mg or 15 mg per kilogram of your bodyweight . your doctor will prescribe a dose of one infusion of  mvai that is right for you . you will be treated with m Vasi once every 2 or 3 weeks . frequency of infusions will depend on how you are responding to treatment . this medicine can be given at any time of the day , but it may not stop mbusi growing . how mvasesi is given makai is a concentrate for solution for infusion . depending on the dose prescribed for you by your doctor , some or all of the contents of the mwasi vial will be diluted with sodium chloride solution before use .
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . the side effects listed below were seen when mvasi was given together with chemotherapy . most of these side effects were mild in nature and short term . your doctor may decide to keep you under closer observation or change your dose . during the marketing of mvai you may experience allergic reactions . signs of an allergic reaction may include difficulty in breathing or chest pain . you may also experience redness or flushing of the skin or a rash , chills and shivering , feeling sick ( nausea ) or being sick ( vomiting ). the following side effects have been observed with mVAi . severe side effects may include redness and swelling of the face 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer container in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 , unless the infusion mixture has been prepared in , or is stored in : - in sterile environment . when dilsution has taken place in  a steril environment , the product should be immediately discarded . however , chemical and physical in 
what mvasi contains the active substance is bevacizumab . each ml of concentrate contains 25 mg of bevacitzumabine , corresponding to 1 . 4 to 16 . 5 mg / mL when diluted as recommended . one 4 mlitre vial contains 100 mg of BEvacizub , equivalent to 14 mg . this corresponds to a 16 - hourly increase of 400 mg of Bevaciumab at a concentration 16 : 5 mg and 16  mmol / min . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what vvasi looks like and contents of the pack mvai is a concentrate for solution for infusion . it is  a clear to slightly opalescent 
tecartus is a gene therapy medicine used to treat mantle cell lymphoma , when other medicines are not suitable . refractory mantLE cell lymphodyma is derived from your own white blood cells ( called autologous anti - cd19 - converted cc3 + cells ). mantlet cell lymphomatoma ( mcl ) is - related to a cancer of the immune system called b - lymphocytes . mantles cell lymphopenia is caused when b- lymph cells accumulate in an uncontrolled way in the lymph tissue ( bone marrow ) and make blood . how tecARTus works tecArtus blocks the b lymphocyte in your blood , so that the white blood cell in your body can be removed and the cancer cells are eliminated from your body . this reduces the amount
do not use tecartus if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using tecARTus . if , you are not sure , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using the medicine . the medicine may decrease the number of white blood cells in your blood ( lymphodepleting chemotherapy ). there are 3 million of these types of white cells left in autologous use and therefore tecarus is not recommended for you . tests and checks your doctor will check your lungs , heart , kidney and blood pressure . tell your healthcare professional immediately if any of these apply to you and tell your family , friends , or carer notices that you have infection or inflammation associated with your cancer . this is called graft -
tecartus is made specially for you by a doctor who has been trained in the use of this type of medicine . your own white blood cells are collected from you and given to you by an infusion in a vein ( a procedure call leukapheresis ). tecARTus is for use by infusion only . if your white blood cell count is too low , your blood will not be pumped into your vein . this will take 3 to 6 hours . the number of your whiteblood cells in your blood is down to 2 to 3 days . medicines given before tecarus treatment , some of the ingredients in the medicine are called lymphodepleting chemotherapy . these are used to keep the modified white blood in your body for 30 to 60 days , and in some cases , it may be given to your child with other medicines to reduce infusion reactions and fever . please
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss your side effects with you and will explain the potential risks and benefits of using tecartus . if you notice any of the side effects below , you may need urgent medical attention . the following side effects have been reported during the tecARTus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure , symptoms such as dizziness , lightheadedness ; fluid in the lungs , which may be severe and can be life - threatening . all symptoms of a condition called cytokine release syndrome include loss of consciousness , decreased level of consciousness as well as confusion , memory loss , and altered sense of taste . common ( might affect up to 1 in 100 people ), diarrho
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and the carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the infusion bag in order to protect from light . from a microbiological point of view , tecartus should be used immediately after dilution . if not used immediately , liquid nitrogen must be used ( no more than 150 ml of solution ). this medicine contains genetically modified human blood cells and is subsequently diluted with human - derived material . these measures will help protect the environment 36
what tecartus contains - the active substance is autologous anti - cd19 - transduced c3+ cells . each patient - specific single infusion bag contains a dispersion of anti  - crd19 car t cells containing 68 x 2 x 106 anti  - cells / kg . - other ingredients are sodium chloride , human albumin , and water for injections ( see section 2 ). what Tecartus looks like and contents of the pack tecARTus is a clear , colourless to yellow dispertion for infusion , supplied in an infusion bags packed in a metal cassette . one single inffusion bag holds approximately 68 kg of cell disperding units .
januvia contains the active substance sitagliptin which is a member of a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4- inhibitors ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2 diabetic condition . you should continue to follow the advice on diet and exercise given to you by your doctor or nurse . janusvia can be used alone or in combination with certain other medicines ( insulin , metformin , sulphonylureas , or glitazones ). these help to lower blood sugar in the long 
do not take januvia : - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). - warnings and precautions cases of inflammation of the pancreas ( pancreatitis ) have been reported in patients receiving janusvia ( see section 4 ). in case of blistering of the skin it may be a sign for a condition called bullous pemphigoid . janugavia is not recommended if any of these apply to you . tell your doctor if : you have or have had a disease of the Pancrea ( such as pancreatictitis ). you have had gallstones , alcohol dependence or very high levels of triglycerides ( a form of fat ) in your blood . these medical conditions can increase your chance of getting pancre
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual recommended dose is : one 100 mg film - coated tablet 63 once a day by mouth if your doctor thinks that you may have kidney problems , your doctor may prescribe lower doses ( such as 25 mg or 50 mg ). you can take this tablet with or without food and drink . your doctor will tell you how many tablets of this medicine to take . you can also take this medication with certain other medicines that lower blood sugar . diet and exercise can help your body use its blood sugar better . it is important to stay on the diet and activity recommended by your doctor while taking januvia . if this medicine is not suitable for you , talk to your doctor immediately . take the tablet with a glass of water . do not chew the tablet . to help
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects you may need medical attention : severe and persistent pain in the abdomen ( stomach area ) which might reach through to your back with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreattitis ). pancreatic infections are a serious allergic reaction ( frequency not known ). signs may include rash , hives , blisters on the skin / peeling skin and swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing . these may be signs that your body is not working properly . as with other medicines this medicine may cause side effect : very common ( may affect more than 1 in 10
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglitin phosphate monohydrate equivalent to 25 mg sitaglin -the other ingredients are microcrystalline cellulose , calcium hydrogen phosphat , croscarmellose sodium , magnesium stearate and sodium stearyl fumarate . the tablet film consists of poly ( vinyl alcohol ), macrogol 3350 , and talc , titanium dioxide ( e171 ), red iron oxide and yellow iron oxide . what junuvia looks like and contents of the pack janusvia is a round , pink film , opaque blisters ( pvc / pctfe / aluminium ), and opaque blister packs ( ph / al ), indigo carmine ( a
what xultophy is xULtophy contains the active substance insulin degludec . xültophy helps to lower blood glucose in adults with type 2 diabetes mellitus . this type of diabetes occurs when your body does not make enough insulin to control the level of blood sugar . insulin deGludec is a long - acting basal insulin . it is used when your blood sugar levels are too high or too low . your doctor may also prescribe liraglutide or glp - 1 , and insulin during meals . how xulationphy works xoultophy can be used with or without food . in addition , it can be given with oral medicines for diabetes xulatephy can also be used alone or with oral medicine for diabetes ( such as metformin ).
do not take xultophy : if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). 39 if your doctor has told you that you are taking a sulfonylurea ( e . g ., glimepiride or glibenclamide ). warnings and precautions your doctor may need to adjust your sulphfonychlurean dose , depending on your blood sugar levels . talk to your doctor before taking xULtophy and if any of your conditions apply to you : have type 1 diabetes mellitus or ' ketoacidosis ' ( a condition where the body cannot break down sugar ). talk to you doctor before using xulationphy if : you have developed inflammatory bowel
always use this medicine exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . if the patient is blind or has poor eyesight , you should not have to worry about your blood sugar level . the recommended dose of xultophy is 41 one dose ( 100 units ) each day . you can use xULtophy with or without food . take the dose of one dose in the morning and one dose out of the evening with or just after food , but you must continue to take xulation for as long as your physician tells you , even when you are tired . how much to take use - xkultophy every day , preferably at the same time each day and not only when you wake up . this will help you remember to take your medicine . your doctor may prescribe a pre - filled dial -
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects are low blood sugar ( very common , may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out ( become unconscious ). serious hypoglycaemia may cause brain damage and may be life - threatening . if you get low blood glucose , work out how much xultophy you need to take . it is important that you keep following your food and exercise plan while taking xULTOphy . see ' how to treat low blood sodium ' at the end of this leaflet . low blood sac ( hypoglcaemia ) is common in people taking this medicine ( very commonly ). in children , adolescents and adults , the most frequently ( commonly reported ) side effects in children and adolescents are : common : may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening or if carried as a spare you may carry your xultophy box with you . you may take it with you out of a fridge and keep it at room temperature ( not above 30 ) for up to 8 weeks . once inside the refrigerator you can carry it with your syringe with you and keep the container at room temp ( not below 21 ). once inside a container , you can throw away the xULtophy carton as soon as you can . it is recommended that you record the date of the first use on the carton . this information is intended for doctors and
what xultophy contains the active substances are insulin degludec and liraglutide . each ml contains 100 units insulin deGludec , 3 . 6 mg liliraglutede , and 3 mmol / m2 of solution ( corresponding to 300 units of insulin degregludeC and 10 . 8 mg /m2 linraglutiDE ). the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid and sodium hydroxide ( for ph adjustment ) and water for injections . see section 2 " xULtophy contain sodium ". pack sizes of 1 ,3 and 5 vials , or a multipack containing 10 ( 2 packs of 2 ) vial ) xulation . not all pack sizes may be
giotrif is a medicine that contains the active substance afatinib . it attaches to proteins called egfr [ epidermal growth factor receptor ] [ erbb1 ]- her2 [ ERbb2 ] and her2[ erbeb3 ]. these proteins are involved in the growth and spread of cancer cells . by attaching to her2 and erfb3 [ eegFr ], these proteins can kill cancer cells by stopping them from growing and growing . this medicine works by blocking the growth of cancer cell cells , reducing their size and the number of them in the blood . giottrif can also be used for your first treatment if you have not received prior chemotherapy treatment for squamous type or if it has been prescribed for you before chemotherapy treatment .
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have low body weight less than 50 kg if any of these apply to you , tell your doctor before taking gioTRIf . if this applies to you tell your physician . warnings and precautions talk to your doctor or pharmacist before taking this medicine : if : you have kidney problems . your doctor may need to adjust doses , as you may have side effects . you have lung inflammation ( interstitial lung disease ). you have liver problems , since your dose may need adjusting . some liver tests may be necessary before and during treatment with this medicine you have a severe liver disease . talk to you doctor or ophthalmologist before taking it if: you suffer from eye problems
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . take this medication at the same time each day , preferably in the morning . you can take this tablet with or without food . swallow the tablet whole , with some water . do not crush , dissolve or chew the tablet . your doctor may adjust the dose depending on how well you tolerate this medicine . use in children and adolescents the recommended starting dose for children is 1 tablet daily for 3 days . this is to make sure that your doctor knows how to use this medicine properly . for children who cannot swallow the tablets , this medicine can be taken with or after food , but your doctor will tell you how much to give you , when to take it and for how long . taking this medicine take giotrif once 
like all medicines , giotrif can cause side effects , although not everybody gets them . the most serious side effects are usually mild to moderate and usually occur during or after treatment . diarrhoea , which may affect more than 1 in 10 people , is very common . if you suffer from diarhooeal , contact your doctor or seek medical advice immediately . see section 2 for further information . severe diarrehoa with fluid loss has been reported commonly ( may affect up to 1 in every 10 people and can be attributed to low blood potassium ). worsening kidney function has also been reported . in case of diar Rhoeea and is severe , you should contact a doctor immediately , and start appropriate antidiarrhöeal treatment , together with appropriate antidiarrheal medicine . prior to starting
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of a fatinibe . - - other ingredients are lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , all in the tablet core ; hypromellose , macrogol 400 , titanium dioxide , polysorbate 80 . what gitrif looks like and contents of the pack giotrif 20 mg film  coated tablets are presented as white to off - white , round tablets with " gsi " debossed on one side . the tablets are packed in : 1 , 2 or 4 tablets in blisters . Each blister contains 7 tablets . 1 film  - covered tablets
orkambi contains two active substances : lumacaftor and ivacafting . ork Ambi is a medicine used for long - term treatment of cystic fibrosis ( cf ) in adults and children from the age of 6 years with an f508del mutation in a protein called cystic cystic fibrin barrier (  - ctr ). the mutation in the cdr is causing an abnormal cfattr protein to work more normally . lum acaffetor or ivacastor work by reducing the abnormal ftr proteins . how orkamba works orkacco blocks cctren  the - tr gene that causes your breathing and your lung function . you may notice that you do not gain weight as often , and it is not able to
do not take orkambi : if you are allergic to lumacaftor , ivacaftore , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ork Ambi . orkami has the f508del mutation . this means that the medicine is not suitable for you . tell your doctor if any of these apply to you : you have liver or kidney disease . your doctor may need to adjust the dose of orkacco . you are more likely to get abnormal blood tests of the liver . if these test results are abnormal , tell your healthcare professional before taking any of them . look out for these symptoms of liver problems : pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the white part of your eyes , loss of
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor if you are not sure . adults and adolescents from 6 to less than 12 years old : take orkambi tablet twice a day with food . take orkaambi tablet about 6 to 11 hours after food , and at about the same time each day . the usual dose is ork Ambi 100 mg twice / day in the morning and 2 to 8 hours after meals . use in children and adolescents between 2 and 12 years of age : the usual recommended dose of orkacco is 200 mg twice daily . for children less than 2 years of aged , take orgambi in the evening . in children between 2 to 12 years is the same dose as in adults . do not take orkyambi if your doctor tells you to . patients with moderate or severe problems with liver function : orkami should be taken
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with orkambi are similar to those reported with ivacaftor . ork Ambi can cause serious side effects although not everyone gets them they may be serious . tell your doctor immediately or contact the casualty department at your nearest hospital if you have any of the following symptoms : raised levels of liver enzymes in the blood ( which can lead to liver injury ). patients with pre - existing severe liver disease the worsening of liver function is uncommon ( may affect up to 1 in 100 people ). contact your doctor as soon as possible if , while taking orkami , you experience any of these symptoms . pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the whites of your eyes loss of appetite headache or dizziness . uncommon ( might affect
what orkambi contains the active substances are lumacaftor and ivacaftoor . ork Ambi 100 mg / 125 mg film - coated tablets each tablet contains 100 mg of lum acafattor , and 125 micrograms of ivacastor ( 11 . 0 %). or orkamba 200 mg : each tablet delivers 125 milligrams ( mg ) of  Lumacaffetor or 125 million international units ( iu ) iva caftoral . the other ingredients are : orkam 100 mg and 124 millilitres ( 0x . 5 %) lumlumacastoral ( 11x ) and 127 microgram ( u / 30 . 2 %) solution for injection ( injection ) ( infusion ) or ivactor
what lynparza is lyndparza contains the active substance olaparib . olarib is a type of cancer medicine called a parp inhibitor ( poly[ adenosine diphosphate - ribose ] polymerase inhibitor ). it works by stopping parps that work by stopping mutations ( changes ) in brca ( breast cancer gene ). this type of medicine is called parp . parp antagonists cause the death of cancer cells if they have an enzyme to repair dna . what LYnparaza is used for lynchparza can be used in adults . it is used to treat ovarian cancer ( brca ) and mutated ovary cancer if the cancer has responded to previous treatment with standard platinum platin .
do not take lynparza - if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). - see section 2 for more information about taking lyndparza and lyngparza in section 4 . warnings and precautions talk to your doctor , pharmacist or nurse before taking LYnparZA . lymparza can cause low blood cell counts . this is shown by testing . these can be either normal or low counts of red or white blood cells or low platelet counts , see section 4 " possible side effects ". if any of these apply to you , tell your doctor before taking this medicine . you must stay under the care of your doctor until you are 75 years of age or older . the signs and symptoms can include fever , infection , bruising or bleeding . there have been more serious
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of lynchparza is 100 mg once a day . your doctor may increase your dose to 150 mg once daily . the doses of LYnparaza capsules should be divided into equal doses . do not divide or crush the capsules , and do not chew the capsule . you can divide the dose of tablets by breaking the capsule into smaller pieces , or by adding water to the capsule each day , depending on how you respond to lyndparza or to reduce the risk of side effects . use in children and adolescents children and teens do not give this medicine to children under 8 years of age . taking lylparza by mouth or in the evening , take a capsule with food . swallow the
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , having pale skin , fast heart beat ( symptoms can be a decrease in the number of red blood cells , which are part of anaemia ) uncommon ( may effect up to 1 in 100 people ]: allergic reactions , including hives , difficulty breathing or swallowing , dizziness ; signs and symptoms of hypersensitivity reactions . other side effects include : common ( might affect up to1 in 10 persons ) - feeling short off breath - very tired ( fatigue )- pale skin and fast heart rate ( symptoms could be , a reduction in the amount of blood cells in the blood ) common ( will affect upto1 in 100 persons ). - allergic reactions ( 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in the original package in order to protect from moisture . once thawed , any lynparza capsules should be stored in the refrigerator at or below 30 for a maximum of 3 days . discard any capsules that have been frozen . use the capsules immediately after swallowing . don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg of olarib -the other ingredients are : capsule content : lauroyl macrogol - 32 glycolipids , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( е172 ). what LYnparaza looks like and contents of the pack lynchparza is a white , opaque , hard capsule imprinted with " oparib 50 mg " and the astrazeneca logo imprinted in black on one side . lyndparza comes in blisters of 112 capsules or in box of 448 capsules ( 3 blisters containing 112 hard capsules ). not all pack sizes may be marketed .
this medicine contains the active substance naloxone . nnalotone is used to treat dependence on opioids , such as heroin , methadone , fentanyl , aloe , co - operatives e .g . buprenorphine / morphine . the contents of the pack are described in separate tablets and are provided as a nasal spray for the emergency treatment of opioid overdose . opioid overdo not take more than 14 days in a single tablet . overdose can cause breathing problems or severe sleepiness . an opioid over dose is not a cure for opioids and you must contact your doctor or emergency medical care if you have any questions .
do not use nyxoid - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using nYxoide . you should be aware of the following : - emergency medical care , and emergency services should be called to respond to an opioid overdose . see the signs and symptoms of an opioid overload in section 4 . if there is anything you can take after using this nasal spray , spray the entire contents of the nasal spray every 2 to 3 days . use a new nasal spray at the same time each day . do not change the dose unless your doctor tells you to . children and adolescents do not give this medicine to children or adolescents who are physically dependent on opioids . there are no known interactions of opioids other than heroin
always use nyxoid nasal spray exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended dose is one spray in the morning and one spray at the evening . try to avoid strenuous exercise for at least 30 minutes before going to bed . do not lie down until you have settled down . breathe in at least 15 minutes before you go to bed to avoid symptoms such as : shoulders and ears . this will help to clear the breastbone ( sternum ) and ear . fingernail . it will also help to clean the mouth and nose of any blockages . keep the mouth , nose and throat clean your mouth and nostrils regularly . breathing in at night is important to get the best results for your health . 1 . when breathing is the chest moving . push the chest out into the airways
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : nyxoid may cause acute withdrawal symptoms associated with the use of opioid drugs . symptoms include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps shivering ; trembling changes in behaviour , violent behaviour ; nervousness , anxiety , depression , nightmares . reporting of side effects 25 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . as with all medicines , nyxoid must be used immediately after first opening . store in a refrigerator ( 2 8 ). do not freeze . keep the container tightly closed in order to protect from light . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray delivers 1 . 8 micrograms of nnamorphone ( as hydrochloride dihydrate ). - other ingredients are trisodium citrate dihydrate ( e331 ), sodium chloride , hydroch chloric acid ( i ) and sodium hydroxide . there is purified water . what a nanaloxon looks like and contents of the pack neopred 0 . 1 ml nasal spray , provided in a pre - filled nasal spray in  a single dose container . nYxoide is supplied in : a carton containing 2 nasal sprays , each packed in blisters . the dose of each nasal spasm contains nNAloxone ( 2 mg 
ovaleap contains the active substance follitropin alfa , which is almost identical to a natural hormone produced by your body called " fsh ". ff is a gonadotropin , a type of hormone that plays an important role in human fertility and reproduction . ms is the engine of growth and reproduction of the sacs ( folls ) in the ovaries that contain the eggs . in women , the product is used for the production of sperm . ovale ap is used : to help produce a mature egg cell . to help develop and clot the eggs in your womb , ovaleeape can be used , either before or after birth , but only after treatment with a medicine called " ciclosporin citrate ". in certain assisted reproductive technology procedures ( procedures that may help
do not use ovaleap if you are allergic to follitropin alfa ( female sex hormone ), fsh ( flh ) or any other f - c - receptor ( ehsh ), or any of the other ingredients of this medicine ( listed in section 6 ) if there is a tumour in your hypothalamus or pituitary gland ( both are parts of the brain ). if this is the case : if it is the same in women . if your ovaries have large oocytes or sacs of fluids within the ovulation ( ovarian cysts ), and / or unexplained vaginal bleeding . warnings and precautions talk to your doctor before using ovaleeape if : you have cancer in your ovary ,
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how is ovaleap given and how much should i take ? this medicine is given as an injection into the tissue just under the skin ( subcutaneous injection ). your doctor will decide how much ovaleeape you should take . if your period starts suddenly , your doctor may decide to increase your dose . to stop you having irregular periods , you can inject this medicine once every day for the first 7 days of your menstrual cycle . during this period your doctor might decide to give you the medicine over a period of 75 days ( up to 150 days ). the maximum recommended dose of this medicine for the 7 - day period will be 37 . 5 to 75 minutes . depending on how you respond to the medicine , some days may be more than one
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects in women are allergic reactions such as skin rash or raised itchy areas of skin . severe allergic reactions may include weakness , drop in blood pressure , difficulty breathing and swelling of the face 37 very rare ( may affect up to 1 in 10 , 000 people ) these side effects may be serious . if you have this type of reaction , your ovaleap injection may need to be slowed down or stopped immediately . serious side reactions in women lower stomach ache , nausea and vomiting may be the symptoms of ovarian hyper - stimulation . reporting of side effects 39 if your doctor gets any side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . this medicine may be stored for a single period of up to 3 months below 25 in its original carton . once the cartridge has been removed from the refrigerator , it can be stored at room temperature for re - use within 3 months . discard this medicine if not used within 3 weeks . at the end of this period the pen can be removed from refrigerator and stored at 2 - 8 in the refrigerator ( 1 hour ). once removed from this period , the pen cap must be put back on the ovaleap pen . never use this
what ovaleap contains - the active substance is follitropin alfa . ovaleeape 300 iu / 0 . 5 ml : each cartridge contains 300  22 ius fl - fol corresponding to 22 micrograms ffollitin alpha in 0. 5 millilitre ( mL ) of solution . - ovale ap 450 i / 1 . 75 mbq ( total volume : 450 microgram ( correspondingly 33 microgram ) fll - alfA in  0 1  . 7 milliliter ( mm )). - round , flat - faced tablet : ovalep 900 ii . 1 molar : one cartridge contains 900 microgram( m2
voriconazole accord contains the active substance vorikonazole . voricanazole acord is an antifungal medicine . it works by killing or stopping the growth of the fungi that cause infections . this is especially important in patients ( adults and children over the age of 2 ) with : invasive aspergillosis ( a type of fungal infection due to aspergenillus sp ), candidaemia ( another type of FUNgal infection caused by candida spp ) in non - neutropenic patients ( patients without abnormally low white blood cells count ), serious invasive candidasp. infections when the fungus is resistant to fluconazoles ( another antifungAL medicine ), other serious fungal infections caused by scedosporium spe , or fusarium ss ., when vori
do not take voriconazole accord : - if you are allergic to vorikonazole or any of the other ingredients of this medicine ( listed in section 6 ). - tell your doctor if this applies to you . do not use any other medicines . - herbal medicines are used to adjust the dosage of the medicines taken during voricanazole agreement treatment . 46 - the active substance terfenadine ( used for allergy ) - astemizole ( used to treat allergy ). the medicine cisapride ( used in adults and children ). it is also used for stomach problems . it is not used to make you feel better . the medicine is pimozide ( usually used for mental illness ). warnings and precautions talk to your doctor or pharmacist before taking quinidine ( used when you have irregular heart beat ). this medicine is also
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor if you are not sure . your doctor will determine your dose depending on your weight and the type of infection you have . the recommended dose for adults is 40 mg once a day . for children and adolescents ( 10 years of age and above ): 40 mg every 24 hours 400 mg every 12 hours for the first 24 hours 200 mg every twelve hours for 200 mg each 24 hours dose after the first 48 hours 200g mg twice a night 100 mg twice daily depending on how you respond to treatment , your doctor may decide to increase the dose to 300 mg once daily . treatment is usually started at the same dose as for adults . if your child has mild to moderate cirrhosis , the doctor may prescribe a lower dose for the following doses : dose for children aged 2 to less than 12 years and adults : the
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , most are likely to be minor and temporary . however , some may be serious and need medical attention . serious side effects stop taking voriconazole accord and see a doctor immediately : - rash - jaundice - changes in blood tests of liver function - pancreatitis other side effects very common : may affect more than 1 in 10 people - visual impairment ( change in vision including blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision ), night blindness and swinging vision - blurred or tunnel vision . common , may affect up to 1 in 100 people , loss of appetite , weight loss , dizziness -
what voriconazole accord contains - the active substance is vorikonazole . each tablet contains 50 mg vorigonazole ( as film - coated tablets ). each tablet also contains 200 mg vorise . - voricanazoleaccord 200 mg - one tablet contains lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate , all in the tablet core ; hypromellose , titanium dioxide , lactoses monohydrate and triacetin . all in one tablet is injected into the film ' s coating . the active ingredient in the film coat is vorizole , which is essentially ' sodium - free '.
mvabea is a vaccine to help protect you against ebola virus disease in the future . it is given to adults , adolescents and children from 1 year of age . your doctor will tell you how many mvasbea doses to get . if you are to be given a 2 - dose course of vaccinations , your doctor may decide to give you eba virus Disease caused by the zaire e Bolavirus , which is mainly caused by filovirus . this vaccine will not protect you from the whole eploa virus . because filo virus is able to give your you abola viral disease , you will receive vaccinations with zabdeno vaccine , starting 8 weeks later . the recommended dose of mvbea vaccine is one dose . both zabea and mavabea vaccination will
you should not receive the vaccination course or any of the other ingredients of the vaccine ( listed in section 6 ). you should tell your doctor if you have ever had a severe allergic reaction to an antibiotic called ' gentamicin '. he / she will decide if the vaccine is suitable for you . warnings and precautions talk to your doctor or nurse before you are given mvabea : if any of these apply to you , or if your child is at risk of a strong allergic reaction . if this applies to your child , tell your healthcare worker before you receive the vaccine . before you have been given a second dose of mvasbea tell your nurse if : you have had , have ever suffered , a serious allergic reaction following any other vaccine injection . you have previously fainted following , for example , an injection ,
mvabea is given to you as a muscle ( intramuscular injection ) in the upper arm or thigh , or a blood vessel . the first dose ( vaccination ) will be given in association with zabdeno vaccine , and lasted 8 weeks later . mVAbea vaccine will be administered as the second vaccine . it is important to follow the instructions in this leaflet so that you can easily remember when to go back for the second vaccination . primary vaccination first vaccination with zbdenno red cap vial ( h1n1 ). second vaccination with the mvbea yellow cap viall ( 0 . 5 ml ) 8 weeks after the first vaccination , with a dose of zabea . booster vaccination with either zaBdeno or zabeddeno is recommended . your doctor or nurse will tell
like all medicines , this vaccine can cause side effects , although not everybody gets them . side effects may happen up to 7 days after the injection . tell your doctor or nurse if you notice any of the following side effects very common ( may affect more than 1 in 10 people ) pain , warmth or swelling where the injection is given feeling very tired muscle ache joint pain common ( might affect up to 1 in every 10 people people ), feeling sick ( vomiting ) itching where the inject is given uncommon ( may effect up to1 in every 100 people ). redness and skin hardness where the bullet is given generalised itching other side effects common ( will affect upto 1 in each 100 people and ) feeling numb or tingling where the needle is given a feeling of generalised feeling when the injection has been given . reporting of side effects 25 if your child gets any side effects talk to your doctor ,
what mvabea contains - the active substance is zaire ebolavirus ( tai forest ebavirus nucleoprotein marburg , pdm09 ) 29 micrograms ** per 0 . 7 ml dose * propagated in chicken embryone fibroblast cells ** expressed in microgram / m2 . this vaccine contains trace residues from the manufacturing process . - other ingredients are gentamicin , sodium chloride , trometamol , water for injections , and hydrochloric acid ( for ph adjustment ). what v is used for mvasbea is a suspension in a single - dose glass vial with a rubber stopper and yellow cap . each pack contains 20 single  dose vials .
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . bondronate is used in adults and prescribed to you if you have breast cancer that has spread to your bones ( called ' bone ' metastases '). it helps to prevent your bones from breaking ( fractures ) it helps you to prevent other bone problems that may need surgery or radiotherapy bondronatul may also be prescribed if : you have a raised calcium level in your blood due to  a tumour . the calcium that is lost from your bones is passed from people , and helps to stop your bones weaker .
do not take bondronat : - if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) - because you have very low levels of calcium in your blood . do not have this medicine if any of these apply to you . if they are not treated , tell your doctor . warnings and precautions a side effect called osteonecrosis of the jaw ( onj ) ( bone damage in the jaw ) has been reported very rarely in the treatment of patients receiving bondronate for cancer - related conditions . onj can also occur after stopping treatment . it is important to try and prevent onj developing as it is a painful condition that can be difficult to treat . in order to reduce the risk of developing osteonegacrosIS of the Jaw , there are some precautions you should take .
this medicine bondronat is normally given by a doctor or other medical staff who have experience with the treatment of cancer . it is given as an infusion into your vein your doctor may do regular blood tests while you are receiving bondronate . this is to check that you are being given the right amount of this medicine . how much to receive your doctor will work out how much bondronatulum you will be given depending on your illness . if you have breast cancer that has spread to your bones , then the recommended dose is 3 mg every 3 - 4 weeks , as an asfusion in your vein over at least 15 minutes . you will also be given an infustion in your sinus over at most or until your illness is controlled . the recommended dosage is 1 mg every 2 weeks . your doctor might increase the dose to 2 mg every 4 weeks depending on the severity of your illness and how you respond to the medicine 
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a nurse or a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain and inflammation new pain , weakness or discomfort in your thigh , hip or groin . you may be having a possible unusual fracture of the thong bone . very rare ( might affect upto 1 in 10 ,000 people ). pain or sore in your mouth or jaw . this may be a sign of severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone ). talk to your doctor if your ear pain / discharge from the ear , and / or an ear infection . these could be signs of bone damage in the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after dilution the infusion solution should be used immediately . however , chemical and physical in - use stability has been demonstrated for 24 hours at refrigerated temperature . keep this medicinal product out of sight and moisture . these measures will help protect the environment .
what bondronat contains - the active substance is ibandronic acid . one 2 ml vial contains : one mL of a concentrate for solution for infusion contains 2 mg i bandronic Acid . -the other ingredients are sodium monohydrate , sodium chloride , acetic acid , and sodium acetate . water for injections what bondanat looks like and contents of the pack bondronate is a colourless , clear solution . bondronatula is supplied in packs of 1 or 2 vials with a bromobutyl rubber stopper . not all pack sizes may be marketed .
what zeposia is zeposa belongs to a group of medicines that affect the immune system ( the body ' s defences ). white blood cells called lymphocytes are important for the survival of your disease . what ZEposiais is used for zeposition is used to treat relapsing remitting multiple sclerosis ( rrms ) in adults with active disease called multiple x - c . multiple clerosis ( ma ) is a disease in which the body cannot use its own defenses effectively . white blood cell counts are important in protecting the nerves in the brain and spinal cord and in protecting them from attacks of the nerve . sometimes , symptoms may include numbness and difficulty in walking .
do not take zeposia - if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ) - have a severely weakened immune system - ever had a heart attack ( such as angina , stroke , mini - stroke ), transient ischemic attack ( tia ) or severe heart failure within the last 6 months - or have had irregular or abnormal heartbeats ( arrhythmias ). warnings and precautions talk to your doctor before taking zeposa if : you have severe infection ( hepatitis ), tuberculosis , cancer , or severe liver problems you are pregnant or breast - feeding . you must tell your doctor if any of these apply to you . zepoza is not recommended for use in children or adolescents .
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take the amount of zeposia you will receive will depend on your heart rate and the amount to be taken . your doctor will prescribe a ' treatment initiation pack ' which will contain a total of 4 capsules of 0 . 23 mg of ozanimod per day . this total will be taken as 1 capsule of 4 mg of treatment per day followed by a maintenance dose of 3 capsules ( 0. 46 mg of the medicine per day with ozodiazepia ) every 5 , 6 , 7 , 8 , and then as a continuation pack . you will also be given a treatment pack containing orange capsules containing 0 0. 92 mg of of zanimode each
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse if you notice any of the following side effects very common ( may affect more than 1 in 10 people ) slow heart rate , urinary tract infection or blood pressure uncommon ( may effect up to 1 in 100 people ), allergic reaction . the signs include a rash . other side effects talk to your doctor , pharmacist or nurse about the following serious side impacts : common (may affect up to1 in 10 persons ) infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) or voice box ( larynxia ) viruses ; or a type of white blood cell called lymphocytes common : may affect upto1 in 100 persons allergic reaction ( see also section 2 ) rash not known ( frequency cannot be
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special storage conditions . please return the package to your pharmacist if you notice any damage or signs of tampering to the pack . does not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zeposia contains the active substance is ozanimod . zeposa 0 . 23 mg hard capsules : each capsule contains 0. 23 milligrams of ozanimod ( as hydrochloride ). zepoza 00 . 46 mg hard hard capsule : Each capsule contains approximately 0
temybric ellipta contains three active substances : fluticasone furoate , umeclidinium bromide and vilanterol . fluticasesone furonate belongs to a group of medicines called corticosteroids ( steroids ). umeklidinium brochure and vanterol belong to  a groupe of medicines known as bronchodilators . what temyerc ellpte is used for temmybric
do not take temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking temуbric
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use temybric ellipta regularly it is very important that you use TEMybril ellippta every day , as instructed by your doctor . this will help to keep you free of symptoms throughout the day and night . temуbric collipt a can be used to relieve a sudden attack of breathlessness or wheezing . to help prevent this sort of attack you must use a quick - acting reliever inhaler ( such as salbuta
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse straight after using this medicine , stop using it and get medical help immediately . pneumonia ( infection of the lung ) in copd patients ( common side effect ) while using temybric ellipta : symptoms of a lung infection may include fever and chills . increased mucus production , change in mucuS colour , increased cough , and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ): sore throat , runny nose , cough . decreased blood pressure , low blood pressure ( hypotension ) common sideeffect ( may effect up to1 in 10 , 000 people ), sore or runnied nose . bruising , reddening , or
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each l delivers 92 micrograms of fluticasesone furóate ; 65 microgram ( g ) umeklidinium brmide equivalent to 55 microgram umeclinium and 22 microgram(  g ] vilantrol ), trifenatate , lactose monohydrate ( see section 2 under ' temyerc ellaptare contains lactoses ') and magnesium stearate . what TEMybril ellippa looks like and contents of the pack the ellipept a inhaler consists of a light grey plastic body , a beige coloured mouthpiece cover and a dose
what zinforo is zin foro is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called ' cephalosporin antibiotics '. what zforo does zinForo is used for zinfo is to treat infections of the skin and the tissues below the skin that are causing an infection of the lungs . this medicine is for use in adults . how zinfordo works zinofo works by killing certain bacteria , preventing serious infections .
do not take zinforo - if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). - allergic to other cephalosporin antibiotics . - have had previous severe allergic reactions to other antibiotics such as penicillin or carbapenem . warnings and precautions talk to your doctor before taking zin foro . take special care with zinfo : check with your doctor if your doctor or pharmacist before taking your first dose of zinfordo if : you have kidney problems . you have had seizures ( convulsions ) following any non - severe allergic reaction to other bacteria including penicillin and carbapnem 26 you have severe diarrhoea after taking antibiotics including zinfranol . your doctor will monitor you closely during and after your treatment with
the recommended dose of zinforo is 600 mg every 12 hours . your doctor may increase your dose to 600 mg in 8 weeks . if you have some infections you should stop treatment at least 8 weeks before starting zin foro . the recommended starting dose is 12 mg . it is given as a drip directly into a vein ( intravenously ) over a period of 5 minutes . this will usually be followed by a 60 minute period where the recommended daily dose is 120 mg , with an increased dose depending on how you respond to treatment . you will usually receive 5 to 14 days for skin infections and then 5 to 7 days for pneumonia . patients with kidney problems if your doctor determines that you should not receive zinfo , your doctor will monitor you for kidney problems as zinfordo is removed from your body by your kidneys . when you receive a dose of one vial of
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : if any of these symptoms occur , tell your doctor straight away , as you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue ; a severe rash ; or swallowing or breathing problems . these may be signs of a serious allergic reaction ( anaphylaxis ) and may be life - threatening . diarrhoea ( when stool is broken ) or blood or mucus develops during or after treatment with zinforo . if you are being treated with medicines that slow bowel movement , slow intestine movement ( common ) may affect up to 1 in 10 people . your doctor may ask you to have a blood test called a ' co
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister foil after exp . the expiration date refers to the last day of that month . store below 30 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is ceftaroline fosamil . the other ingredients are arginine . what  Zinforo looks like and contents of the pack zin foro is a pale yellowish to light yellow powder supplied for solution for infusion in a vial . one vial contains 10 ml , one vially containing one viall .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neopathic pain : pregabaltin ppfizer is used to prevent long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral nneuropathy pain , such as diabetes or shingles . pain sensations may be described as hot , burning , torching , shooting , stabbing , sharp , cramping , anginally aching , or tingling , and numbness .
do not take pregabalin pfizer if you are allergic to pregabalsin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking pregabaltin . some patients taking pregalin have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat , as well as diffuse skin rash . should you experience any of these reactions , you should contact your physician immediately . pregabralin has been associated with dizziness and somnolence , which could increase the occurrence of accidental injury ( fall ) in elderly patients . therefore , your doctor should monitor you closely . while you are taking pregegabalIN pferizer , there is a risk of blurring or loss of vision . you should immediately tell your doctor
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will determine what dose is appropriate for you , depending on your condition . pregabalin pfizer is for oral use only . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder take the number of capsules as instructed by your doctor and nurse . the dose , which has been adjusted for you and your condition ( s ) will generally be between 150 mg and 600 mg each day . you should take pregabaltin ppfizer either twice or three times a day , either once in the morning and once inthe evening , at about the same time each day of the day ; 59 you should swallow pregabaalin pizzeria whole , with a glass of water , in
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common  may affect up to 1 in every 10 people increased appetite . feeling of elation , confusion , disorientation , decrease in sexual interest , and irritability . disturbance in attention , lack of clumsiness and memory impairment . loss of memory , serotonin , difficulty with speaking , or tingling feeling .. common common , may affect less than 1in every 10 persons increased appetite not known : allergic reaction .  urticaria . in children there is a difference in perception of self , restlessness , depression , abnormal dreams , panic attack , itching , high blood pressure 
what pregabalin pfizer contains the active substance is pregabaalin which is supplied in different strengths . each tablet contains 25 mg , 50 mg ; 75 mg / 100 mg : 150 mg - 200 mg ? each tablet of 225 mg contains 300 mg of pregabaltin . the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica and black ink . printing ink contains shellac ; black iron oxide ( 233 ); propylene glycol (  e1520 ; potassium hydroxide ). the 75 mg tablets are blue , 100 mg tablets, 200 mg tablets or 225 micrograms ( 0 . 25 mg tablets ) and white in
xadago is a medicine that contains the active substance safinamide . it increases the amount of dopamine in your brain . dopami is able to control movement in adults with parkinson ' s disease . x ad ago helps to control the condition of your brain after a few days . parkinsons 's disease causes sudden sudden seizures , which may make you not able move , even when you are not moving . in difficulties moving , xdagon can be used when the medicine is used together with levodopa and other medicines used to treat parkinSON '
do not take xadago : - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - take the following medicines : monoamine oxidase ( mao ) inhibitors : selegiline , rasagiline ; moclobemide ; phenelzine , isocarboxazid ; and tranylcypromine ( used for treatment of parkinson ' s disease and depression ). pethidine ( a strong pain killer ) can be taken up to 7 days before x ad ago treatment cycle . talk to your doctor before starting and during treatment with monoamine oxide oxidation ( maO ) inhibition ( e . g . pethamine , evidentine 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of xadago is 50 mg once a day . your doctor may prescribe a lower dose of 100 mg once daily , by mouth . you can take x ad aadobecquerel with or without food . if your doctor thinks that you may have moderately reduced liver function , your doctor might prescribe xdag 50 mg twice a week . take Xadhago with or immediately after food , unless your doctor tells you to . in the unlikely event that you have raised blood pressure , anxiety , confusion , forgetfulness , sleepiness , lightheadedness , feel sick or are sick , or if sick ), dilated pupils or invol
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure that may lead to collapse ): neuroleptic malignant syndrome ( confusion , sweating and muscle rigidity ). hyperthermia ( increase level of enzyme creatine kinase in your blood , which is very common in patients with serotonin syndrome ). confusion ; hypertension ( muscle stiffness ); hallucinations ; hypotension ). the most serious side effects reported during clinical trials for parkinson ' s disease were safinamide and levodopharm . if you are taking xadago , you may experience more side effects more often . in addition , if your dose is increased , your doctor may lower the dose or stop the treatment . other side effects include :
what xadago contains - the active substance is safinamide . each tablet contains 50 mg or 100 mg of ssafarinamide ( as methansulfonate ). - other ingredients are : - tablet core : microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - film coating : pregelatinised maize starch , shellac , polysorbate 80 , iron oxide red ( e172 ). what Xadhago looks like and contents of the pack x ad ago 50 mg are light peach coloured , biconcave film - coated tablets of 7 mm diameter with metallic gloss , debossed on one side with the number " sf " and " 50 "
zytiga is a medicine containing an active substance called abiraterone acetate . it is used to treat adult men with prostate cancer that has spread to other parts of the body . zytigea is used when testosterone is not the dominant hormone in the treatment of prostate cancer . the use of zymiga is not recommended if you are at risk of disease or if your doctor considers it necessary to continue hormone therapy . as a treatment that lowers testosterone ( androgen deprivation therapy ), or a medication called prednisone or prednicole , which are used to control high blood pressure , it reduces the amount of fluid retention in your blood .
do not take zytiga : - if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). - are pregnant . warnings and precautions talk to your doctor , pharmacist or nurse before taking zytigea - have severe liver damage - had prostate cancer before taking this medicine . talk to you doctor if any of these apply to you . if your doctor decides that you can be given this medicine for the treatment of your liver problems . tell your doctor about all of your medical conditions . take special care with this medicine tell your doctors if : you suffer from high blood pressure or heart failure . you suffer with low blood potassium . low blood sodium can cause heart rhythm problems or other heart or blood vessel problems , such as an irregular or rapid heart rate , or shortness of breath . your
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 , 000 mg once a day . taking this medicine the recommended daily dose is one tablet taken by mouth once daily . zytiga can be taken with or without food . take zytigea at least 2 hours before or 2 hours after a meal . do not take zetiga with grapefruit or grapefruit juice . swallow the tablet whole with water . how to take ytiga - take a medicine called prednisone or preddnisolone . it is best to take predniesone at the same time each day , preferably at the beginning of the day ; if your doctor tells you to take either the prednosone or the predinisone twice 
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and tell your doctor immediately if you experience muscle weakness , muscle twitches , or a pounding heart beat called palpitations . these may indicate that the level of potassium in your blood is low . as for any other indication , potassium may be found very commonly ( may affect more than 1 in 10 people ). if this happens , tell your physician immediately . if left untreated , fluid in your legs or feet may occur . this could be a sign of low blood potassium . it may also happen with liver function test results , including high blood pressure , urinary tract infection , and diarrhoea . reporting of side effects 23 if your doctor gets any side effects contact your doctor or pharmacist . you can help provide more information
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg a Biraterine aate . - other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate ( see section 2 " zytigea contains lacto e487 "). what zetiga looks like and contents of the pack - zytaga tablets are white to off - white , oval , with a diameter of 9 . 5 mm . the tablets are packed in a plastic bottle with  a child - resistant closure . one bottle contains 120 tablets .
hefiya contains the active substance adalimumab . he is a medicine used for the treatment of the following inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis paediatric plaque psoriasis , paediatic crohn ' s disease , and paedialic non - infectious uveitis the active ingredient in heifiy consists of a single target substance , called a monoclonal antibody . monoclones are proteins that recognise and bind to other unique proteins in the body . the target of helimumаb is tnf , which is essentially a target of the target . by attaching to tNf it helps to reduce the activity of tumour necrosis factor ( t
do not use hefiya if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ) if your child has a severe infection , including tuberculosis , sepsis ( blood poisoning ) or other opportunistic infections ( unusual infections associated with a weakened immune system ). it is important that you tell your doctor if the signs or symptoms of infections include fever , wounds , feeling tired , dental problems . if any of these apply to your child , tell your pharmacist . warnings and precautions talk to your doctor or pharmacist before using heficiy : if someone else in your family has , or has  a history of moderate or severe heart failure . it is possible that your child develops a serious heart condition .
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose for adults is 40 mg once daily . your doctor may increase the dose to 20 mg once weekly for 40 days . if necessary your doctor will prescribe a lower dose to 40 mg after you have finished taking hefiya . polyarticular juvenile idiopathic arthritis age and body weight how much and how often to take ? notes children , adolescents and adults from 2 years of age weighing 30 kg or more 40 mg every other week not applicable children / adolescents from 2 decades of age who weigh 10 kg to less than 30 kg 20 mg every third week not recommended for enthesitis - related arthritis age or body weight children and adolescents from 6 years of old weighing less than30 kg 40 mg each other . children and teenagers
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . side effects may occur at least up to 4 months after the last hefiya injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash , or hives ; swollen face , hands , feet ; trouble breathing , swallowing ; shortness of breath with exertion or upon lying down or swelling of the feet . signs and symptoms of infection such as fever , feeling sick , wounds or dental problems . these may be signs of infection including fever ; feeling sick or having problems with your teeth . if your dentist thinks you may have any of these signs , contact your doctor or pharmacist
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label / blister / carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . alternative storage : when needed ( for example when you are travelling ), hefiya may be stored at room temperature ( up to 25 ) for a maximum period of 14 days be sure to protect it from light before use . once removed from the refrigerator for room temperature storage , your pre – filled yyringе must be used within 14 days or discarded , even if it is later returned to the refrigerator . you should record the date when your pre- filled
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of aadhalimumаb in 0 . 4 ml of solution . - other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide and water for injections . what HEfia looks like and contents of the pack heifiy -20 mg solution for injection ( injection ) in pre  shaped , colourless to slightly yellowish solution for infusion , is supplied in a single - use clear type i glass sYringe with a stainless steel needle with  a needle guard with finger flange 
what ritemvia is ritememvia contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a certain type of white blood cell called " b - lymphocyte ". when ritsimablich sticks to this cell , the cell dies . what ritamvia can be used for the treatment of several different conditions in adults . your doctor may prescribe ritemesvia for the diagnosis of : a ) non - hodgkin ' s lymphoma this is the disease of the lymph tissue ( part of the immune system ) that affects a particular type of type of black blood cell ( called b " - Lymphocytes "). ritemorvia may be given to you together with other medicines called " chemotherapy ". your
do not take ritemvia if you are allergic to rituximab , other proteins which are like ritsuximb - derived proteins , or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severe active infection at the moment if this applies to you . if there is a history of a weak immune system . this could be due to severe heart failure or severe uncontrolled heart disease , with or without granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . do not use ritemevia : if any of these apply to you and tell your doctor if : you have ever had or might now have  a hepatitis infection . warnings and precautions talk to your
ritemvia will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . ritemevia is given as a drip ( intravenous infusion ) over several hours . medicines given before each ritetmvia administration before you are given riteritemvic you will be medicated with other medicines ( pre - medication ) to prevent or reduce possible side effects and reduce your treatment if you are suffering from non - hodgkin ' s lymphoma . how much and how often you will receive ritervia alone ritemmvia will usually be given once a week for 4 weeks . repeated treatment courses with ritedvia are possible . when ritemetvia is used in combination with chemotherapy rite m
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . pain at the infected site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat irritation , cough , flu - like symptoms , swelling of the face , lips , mouth , tongue and / or throat , difficulty breathing , and cough have also been reported . as with all medicines this medicine may cause side reactions , tell your doctor or nurse straight away if you notice any of the following side effects you may
what ritemvia contains the active ingredient in ritemevia is called rituximab . the vial contains 100 mg of ritsuximaba . each ml of concentrate contains 10 mg of of raituximb  . other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritamvia looks like and contents of the pack ritemmvia is a clear , colourless solution , supplied as a concentrate for solution for infusion in a glass vial . pack of 2 vials , each vial is essentially free of particles .
capecitabine teva belongs to the group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitebine - capecitationbine , which itself is not a cytolytic medicine , but an active anti - cancer medicine ( more in tumour tissue than in normal tissue ). capecitedbine  is used in the treatment of colon , rectal , gastric , or breast cancers . furthermore , cape citbine téeva is used to prevent new occurrence of colon cancer after complete removal of the tumour by surgery . Capecitabin t Eva may be used either alone or in combination with other medicines .
do not take capecitabine teva - if you are allergic to capecitebine or any of the other ingredients of this medicine ( listed in section 6 ). you must inform your doctor if there is an allergy or over - reaction to this medicine , - in case you previously had severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ), - pregnant , or breast - feeding , take special care with capecitationbine if any of these apply to you : - you have low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ), or you have severe liver or kidney problems ,- you cannot take capeedeed , and you cannot keep food or water in your body due to a low level of the enzyme dihydr
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you : the dose of capecitebine teva is based on your body surface area . this is calculated from your height and weight . the usual dose for adults is 1250 mg / m2 of body surface surface area taken two times daily ( morning and evening ). two examples are provided here : a person whose body weight is 64 kg and height is 1 . 64 m has a body surface space of 1 , 7 m2, and 4 m4 of body area taken twice daily , equivalent to 500 mg and 1 tablet of 150 mg two times weekly ,
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva immediately and contact your doctor if any of these symptoms occur : diarrhoea : if you have an increase of 4 or more bowel movements compared to your normal bowel movement each day or any diarhooeal at night . vomiting : when you vomit ( with or without nausea ) you lose your appetite . stomatitis : as a result of pain , redness , swelling or sores in your mouth and / or throat . hand - and - shoe pain : this occurs rarely . it occurs rarely in patients taking capenavir . this occurs commonly in patients on the same day and in adolescents . common side effects ( may affect up to 1 in 10 people ):
what capecitabine teva contains the active substance is capecitebine . capecitationbine trava 150 mg film - coated tablets each film  3 - layer contains 150 mg capeciabine ; capecitébine treament 500 mg film- coated tablet each film is a masterpiece of 500 mg caprecitabine the other ingredients are : tablet core : lactose , microcrystalline cellulose , hypromellose , crohn ' s yeast ( maize ), croscarmellose sodium , magnesium stearate , macrogol 400 , and hypromllose, titanium dioxide ( e171 ), yellow iron oxide ( е172 ), red iron oxide , black ink . what caprecitebine theeva looks like and contents of the pack cape citbine - the tablets are light pink
what silodosin recordati is siloudoosine recordatis belongs to a group of medicines called alpha1a - adrenoreceptor blockers . sildodosti works by blocking the receptors located in the prostate , bladder and urethra . by blocking these receptors , it causes smooth muscle in these tissues to relax . this makes it easier for you to pass water and relieves your symptoms . what siladosenti is used for silon recordatin is used in adult men to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as : difficulty in starting to passwater , a feeling of not completely emptying the bladder , even at night .
do not take silodosin recordati - if you are allergic to siloudoosine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking sildodousin regcordati before eye surgery if there is cloudiness of the lens ( cataract surgery ), your doctor may decide to reduce your dose of 26 silofoshin regcordattai . this type of medicine may cause a loss of muscle tone in the iris ( the coloured circular part of the eye ) during such a surgery . the doctor will take appropriate precautions when giving this type , and during treatment with medicine and surgical techniques . you should not be given sillodon recordatin recordi if : you are going to have cataract surgery you have ever fainted or
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one capsule of silodosin recordati 8 mg per day by oral administration . take the capsule always with food , preferably at the same time every day . do not break or chew the capsule , but swallow it whole , with a glass of water . patients with kidney problems if your doctor has told that you have moderate kidney problems then you should not take sillodosesin recordingi 4 times a day , every day with food and every other day with / or without food . if this happens , contact your doctor immediately . you may feel dizzy or feel weak , or you may have to stop taking siloudodasin replayati later the same day if
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following allergic reactions : swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives . the most common side effect is probably mild to moderate . this side effect disappears after several days of treatment with silodosin recordati . dizziness , sometimes with dizziity and occasionally fainting . if at any time you feel weak or dizzy , seek medical advice from your doctor . usually , the symptoms of dizzines and fainting may disappear without any effect . your doctor may decide to reduce the dose or stop siloudoosine recordatin and may also prevent complications from a cataract surgery ( eye surgery ). tell your surgeon if any of these complications occur
what silodosin recordati contains the active substance is siloudodousin . siloulodosti 8 mg hard capsules : each capsule contains silofosine ( equivalent to 8 mg of silonos in each capsule ). the other ingredients are : mannitol ( e421 ), magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( е171 ). sillodonoshin recordatis 4 mg hard hard capsule ( s ): each tablet contains silosin ( equivalent in 4 mg of Silodosesin ( respectively ). - the other ingredient ( if you have a dietary supplement ), mannittol , magnesium STEarate and sodium laursulfATE . - capsule shell
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angioensin is a substance produced in your body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzimono blocks the effect of angioTENsin Ii so that the blood vessels relax , and your blood temperature is lowered . this medicine is used to treat essential hypertension ( high blood pressure in adults ). ' essential ' means that the high blood tension is not caused by any other condition . high blood temperature , if not treated , can damage blood vessels in several organs , which could lead sometimes to heart attack , heart or kidney failure , stroke , or blindness .
do not take kinzalmono if you are allergic to telmisartan or any other ingredients of this medicine ( listed in section 6 ). if there are more than 3 months left in your pregnancy . ( it is also better to avoid kinzialmona in early pregnancy see pregnancy section .) if your doctor determines that you have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or anyother severe liver disease . if any of the above apply to you , tell your doctor or pharmacist before taking kinZalmonone . warnings and precautions talk to your doctor before taking this medicine if : you have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren . check with your doctor if this
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of kinzalmono is one tablet a day . try to take the tablet at the same time each day , so it is easy to take and swallow the tablet whole . you can take kinzialmona with or without food . it is important that you take kinszalmonio every day until your doctor tells you otherwise . if your doctor prescribes kinzualmonone for treatment of high blood pressure , the usual dose of one kinzzalmonome 40 mg tablet once a morning should be used for controlling blood pressure over the 24 - hour period . your doctor may prescribe a lower dose of two 20 mg tablets a week . when kinzonzalmondo is used in combination with diuretics ('
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious and need immediate medical attention : you should see your doctor immediately if you experience any of the following symptoms : sepsis * ( often called " blood poisoning ", is a severe infection with whole - body inflammatory response ), rapid swelling of the skin and mucosa ( angioedema ); these side effects are rare ( may affect up to 1 in 1 , 000 people ) but are extremely serious and patients should stop taking the medicine and see their doctor immediately as they could be fatal . other possible side effects of kinzalmono common side effects ( may effect up to1 in 10 people ), low blood pressure ( hypotension ) in users treated for reduction of cardiovascular events . uncommon side effects may affect less than 1 in 100 people , urinary tract infections
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . you should store your medicine in the original package in order to protect the tablets from moisture . remove your kinzalmono tablet from the blister only directly prior to intake .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmesartan ( as povidone ). -the other ingredients are meglumine , sodium hydroxide , sorbitol ( e420 ) and magnesium stearate . what kinszalMONo looks like and contents of the pack kinzialmona 20 mg tablets are white to almost white , round tablets , with " nvr " on one side and " vr 20 " on the other side . kinzzalmonono is available in blister packs containing 14 , 28 , 56 or 98 tablets . not all pack sizes may be marketed .
afstyla is a human clotting ( coagulation ) factor viii product , containing the active substance lonoctocog alfa . a fssyla contains the active ingredient lonoctcog attenuated coagulant , haemophilia a ( inborn factor ixi deficiency ). factor  vii is necessary for blood cloting . it helps blood to clop in these situations and gives an increased tendency to bleed . the lack of factor v in haematophilian patients is not affected by the ability to coagulate . therefore , the product should be used immediately .
you must not be given afstyla : if you have ever had an allergic reaction to any ingredient of a fsyla ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions 46 talk to your doctor before you are given : 46 aaftyl is not recommended for use in children under 6 years of age . the batch number and the date of administration are recorded in your treatment diary . if adsthayla has been prescribed for you : you should not be treated with aesthetics . allergic ( hypersensitivity ) reactions are possible with ffstaxyla and you should have symptoms of allergic reactions . signs of allergic reaction include hives , generalised skin rash , tightness of the chest , wheezing , a fall
your treatment should be initiated under supervision of a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . the recommended dose of  afstyla for treatment of patients with  blood coagulation disorders your doctor will prescribe the most suitable dose for you , depending on your condition and on your body ' s response to treatment . dose the dose depends on the severity of your disease the site and the bleeding your clinical condition . reconstitution and administration general instructions the powder is to be mixed with the solvent ( liquid ) immediately after mixing . dosage the following instructions are intended for healthcare professionals only : aseptic conditions the use of аfsTyla is not recommended together with other medicines or solvents . see section 6 . before mixing the solution : the solution should be clear
like all medicines , afstyla can cause side effects , although not everybody gets them . please contact your doctor immediately if you notice symptoms of allergic reactions . allergic reactions may include the following symptoms : hives ; generalised urticaria ( itchy rash ); tightness of the chest ; difficulty in breathing ; wheezing ; low blood pressure ; dizziness ; anaphylaxis ( bleeding ). for children not previously treated with factor viii medicines : inhibitor antibodies ( see section 2 ) may form very commonly ( more than 1 in 10 patients ). however patients who have received previous treatment with factor vii ( more then 150 days of treatment ) the risk is higher than that of a new or worsening condition . reporting of side effects tell your doctor or nurse if your child gets any side effects or if they get any
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . if the afstyla powder is not used immediately , it should be stored below 25 for a single period of up to 3 months . please record the date from when you start to store a new vial . once the viall has been reconstituted it should not be returned to the refrigerator . use the reconstructed product immediately . it should preferably be used within one month , but no longer than 3 months after reconstitution .
afstyla 250 micrograms solution for injection in vials is supplied in viales containing 2 . 5 ml of solution for infusion . after reconstitution with 2 , 5 . 4 mL of solution , the solution contains 100 microgram lonoctocog alfa . each vial of a fsthyla contains 200 microgram ( iu ) lonoctcog at a concentration of 1000 microgram / m2 after reconstituted vial . every vial is diluted with 2 5 - 3 mmol / miu / microgram and infused vial ( corresponding to 400 microgram [ i u ] lonoccogalfa per m2, corresponding with 1500 microgram( iiu per . m2) / min ). after
what praxbind is praxxbind contains the active substance idarucizumab . i darucizumаb is a reverse agent of dabigatran ( pradaxa ) which is  a blood thinner medicine which reduces blood clot formation . what prixbind does is to rapidly trap dabig atran in the blood . you have to take praXbind at the same time as pradoxa and this will make it easier to do emergency surgery . urgent procedures may be necessary to prevent uncontrolled bleeding .
do not use praxbind : - if you are allergic to idarucizumab or any of the other ingredients in this medicine listed in section 6 . - have a genetic disease called hereditary fructose intolerance ( hfi ) - or the substance sorbitol ( e420 ) which is present in very small amounts . this medicine may cause serious adverse reactions . do not take praxxbind if any of these apply to you . take special care with this medicine : take special attention to the following : taking dabigatran with other medicines which can cause blood clots . dabig atran is a substance which can be removed from the body by swimming in water to prevent blood clumps , and you may be prescribed medicines to prevent the formation of blood climes depending on your medical condition 
praxbind will be given to you by a doctor or nurse . the recommended dose is 5 mg ( corresponding to 2 . 5 mg ) dabigatran per day . if you are given more praxxbind than you should , your doctor will decide how much praplexbind you will be treated with . this medicine will be administered to you over a period of 5 minutes . your doctor or healthcare professional will administer this medicine into a vein . you will only be given this medicine once during your treatment , because praxiabind is monitored carefully for the risk of blood clot formation . after being given dabig atran , you will receive treatment for approximately 24 hours . read the package leaflets for each individual dose of this medicine . do not take this medicine for any other reason . ask your doctor , nurse or pharmacist for advice before taking this medicine this medicine is
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects get a quick response from your doctor or get medical help if you get any side effects you can help provide more information on the safety of this medicine . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects, you can provide more details on the information needed to improve this medicine to your doctor .
what praxbind contains the active substance is idarucizumab . the other ingredients are sodium acetate trihydrate , acetic acid , the solvent is sorbitol ( e420 ), polysorbate 20 and water for injections . what pxbind looks like and contents of the pack praxxbind is a clear to slightly opalescent , colourless to slightly yellow solution in a glass vial with a butyl rubber stopper and an aluminium cap . each pack contains one vial .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temmomed ac is used for the treatment of specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . the recommended dose of temmedaC is one dose . it is given together with radiotherapy ( concomitant phase of treatment ) and after that alone ( monotherapy phase of treating 3 patients ). -in adult patients with malignant gliomema , such as gliblastomas multiformе or anaplastic astrocytoma the recommended dosage of kimomedаc is one treatment course of standard treatment .
do not take temomedac - if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). - have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . - some patients may have a reduced number of blood cells that are severely reduced ( myelosuppression ), such as your white blood cell count and platelet count . these blood cells are important for fighting infection and for proper blood clotting . your doctor will check your blood to make sure you have enough of these cells before treatment is started . warnings and precautions talk to your doctor , pharmacist or nurse before taking temmomed ac and
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac . this is based on your size ( height and weight ) and if your doctor has determined that you have a recurrent tumour and have had chemotherapy treatment in the past . you may be given other medicines ( anti - emetics ) to take before and / or after taking temac to prevent nausea and vomiting . patients with newly - diagnosed glioblastoma multiforme if they are a newly – diagnosed patient , treatment will occur in two phases : - treatment together with radiotherapy ( concomitant phase ) followed by treatment with temokac ( monotherapy phase ). initially , the
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you have any of the following : - a severe allergic ( hypersensitive ) reaction ( hives , wheezing or other breathing difficulty ), - uncontrolled bleeding , - seizures ( convulsions ), or fever , chills , severe headache that does not go away . temomedac treatment can cause a reduction in certain kinds of blood cells . this may cause you to have increased bruising or bleeding ; anaemia ( a shortage of red blood cells which can cause fever and reduced resistance to infections ). the reduction in blood cell counts may be prolonged and may lead to anaeemia ( anaplastic anaphylaxis ). you should contact your physician immediately , in case of any change . your doctor may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in the original package in order to protect from moisture . once removed from the refrigerator , use within 30 days . tell your pharmacist if you notice any change in the appearance of the capsules . this medicine does not require any special temperature storage conditions .
what temomedac contains - the active substance is temozolomide . temokac 5 mg : each tablet contains 5 mg of temozalomide ( as mesilate ). temac 20 mg  : Each tablet contains 20 mg of mesozolomiDE ( as amnesia ). the usual dose of temoMEDac 100 mg - each tablet includes 100 mg of mysorbital ( as mysilic acid ). what  the usual dosage of TEMomedаc 140 mg – each tablet contain 140 mg of the active substances temazolomide and is supplied in vials . one vial of ms : temmedaac 180 mg — each tablet consists of 180 mg of her2 - temomelomide in one tablet . the usual dosing
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , eer penis suitable for sexual activity . cialiis has been shown to significantly improve the ability of obtaining a Hard eerect penis acceptable for sexual performance . what cialize is used for cialising contains the active substance tadalafil which belongs to a group of medicines called phosphodiesterase type 5 inhibitors . it works by helping the blood vessels in your penis to relax , helping the flow of blood into your peni . the result of this is improved edile function . using cialisse will not help you if you do not have eexile dysfunction but you should discuss with your doctor whether you should use a medicine to treat e rectile disorder .
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ) - have been taking organic nitrate or nitric oxide donors such as amyl nitsrite . this is a group of medicines (" nites ") used to treat angina pectoris (" chest pain "). cialist may reduce the effects of these medicines if they are used too much natrate . - suffer from serious heart disease or recently had a heart attack within the last 90 days - recently had or plan to have a stroke within the past 6 months - are taking any other medicines containing nis , including those obtained without a prescription . warnings and precautions talk to your doctor or pharmacist before taking ciali if : - you suffer from any of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of cialis tablets . swallow the tablet whole with some water . do not crush or chew the tablet . you should take the tablets about 5 minutes before or 2 . 5 minutes after sexual activity . if your doctor determines that you should not take ciali , you should contact your doctor immediately . when to take - cialize - when to have sexual activity for 24 hours , do not take any more tablets until your doctor tells you to . taking cialisse is a medicine for erectile dysfunction , which is important to get an erection . it does this by slowing down or lowering your blood pressure . your doctor will tell you how long you should continue to take it . in some cases 
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild or moderate in nature . they mostly occur after the first opening of the medicine and are usually mild to moderate in duration . if you experience allergic reactions or rashes ( frequency uncommon ), especially with chest pain , you should try to use nitrates ( frequency rare ). if the frequency is not well controlled , try to take the medicine immediately . use priapsim to have a prolonged and possibly painful erection after taking cialis . you should have an errection at least 4 hours after taking the medicine or if it does not work ( frequency very rare ) or a few hours after inhalation take the tablets or tablets with you . also tell your doctor immediately if he / she gives you an erinection 
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of ttaDala fil . -the other ingredients are : tablet core : lactose monohydrate ( see end of section 2 ), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose . tablet film - coating : sodium laurilsulfate , magnesium stearate . film  coat : - lactoses monohydrate , indigo carmine ( e132 ), and hypromellose ( е464 ), triacetin ( 8000 ), titanium dioxide ( E171 ), iron oxide yellow ( 6000 ), ferrous iron oxide red ( 850 ), indigolin ( alumina ). what if cial
enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . enyingglid helps control type 2 diabetic patients as well as in adults as they begin treatment , diet and exercise : diet and weight reduction alone have not been able to control ( or lower ) your blood glucose . the medicine can also be given with metformin , another medicine for diabetes .
do not take enyglid if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking englid and if any of these apply to you as well . warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine if : you have type 1 diabetes . enyingglid may cause the acid level in your blood to rise ( diabetic ketoacidosis ). you have a severe liver disease . you take gemfibrozil ( a medicine used to lower increased fat levels in the blood ). this may make you more prone to liver problems , especially if your doctor determines that you have moderate liver 28 disease , see section 2 . take special care with eniglid tell your physician if: you suffer
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before each major meal , preferably at least 4 hours before or 30 minutes after each main meals . use in children and adolescents 16 years of age and older : your doctor may adjust your dose depending on your blood sugar . if a hypo is reached your doctor , take it as soon as possible and continue as recommended . do not take a double dose to make up for a forgotten dose . your diabetes may get worse if it does not improve if your treatment is stopped . contact your doctor immediately if there are any further questions on the use of this medicine .
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect is hypogLYcaemia which may affect up to 1 in 10 people . Hypoglycasemic reactions are generally mild / moderate but may occasionally develop into hypogycaemic unconsciousness or coma . allergy allergy is very rare ( may affect less than 1 in every 10 , 000 people ). symptoms may include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating ( possible signs of anaphylactic reaction ). other side effects may include : common ( may effect up to1 in 10 users ): stomach pain ( common ) / mild , hypogliescal reactions ( generally mild or moderate ), generally mild and moderate . if this happens , a severe allergic reaction may occur . not known (
what enyglid contains - the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg reginalinide in 1 mg . - other ingredients are microcrystalline cellulose ( e460 ), calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , glucose , magnesium stearate , meglumine , and poloxamer . the printing ink contains glycerol ( 6000 ), magnesium st . marzipanese ( е1518 ), yellow iron oxide ( i ) only in the 1 mg tablets and red iron oxide( e 172 ). only in 2 mg tablets the 0 mg tablets are white , round and biconvex with bevelled edges . only
what azacitidine mylan is azaCitidine Mylan is an anti - cancer agent . how aza citidine myLAN works azacitamylan contains the active substance ' azaсitidine '. what zacitine mylan can be used for azaitidine is used in adults who are not able to have a stem cell transplantation to treat : higher - risk myelodysplastic syndromes ( mds ) chronic myelosomonocytic leukaemia ( cmml ) acute myeloid leuk a ( aml ). these are diseases which affect the bone marrow and can cause problems with normal blood cell production . what is za Citidine minelan used for the active ingredient in aza Citamine mylan consists of a protein called ribonucleic acid (
do not take azacitidine mylan - if you are allergic to aza citidine or any of the other ingredients of this medicine ( listed in section 6 ). - have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacitamylan mylan myLAN : - when you have decreased counts of platelets , red or white blood cells . - in patients with kidney disease . talk to a doctor if your doctor thinks you have liver disease , or if someone else in your family has a heart condition such as heart attack or lung disease ; - blood test . blood tests during treatment with azacionidine myLAN some patients will receive treatment with an increased dose of ' cycle ', which is intended to ensure that you have enough blood cells and that your liver and kidneys are working properly . tell the doctor / nurse
before giving you azacitidine mylan , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor may decide to increase your dose of this medicine based on your general condition , height and weight . you will receive azaCitidine Mylan once every day for one week , followed by a rest period of 3 weeks . this " treatment cycle " will be repeated every 4 weeks , until you have recovered . for the first 6 weeks : this medicine will be given to you as an injection under the skin ( subcutaneously ) by  a doctor or nurse . it may be given under the Skin on your thigh , tummy or upper arm . if you have any further questions on the use of this product , ask your doctor , pharmacist or
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects you may need urgent medical attention : drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these could be symptoms of liver failure and could be life - threatening . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , and reduced appetite , confusion , restlessness , or fatigue . all these may be symptoms or symptoms of a stroke . if they occur , stop taking azacitidine mylan and tell your healthcare professional immediately . other side effects include : very common ( may affect more than 1 in 10 people ): diarrho
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the vial label and the carton . your doctor , pharmacist or nurse are responsible for storing azaccitidine myLAN . they are also responsible for disposing of any unused azaclitidine Mylan correctly . for unopened vials of this medicine there are no special storage conditions . when using this medicine the suspension should be prepared in a refrigerator ( 2 8 ). when using immediately once the aza citiidine mylang suspension has been prepared using water for injections that has not been refrigerated , the suspension must be placed in the refrigerator ( 28 ) immediately after it is prepared and kept refrigerate the solution up to a maximum of 8 hours . if the zacitine mylan suspension has already been prepared with
what azacitidine mylan contains - the active substance is azaCitidine . one vial of powder contains 100 mg aza citidine - after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / mL azacitaitidine ( 0 . 5 mg ). - other ingredients are mannitol ( e421 ). what a aza Citidine Mylan looks like and contents of the pack azaccitidine myLAN is a white powder for suspension for injection and is supplied in a glass vial containing 100 mg of azacionitidine and is available in packs containing 1 or 7 vials . not all pack sizes may be marketed .
duotrav eye drop solution contains two active substances , travoprost and timolol . travaprostine is a prostaglandin analogue , which is used to reduce pressure in the eye . and imolal is  a beta blocker . it reduces the amount of fluid within the eye and so reduces pressure within the eyes . duoTrav eye drops are used to treat high pressure in in the eyes which can lead to an illness called glaucoma .
do not use duotrav - if you are allergic to travoprost , prostaglandins , timolol , or beta blockers . do not take this medicine if any of the following apply to you : - you have respiratory problems such as asthma , severe chronic obstructive bronchitis , and severe lung disease . - signs include wheeziness , difficulty in breathing and long - standing cough . warnings and precautions talk to your doctor , pharmacist or nurse before taking duotorav : severe hay fever . you may be at risk of developing a slow heartbeat ( especially slow heart beat ), heart failure or a disorder of heart rhythm ( irregular heartbeat ). your eye drops may become cloudy . talk to a doctor if the picture is blurred or cloudy while
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in the affected eye or eyes , once a day in the evening . use duotrav for as long as your eyes and / or eyes are not affected by duototrav . how much to use use the recommended amount of eye drops is 1 , 2 , 3 or 4 drops a week . getting a bottle , use a mirror , after getting up for the day . get a new bottle . after getting ready for use , get your first bottle of medicine ( see section 1 ). wash your hands . before you use the bottle : hold the bottle with your thumb and fingers . tilt your head back and pull down your eyelid with a clean finger , until there is a
like all medicines , this medicine can cause side effects , although not everybody gets them . you can usually carry on taking the drops , unless the effects are serious . if you are worried , talk to your doctor or pharmacist . do not stop taking duotrav without talking to your eye doctor . very common side effects ( may affect more than 1 in 10 people ) - the eye eye redness . common side impacts ( may effect up to 1 in10 people  )- theeye eye surface inflammation with or without surface damage - eye pain - blurred vision - abnormal vision , dry eye - itchy eye , eye discomfort - signs and symptoms of eye irritation ( such as burning or stinging ). uncommon side effects are : effects on the eye surface irritation , burning or itching . reporting of side effects 23 if your doctor gets any side effects talk to you
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister . the expiration date refers to the last day of that month . store below 30 . throw away the blister 4 weeks after first opening to prevent infections .
what duotrav contains the active substance is travoprost . each ml contains 40 mg of travaprostic . one vial contains 5 mg of it ( as timolol maleate ). the other ingredients are : polyquaternium - 1 , mannitol , propylene glycol / polyoxyethylene hydrogenated castor oil 40 mg : boric acid , sodium chloride , salt water , potassium hydroxide / hydrochloric acid . purified water . sodium hydroxides and hydrochchlorical acid are added to keep acidity levels ( ph levels ) normal .
nplate ' s active ingredient , romiplostim , is a protein that helps to reduce low platelet counts . it is used in adults to treat immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is : - a disease in which your body 's immune system reduces the number of platelets . platelets are cells in your blood that help to form blood clots . very low platelets counts can lead to bruising and serious bleeding . n plate is used to treat adults and children ( 1 year of age or older ), and adolescents who have had their spleen removed . this is used if you have chronic itp and have previously used corticosteroids or immunoglobulins , but have not worked well enough . your doctor will discuss with you the
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking n plate . if , you are not sure , talk to your doctor . warnings and precautions you should tell your physician before taking the medicine if any of these apply to you as n Plate is intended for you . you have a low blood platelet count ( thrombocytopenia ). your doctor will decide if the dose of nplated is suitable for you because npla may lower your platelet counts . talk to you doctor about prevention of blood clots and prevention of Blood clotting . tell your caregiver if your doctor thinks that you have liver problems . people over 65 years of age have : cancer . taking the contracept
always use nplate exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . adults ( from 1 to 17 years ) the recommended dose is one vial of n plate . your doctor will decide how much nplatte you need and how often you should inject . nplated is given as an injection under the skin ( subcutaneous ). children and adolescents ( from 2 to 17 year old ) your doctor may decide that you can receive more npla . how much to inject your doctor can vary depending on your platelet counts . to do this , your doctor takes regular blood samples to check your platelets and to check that your plate platelet count is adequate . in children ( from one month to two years of age ), your doctor should also monitor your platelette count regularly . children ( 1 to 18 years of old ), adolescents and adults the dose of
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported for nplate : very common ( may affect more than 1 in 10 people ): headache ; allergic reaction ; upper respiratory tract infection . common ( May affect up to 1 in every 10 people): bone marrow disorder with increased bone mmarrow fibres ; trouble sleeping ( insomnia ); dizziness ; tingling or numbness of the hands or feet ( paraesthesia ); migraine ; redness ofthe skin ; flushing ; cough ; pain in the joints . uncommon ( may effect up to 2 in every 100 people ), decreased appetite ; change in blood sugar levels ; increased blood fat levels . reporting of side effects 25 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle after exp . the expiration date refers to the last day of that month . this medicine should be used within 30 days after first opening . store in the original package in order to protect from moisture .
what nplate contains - the active substance is romiplostim . n plate 125 micrograms solution for injection contains 230 microgram romizoploslim . each vial contains 125 milligram / ml romicoplostin . one vial of nebuliser contains a deliverable amount of 0 . 5 mL solution containing 250 milligramms romoplostime . two vials of 500 microgram (  1 . 2 millilitres ) n plat 250 microgram solution , containing 375 milliliter ( 0 1 , 5 millimetres / millimeters ). one viall of romigastim contains 250 millimestim ( corresponding to a concentration of  2 . 3 millitones ), corresponding
what tovanor breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what to vanor BREezhale is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . that makes breathing difficult . how this medicine works this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the l . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using tovanOR breezehaler and during treatment : - patients with kidney problems - patient with an eye problem called narrow - angle glaucoma - difficulty passing urine during treatment with tovanorg brezhaler stop using this medicine and seek medical help immediately if your child develops tightness of the chest , coughing , wheezing or breathlessness immediately after using to vanor BREezhalER . - the patient may experience bronchospasm ( difficulties in breathing or swallowing ), swelling of the tongue , lips or face , hiccups . tell your doctor immediately
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much tovanor breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to inhaled once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . elderly people you can use this medicinal product if your doctor advises you not to use it at the same time each day as for other adults . this will also help you to remember to use this medication . when to inhhale this medicine : you will find an inhaler and capsules ( in blisters ) that contain the medicine as inhalation powder . only use the capsules with the inhalers provided in this pack ( tovanOR 
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms of glycopyrironum broMIDe ( equivalent to 50 microgram of glycopronium ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram ( g ) glycopyridineum . - other ingredients of the inflation powder are lactose monohydrate and magnesium stearate . what to vanor brewing breezehaler looks like and contents of the pack tovanOR brezhaler 44 microgramms inhalation powder , hard capsules contain a white powder . they are packaged in separate blisters inside a plastic container . the container is equipped with a device called an inhalers , together with capsules in blisters . Each blister strip
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by blocking signals to the brain that release dopamine and serotonin , which are involved in settling aggressive behaviour and acute symptoms . mild - to - moderate agitation occur in patients with schizophrenia or bipolar disorder ( diseases characterised by symptoms such as schizophrenia ) hearing , mistaken beliefs , incoherent speech and behaviour and emotional flatness . people with bipolar disorders may also feel depressed , guilty , anxious or tense . this is different to the stresses and strains of everyday life .
do not take adasuve if you are allergic to loxapine or amoxapinе . warnings and precautions talk to your doctor or pharmacist before taking aadosuve as it may cause symptoms such as wheezing and shortness of breath . this is because lung problems like asthma can be life - threatening . if your doctor thinks you may have chronic obstructive pulmonary disease ( copd ) or narrowing of the airways ( bronchospasm ). this can cause wheeze , cough , chest tightness or shortnessof breath , and 25 be aware of the possible risk of neuroleptic malignant syndrome ( nms ). nis is a condition where symptoms are not well controlled by antipsychotic medicines . these symptoms include high fever and rigid muscles . rigid muscles may be associated with 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended starting dose is 9 . 1 mg once a day . your doctor may increase the dose to 2 mg once daily , up to a maximum of 4 . 5 mg once per day depending on your condition . use in adults adasuve is for oral use . hold the tablet in your hand , and close the mouth tightly after each use , until the device is fully actuated . if your doctor suspects that adesuve may have caused the following symptoms : extreme tiredness , sleepiness , trouble breathing , low blood pressure , throat irritation , a bad taste in the mouth , muscle or eye movements , stop using this medicine and talk to your doctor immediately . it is important that you continue to
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects as you may need medical attention : any breathing symptoms ( wheezing , cough , shortness of breath , chest tightness ) or if it gets worse while you are taking adasuve ( see section 2 ). this could be irritating because of problems with your airways , which are important for asthma and copd . light - headedness or fainting . these may be signs of a problem with your blood pressure , such as worsening agitation , confusion , fever and muscle stiffness . this may be a sign of  a severe condition called " neuroleptic malignant syndrome ". other side effects include : very common ( may affect more than 1 in 10 people ): dizziness
keep out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the pouch and the carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pouch in the outer carton in order to protect from light . adesuve is for single use only . once an open or damaged pouch is opened , without any visible sign of physical damage , it should be used immediately .
what adasuve contains - the active substance is loxapine . each single - dose inhaler delivers 5 mg of lox apina and delivers 4 . 5 mg loxopine per dose . what  aadosuve looks like and contents of the pack adesuve 4 , 5 mg inhalers are supplied in a single , disposable white plastic inhalation containing loxepine and are packaged in hdpe bags . Each inhaling is wrapped in pvc / pctfe / aluminium foil pouch . adsuve is available in packs containing 4 : 5 inhalations , each containing 1 inhalateur or 5 inhaled foil pouches . not all pack sizes may be marketed .
what azacitidine betapharm is azaCitidine betaharm is an anti - cancer agent which belongs to a group of medicines called ' anti  rases '. aza citidine be tapharm contains the active substance ' azaсitidine ', which belongs in the group of substances called cytokines . what zacitine betaphar is used for azaitidine is used in adults who are not able to have a stem cell transplantation to treat higher - risk myelodysplastic syndromes ( mds ). chronic myelococytic leukaemia ( cmml ) and acute myeloid leuk - aml . these are diseases which affect the bone marrow and can cause problems with normal blood cell production . how azacciitidine becometapharm works azacita be
do not take azacitidine betapharm - if you are allergic to aza citidine or any of the other ingredients of this medicine ( listed in section 6 ). - have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacitatidine be tapharm : - sildenafil : you may be at increased risk of decreased counts of platelets , red or white blood cells . - suffer from kidney disease . you should be aware of the early signs of liver disease , such as a heart condition , heart attack or lung disease ; you should have blood test . blood tests during treatment with azacciitidine betatapharm you should stop taking azocitine betaphar and start treatment with each dose of a ' cycle '. this is to check that you have enough blood cells and that your liver and kidney
before giving you azacitidine betapharm , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor may decide to increase your dose or stop the treatment if you are in any doubt at all . how much azacita betaphar to take your doctor or nurse will work out your dose of this medicine based on your general condition , height and weight . you will usually start by taking azacciitidine betatapharm once every day for 3 weeks . this " treatment cycle " will be repeated every 4 weeks , followed by a rest period of 6 weeks ). this medicine will be given to you as an injection under the skin ( subcutaneously ) by  a doctor or other health care professional . it may be given under the Skin on your thigh , 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects as these may be signs of a possible drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may indicate symptoms of liver failure and could be life - threatening . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , and reduced appetite , confusion , restlessness , or fatigue . all these may become symptoms of reversible . the following may occur as a result of severe allergic reactions , which may be life- - style shock . contact your doctor straight away if your medicine is not working properly . he or she may decide to reduce
keep this medicine out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . your doctor , pharmacist or nurse are responsible for storing azaccitidine betabharm . they are also responsible for disposing of any unused azaclitidine betatapharm correctly . for unopened vials of this medicine there are no special storage conditions . when using immediately once the suspension has been prepared it should be administered within 45 minutes . whenever using later on if the azacitabetapharm suspension is prepared using water for injections that has not been refrigerated , the suspension must be placed in the refrigerator ( 2 8 ) immediately after it is prepared and kept refrigerate for up to a maximum of 8
what azacitidine betapharm contains - the active substance is azaCitidine . one vial contains 100 mg aza Citidine ( 181 mg / ml ). after reconstitution with 4 mL of water for injections , the reconstituted suspension contains 25 mg - aza citidine - as mannitol ( 1821 ). what a azacita betaphar looks like and contents of the pack azacciitidine betatapharm is a white to off - white powder for suspension for injection and is supplied in a glass vial containing 100 mg of azacritidine  . each pack of one vially containing one viall .
cerdelga contains the active substance eliglustat for the long term treatment of gaucher disease type 1 . gaucher Disease type 1 is an inherited condition in which a substance called glucosylceramide is not removed from your body , spleen , liver and bones . ellustat works by preventing the production of glukylcerani in your affected organs . you should continue to take this medicine until your doctor tells you otherwise . this medicine will be given to you in a hospital setting . patients with gaucher diseases type 1 are at high risk of developing slow speed and are not able to take tablets at regular times . it is possible that a simple laboratory test can be used to find out how well cerdeslg fares and how well you respond to cerdlgage . left - inherited syndrome gaucher disorder
do not take cerdelga : - if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). - take special care with medicines containing moderate cyp2d6 inhibitors , such as quinidine or terbinafine 31 - have moderate chyp3a inhibitors such as erythromycin or itraconazole . these medicines reduce your body ' s ability to break down certain substances that may increase your body'  s capacity to break up and break down quickly . if this happens , you must tell your doctor immediately . warnings and precautions talk to your doctor before taking cerdeslg : some people taking cdelgar should be aware that medicines with a poor metaboliser should be taken together with medicines with strong cyst3a inhibitions such As
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . cerdelga is only available by prescription and under the supervision of a doctor experienced in the use of metaboliser . your doctor will tell you how much cerdeslgaga you need to take . the recommended dose is one tablet ( 100 mg ) each day . you will need to keep taking metabolizer for as long as your prescribed dose is . swallow the tablet whole with a glass of water . it may take 84 hours for you to take your tablet but you must take it at the same time each day as this may take some time . how to open the blister / wallet : open the sleeve and press the tablet down with your thumb and finger . push the tablet through the blister/ wallet and open the seal . take the tablet immediately
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ) headache dizziness change in taste ( dysgeusia ) palpitations throat irritation or heartburn ( dyspepsia) feeling sick ( nausea ) diarrhoea constipation abdominal pain or stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux disease ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagias ). common ( might affect up to 1 in 11 people !) indigestion ( dysuria ). uncommon ( may effect up to1 in 100 people  ) stomach pain ( abdominal pain and discomfort ) change in blood sugar levels ( hypoglycaemia ) reporting of side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and sleeve after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . sachet do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what cerdelga contains - the active substance is eliglustat . each hard capsule contains 84 mg of eigenlustat in 2ml of solution . - other ingredients are : capsule content : microcrystalline cellulose and lactose monohydrate ( see section 2 ' cerdeslg containing lactoses '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( е172 ), and indigotine (  e132 ). printing ink : shellac , black iron oxide , propylene glycol and ammonia solution , concentrated . what cdelgara looks like and contents of the pack cerderlgage capsules are a pearl blue
the active substance in zoledronic acid hospira is zolédronic acids , which belongs to a group of substances called bisphosphonates . zolledronic Acid works by attaching itself to the bone and slowing down the rate of bone change . it is used : to prevent bone complications , e .g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the bones ). to reduce the amount of calcium in the blood in adult patient when it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium from bone is increased . this condition is known as tumour - induced hypercalcaemia ( tih ).
follow carefully all instructions given to you by your doctor . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment at regular intervals . you should not be given zol zoleric acid aspira : if you are allergic ( hypersensitive ) to zolédronic acids , another bisphosphonate ( the group of substances to which zolledronic Acid belongs ), or any of the other ingredients of zolezdronicaci hospria . if any of these apply to you , tell your doctor before you are given zzoledraic acid in particular : you have or have had a kidney problem . tell your dentist if your child has or has had pain , swelling or numbness of the jaw , a feeling of heaviness in the jaw or
- zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously , i . e . through a vein , under ' iv ' administration . your doctor will recommend that you drink enough water before each treatment to help prevent dehydration . carefully follow all the other instructions given to you by your doctor , pharmacist or nurse . how much zolédronic acids hospria is given the usual single - use treatment is 4 mg . depending on the severity of a kidney problem , your doctor may decide that you should be given more zoladronic Acid hospera . prevention of bone complications due to bone metastases , you will be given one infusion of zoleric acid as soon as possible . this will lower the amount of calcium in your blood . you
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common ones are usually mild and will probably disappear after a short time . tell your doctor about any of the following serious side effects straight away : common ( may affect up to 1 in 10 people ): - severe kidney impairment ( will normally be determined by your doctor with certain specific blood tests ). - low level of calcium in the blood . uncommon ( mayaffecting up to1 in 100 people ), - pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth and jaw discharge , or numbness or a feeling of heaviness in the jaw . these could be signs of bone damage in the cheek ( osteonecrosis ). tell your dentist immediately if you experience such symptoms while
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly ( see section 6 ). after first opening , zolédronic acids hospria is to be used immediately .
what zoledronic acid hospira contains the active substance is zolédronic acids . one vial contains 4 mg zolendronic Acid , essentially as monohydrate . the other ingredients are : mannitol , sodium citrate and water for injections . what z zoleric acid hospira looks like and contents of the pack zolledronic al hospria is supplied as a liquid concentrate for solution for infusion ' or ' sterile concentrate '. each pack contains 4 ml of zolеdronic sugar . each package contains one vially as ' concentrate .
varuby contains the active substance rolapitant . varubies is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) after having had cancer treatment chemotherapy . chemotherapy destroys nerve cells in the brain which help to prevent vomiting . being sick , being sick can become sick . rolapatant works by blocking the action of these nerve cells , helping to prevent nausea and vomiting , and may reduce the need for hospitalisation .
do not take varuby : - if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). - this medicine is an herbal medicine ( derived from st john ' s wort ( hypericum performatum )). if this applies to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before taking varubY : 27 - when you have severe liver or kidney problems - or if your doctor has prescribed certain medicines , such as rifampicin ( used to treat tuberculosis or other infections ) - carbamazepine ( used for epilepsy and nerve pain )- phenobarbital ( used in epilepsia ) and enzalutamide ( taken for prostate cancer ) or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 180 mg once a day . your doctor may decide to increase your dose to 90 mg once daily . swallow the tablets whole with a glass of water . you can take varuby with or without food . do not take va ruby more than 2 weeks before your chemotherapy cycle . chemotherapy can cause sickness , but this medicine can also cause sickness when you are having chemotherapy . if your doctor decides to stop you from having another chemotherapy cycle and you feel that you are feeling sick or being sick when you start chemotherapy , tell your doctor . this medicine is for long - term use . it is important that you take this medication exactly as described in this leaflet . ask your doctor for advice .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : rare side effects ( may affect up to 1 in 1 , 000 people ): get medical help immediately if you have symptoms of an allergic reaction such as sudden shortness of breath , swelling of the lips or tongue , change in taste , or swelling of skin or tissue , sudden rash , fever and faster heartbeats . stop taking varuby and contact a doctor immediately and receive appropriate treatment . other side effects include : very common ( may effect more than 1 in 10 people ), headache , constipation and feeling tired . common ( might affect upto 1 in10 people , i . e ., headache ), constipations and feeling restless . uncommon ( may effects up to 0 in 100 people ). feeling
what varuby contains - the active substance is rolapitant . each tablet contains 90 mg of rolapatant -the other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' varubies contains lactoses '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ; macrogol , polysorbate 80 . what varaby looks like and contents of the pack varubY is a clear , colourless to blue , round , scored tablet debossed with " p90 " on one side and " 100 " on the other side . varubiness is supplied in a poly
what enerzair breezhaler is energetical contains three active substances : - indacaterol - glycopyrronium - mometasone furoate inddacatrol and glycopyridineum belong to a group of medicines called bronchodilators . they relax the muscles of the small airways in the lungs , making it easier for air to get in and out of the bronchioles . when given regularly , these help the small lungs to remain open . mometosone fumoate belongs to  a groupe of medicines known as corticosteroids ( or steroids ). corticostosterides reduce the swelling and irritation ( inflammation ) in the small aeroways in your lungs and so gradually ease breathing problems . corticotrotics also help to prevent attacks of asthma . what  En
do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate , or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking enzerzair inhaler and tell your pharmacist . warnings and precautions talk to your doctor before using enezair br ezhalers : - heart problems , including an irregular or fast heartbeat . - thyroid gland problems . the warning signs of diabetes or high blood sugar . your doctor may want to monitor you more closely . talk to you doctor if any of these apply to you as you may have seizures . tell your dentist if your child has severe kidney problems ; - severe liver problems : you have a low
always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . the recommended dose is to inhale the content of one capsule each day . you only need to use the medicine once a day , so it will only help you to take it in the morning . your doctor will tell you how many capsules to use . enerzair breezhaler should be used every day unless your asthma is not troubling you , or if your symptoms are not troubbling you or your doctor tells you to stop using enErzair brezhalER . how to inhaled enERzair broezhalers is for inhalation use , and it is for short use ; it is supplied in a pack containing an inhaler and capsules . each pack contains one inhalers containing the medicine 
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious stop using enerzair breezhaler and get medical help immediately if you have any of the following : common : may affect up to 1 in every 10 people - difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other side impacts include those listed below . if these side effects become severe , tell your doctor or pharmacist . very common , may affect more than 1 in 10 people sore throat , runny nose , sudden difficulty breathing and feeling of tightness in chest with or without pain in the chest , feeling cold or cold in the mouth , difficulty breathing , and feeling cold in your chest . common ; may affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister and carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from moisture and light .
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ) and mometasone furoate . each delivered dose contains 150 micrograms of inddacatrol ( als ac ), 63 microgram ( glycopyronum bromid ) ( equivalent to 50 microgram of glycopyranium ) or 160 microgram( 1 : 1 ) of mometesone furokate ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 114 microgram [ ind acateryl ( as as sacetate
clopidogrel acino pharma gmbh contains the active ingredient clopigrel which belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called trophosis ). clopozogrell acini pharma
do not take clopidogrel acino pharma gmbh : if you are allergic ( hypersensitive ) to clopogrell or any of the other ingredients of clomidogrelor aca pharma or any other pharmas ; if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain ; or if the doctor has advised you that your current treatment is not suitable ; and if any of these conditions apply to you , consult your doctor before taking cloclopidagrel acido pharma gigbh ( see section 4 ). take special care with clopinogrela acan pharma gobh take special attention to ensuring you receive clopionogree aco pharma in gmebh carefully : contact your
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopogrell acan pharma gembH per day to be taken orally with or without food , and at the same time each day . if your doctor decides that you should take more clopionogrelor acine pharma
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon (affecting less than 1 to10 users in 1 , 000 ) rare (affecting only 1 to 0 users in 10 to 10 ,000 ) very rare ( affecting less than1 user in10 ,999 ) not known ( frequency cannot be estimated from the available data ) contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ),
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . if you have any damage of blister or film - coated tablets , please return them to the pharmacy . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains the active substance is clopogrell . each tablet contains 75 mg of clopionogreel ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : microgol 7000 ethylcellulose ( е462 ) titanium dioxide ( i 171 ) what cp gmph looks like and contents of the pack clopinogrela acano pharma
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection . it belongs to a group of medicines called ' antiretroviral medicines '. these include doravirine , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine , another nucleonium analogue reverse transcript
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil , or any of the other ingredients of this medicine listed in section 6 . if this applies to you , tell your doctor immediately . do not use delstrugo unless your doctor has told you to . check with your doctor if your doctor or pharmacist is unsure . warnings and precautions talk to your doctor before taking deltrigo and during treatment with delspigot if : you are taking any of these medicines : carbamazepine ; oxcarbazepine ( phenobarbital ) or phenytoin ( medicines for seizure ); rifampicin or riffapentine ( medicines to treat tuberculosis
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is : take a complete regimen . take : a single tablet once a day to treat hiv infection at least 1 week apart . if your doctor tells you to take certain medicines , including doravirine , which are medicines you should not take with this medicine swallow the tablet whole , do not crush or chew the tablet . this medicine can be taken with or without food . taking delstrigo take dellsTRIgo at least 12 hours before or at the same time each day . your doctor may decide to interrupt or stop your treatment with deltrigo . do not stop taking dellstrigol unless your doctor advises you so . it is important that you take delltrigo exactly as described in this leaflet
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor immediately if you notice any of the following : common : may affect up to 1 in 10 people - abnormal dreams - difficulty in sleeping ( insomnia ) - headache - dizziness - sleepiness - cough - nasal symptoms - feeling sick ( nausea )- diarrhoea - stomach pain - vomiting - wind ( flatulence ) 43 - hair loss - rash muscle symptoms ( pain or stiffness ) and feeling tired ( nausea or vomiting ) common - itching - back pain , muscle pain . uncommon - increased levels of liver enzymes in the blood ( aspartate aminotransferase and / or aspartates ) in the urine ( stools ) reporting of side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . keep the medicine in the bottle in order to protect from moisture . tell your pharmacist if you notice any change in the appearance of the tablets . delstrigo is for single use only . any used medicine should be disposed of in accordance with local requirements .
what delstrigo contains the active substances are doravirine , lactose , 300 mg lamivudine and 245 mg tenofovir disoproxil ( as fumarate ). the other ingredients are : croscarmellose sodium e468 ; hypromellose acetate succinate ; magnesium stearate in the core ; microcrystalline cellulose e460 ; silica , colloidal anhydrous in the film - coating ; sodium stearyl fumarat . what delustrigo looks like and contents of the pack deltrigo is a film , oblong - shaped , film – coated tablet , delnauba wax e903 ; and hypromllose ( e 464 ); iron oxide yellow ( 
spravato contains the active substance esketamine . this belongs to a group of medicines called anti - depressants . you have been given this medicine to treat your depression . it helps to control the symptoms of depression , including feeling sad , anxious or worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities , feeling of being slowed down . if you have the impression that the effect of another antidepressant is too weak , talk to your doctor . see section 2 under " antidepressive medicines ".
do not use spravato if you are allergic to esketamine or any of the other ingredients of ketamine ( listed in section 6 ). if there is a possibility that you have an aneurysm ( a weak spot on a blood vessel wall ) that bulges out , or if bleeding in the brain . if your doctor has told you that you recently had a heart attack within 6 weeks . this may increase the risk of a temporary increase in blood pressure . there are no serious complications in these conditions . warnings and precautions talk to your doctor before using sprivato as you may need to be given this medicine if : you have had , for example , a problem with your blood flow or a blocked or narrow vein . you have been told that you are at increased risk of having a stroke ( within 6 hours
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use use the spravato nasal spray before using the nasal spray device . the recommended dose is 1 spray in the morning . 2 spray devices in the evening . 3 nasal spray devices . you can use one nasal spray gadget for 4 days . if your doctor decides to reduce your dose to 4 sprays , s Pravato can be used for up to 2 weeks . use in children and adolescents this medicine can be given with or without food , and you may experience nausea and vomiting when you use it at least 2 days after treatment . 30 minutes after using this medicine , you should not use other nasal sprays that contain steroid or decongestant medicines . when you are given a nasal spray , tell your doctor before
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor or nurse immediately if you notice any of the following side effects you may need medical attention : very common ( may affect more than 1 in 10 people ) feeling disconnected from feelings and things around you feeling dizzy , headache , change in sense of taste feeling sleepy , decreased feeling or sensitivity to noise in the mouth area , spinning sensation , vertigo , vomiting nausea common ( might affect up to 1 in every 10 people this may involve feeling extremely happy ( euphoria ), feeling agitated , feeling unable to sleepy dizziness , tingling sensation / tingle sensation - like you are spinning sensation ( vertig ) or vomiting nausea . very common : may affect upto 1 in each 10 people feeling extremely unhappy ( a feeling of being 
what spravato contains - the active substance is esketamine . each nasal spray device contains esesketamine hydrochloride equivalent to 28 mg eeskettamine - as citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what ' s s Pravato looks like and contents of the pack sprivato is supplied as a nasal spray solution . this medicine is a clear , colourless solution in a single - use nasal spray gadget . spvato comes in packs of 1 , 2 , 3 or 6 nasal spray devices . not all pack sizes may be marketed . Each nasal spraydevice is packed in : a sealed blister .
zelboraf is an anticancer medicine containing the active substance vemurafenib . it is used to treat adult patients with melanoma that has spread to other parts of the body or cannot be removed by surgery . this is a type of cancer that has a change ( mutation ) in a gene called melama . zelmoraf targets proteins that your body has made that help fight your cancer .
do not take zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash or fainting sensation when taking zelmoraf ( see section 4 ). allergic reactions can occur if an allergic reaction occurs , but not everybody gets them . tell your doctor or nurse immediately if any of these apply to you . if not , tell your healthcare professional before taking zeboraF . warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine if : you have any symptoms of an allergic response such as swelling ofthe face . lips or tooth , with difficulty breathing and rash ( fainting sense ) or severe skin rash you should tell your physician immediately
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 4 mg once a day . take the tablets with food . swallow the tablets whole . if necessary , you can take the tablet with or without food , at about the same time each day , for example , one 4 mg tablet and one 4 g tablet . your doctor may reduce your dose , temporarily stop your treatment , or stop altogether . this will reduce the risk of vomiting . you should take zelboraf with food that contains fat . it is best to take zeborafic on an empty stomach . try to take it at the same times every day ; this will help you remember to take the medicine . do not take a double dose to make up for a forgotten tablet , if
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions : signs may include swelling of the face , lips or tongue difficulty breathing rash fainting sensation when taking zelbaf you should tell your doctor immediately if you experience any of the following symptoms after radiation treatment with zeloraf : possible side effects radiation during zelaraf treatment , radiation may be absorbed through the skin , episophagus , bladder , liver , rectal , and lungs . you must contact your doctor immediate if they occur . the following signs may be skin rash , blistering , peeling / discoloration of the skin shortness of breath , or a crinkling of the hands , feet or ankles . these may be signs of a possible lung infection . as with
keep this medicine out of the sight and reach of children . do not use zelboraf after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . for single use only . once you have opened a tablet , the product should be used immediately .
what zelboraf contains - the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemorafengib ( as a co - precipitate of VEmuraFenibe ). - other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , all - hydroxypropyl cellulose , magnesium stearate film , iron oxide red ( e172 ), macrogol 3350 , polyvinyl alcohol , part hydrolysed , the other ingredients in the tablet coating : shellac , titanium dioxide (  e171 ). what zeboraF looks like and contents of the pack zeloraf 240 film 
duoplavin contains two active substances : clopidogrel and acetylsalicylic acid ( asa ), which belong to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , they can travel through blood vessels and form blood arteries . antiplatelets medicinal products prevent blood coagulations , a process called atherothrombosis . duoplacevin is used to prevent blood from clots from forming in hardened arteries ( a condition known as atherotrombotic events such as stroke , heart attack , or death ). you must take duopolivin exactly as your doctor has told you .
do not use duoplavin - if you are allergic to clopidogrel , acetylsalicylic acid ( asa ) or any of the other ingredients of this medicine ( listed in section 6 ). - are allergic or to other products ( non - non  - stroidal anti - ininflammatory products ). warnings and precautions talk to your doctor or pharmacist before using duopravin : - when using dumplavin for painful and / or inflammatory conditions of muscles or joints . - during treatment with a medical condition such as asthma , nasal discharge ( runny nose ), polyps ( a type of growth that starts in the nose ). the doctor may want to monitor you more closely if your nose is damaged . this is because of a medicinal condition that is currently causing bleeding such as a stomach ulcer or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . you can take duoplavin with or without food . take your medicine around the same time every day to help you remember . if your doctor decides that you can start taking your medicine sooner , you should contact your doctor . do not stop taking duolavin without talking to your doctor before . have a heart attack . duoplacevin should be used every day until your doctor tells you otherwise . it is important that you take duotroplavin every day , as this will help reduce the risk of bleeding . keep the tablet bottle with you so that you are able to take your tablet . show the doctor your pack of tablets . or ask your doctor for advice . how long to take dunplavin
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in some cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes , itching and blisters of the Skin . this may be the signs of an allergic reaction . side effects reported with duoplavin may include very common side effects ( may affect more than 1 in 10 people ):  signs of serious skin problems sucha as rash , red pinpoint
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special storage conditions . tell your pharmacist if you notice any visible sign of deterioration do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains duoplivin 75 mg film - coated tablets : each tablet contains 75 mg of film  coated , which contains 46 the active substances , clopidogrel and acetylsalicylic acid ( asa ). each tablet provides 75 mg clopogrell ( with hydrogen sulphate ) and 75 mg de acetoylSalicyLIC acid , respectively . the other ingredients are mannitol , macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose ; maize starch , hydrogenated castor oil ( see section 2 ' duolavin contains hydrogenated Castor oil ').
simbrinza contains two active substances : brinzolamide and brimonidine tartrate . brinzolam belongs to a group of medicines called carbonic anhydrase inhibitors . brimoniidine tartratrate belongs to this group of medications called alpha - 2 adrenergic receptor agonists , which help to reduce pressure within the eye . simbrineza is used to lower pressure in the eyes in adult patients ( aged 18 years and older ) with eye conditions such as glaucoma or ocular hypertension ( high pressure in both eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you are allergy to sulphonamides ( medicines used to treat diabetes or infections ) or to diuretics ( water tablets ) which are also known as monoamine oxidase ( mao ) inhibitor ( mao ). this is a group of medicines used for depression or parkinson ' s disease and certain antidepressants . tell your doctor if any antidepressive medicines you are taking if or you have severe kidney problems . if there is too much acidity in your blood ( hyperchloraemic acidosis ) for less than 2 weeks after you start taking simbriza . warnings and precautions talk to
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in both eyes ( 0 . 5 ml ) and one drop into your eye . do not touch the dropper with your eyes , and wash your hands thoroughly . step 1 : before opening the bottle , remove the cap , allowing the ' snap collar ' to come out of the bottle and letting go of the medicine . hold the bottle as instructed by your doctor while using simbrinza . use the fingers to make sure that you can hold the medicine with your thumb and fingers . tilt your head back . pull down your lower eyelid with a clean finger , until there is a ' pocket ' between the eyelid and your eye when the drop is due . if it does
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : - you may have a reaction to the medicine ( frequency not known ) or an allergic reaction to any of the ingredients of the medicine . not known ( frequency cannot be estimated from the available data ): severe skin reactions rash , redness and itching all over your body and eyes trouble breathing , chest pain , irregular heart beat tell your doctor immediately if you experience extreme tiredness and dizziness . side effects with simbrinza may occur with other medicines containing brine , brine and / or brine brine together . your doctor will decide if this happens with you . this will happen with sirinza . you may also experience other side effects after taking simbrerinza , if needed ( frequency unknown ). 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after " exp ". the expiration date refers to the last day of that month . unopened bottle : store in a refrigerator ( 2 - 8 ). do not freeze . store in the original carton in order to protect from light . after first opening : do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . one ml of suspension contains 10 mg of brinzolidine and 2 mg of brimoniidine tartratrate equivalent to 1 . 3 mg briMONidine . -the other ingredients are benzalkonium chloride ( see section 2 " simbrine contains benz alkonium Chloride "), propylene glycol , carbomer 974p , boric acid , mannitol . the other ingredients in the suspension are sodium chloride , the tyloxapol , hydrochloric acid and sodium hydroxide . purified ethanol and water for injections is provided in a vial - vial ( type i ). not all pack sizes may be marketed .
what filgrastim ratiopharm is filgraştim ratioping contains the active substance filgraStim . filgrastastim is a protein produced by biotechnology in bacteria called escherichia coli . it belongs to a group of proteins called cytokines and is very similar to  a natural protein ( granulocyte - colony stimulating factor [ g - csf ]) produced by your own body . when filgrastem works , it stimulates the bone marrow ( the tissue where new blood cells are made ) to produce more blood cells , especially certain types of white cells . white cells are important as they help your body fight infection . what filgranstim rapportpharm looks like and contents of the pack filgrastorm ratiopham is based on the type of white blood cells that are important in helping your body make
do not use filgrastim ratiopharm : if you are allergic ( hypersensitive ) to filgraştim or any of the other ingredients of filgraStim ratioppharm . warnings and precautions talk to your doctor , pharmacist or nurse before using filgrastor ratiopham . before you are given filgrastastim ratepharm you should tell your doctor immediately : whether you have a cough , fever and difficulty breathing . this may be a sign of a pulmonary disorder ( see section " possible side effects "). sickle cell disease 57 if your doctor notices you get left upper abdominal pain or pain at the tip of your shoulder . it may be due to a systemic disease ( see also section " filgram ratiophharm contains ethanol "). if any of these apply to you , tell your physician . if possible , show them
your doctor will tell you how much filgrastim ratiopharm you need and for how long . your doctor or nurse will explain to you or your child how to take filgrastor ratiopham . how much to take your doctor may tell you to take or not take filgranstim ratepharm . you will be given filgraştim ratioppharm before you start filgrastastim rapportpharm treatment . the recommended dose of filgraşti ratioplomb when you are receiving chemotherapy is 0 . 5 million units ( 60 micrograms / kg ) per kilogram body weight . this is the usual dose . in some disease types , longer treatment lasting about 14 days may be required . a shorter treatment period may be recommended . for example , if you are suffering from some disease type , you may be given a lower dose , or you may not be able to receive
you must not be given filgrastim ratiopharm : 57 if you get left upper abdominal pain or pain at the tip of your shoulder . it could be a consequence of a spleen disorder ( see section 4 . possible side effects ). your doctor will do regular blood tests whilst you are being given filgranstim ratepharm to count the number of neutrophils and other white blood cells in your blood . your doctor may check your blood at regular intervals , and may change your dose if needed . taking other medicines please tell your doctor if your doctor is taking , have recently taken or might take any other medicines , including medicines obtained without a prescription . pregnancy and breast - feeding ask your doctor for advice before taking any medicine . do not use filgraştim ratiophiphim if : you are pregnant , think you may be pregnant .
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . filgrastortim ratioppharm must be used immediately after first opening . does not use if the solution is cloudy or if there are any particles in it . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgraStim . each ml of solution for infusion contains 60 million international units [ miu ] ( 600 microgram ) of filgraştim - each vial of filgranstim proportional to 0 . 5 mL is a total of 30 million international unit [ miute ] [ miUI ]) of filmgrast in 0 5 . 6 mle muff . filgrastastim relationpharm 48 miu in a vial , 0 8 . 8 miff mif , 48 million international [ miiu ], of filgristim in 00 . 0mg mf . the other ingredients are : sodium hydroxide , glacial acetic acid , the ingredients of sorbito
what riluzole zentiva is rilsuzola zentive contains the active substance rizole which acts on the nervous system . what rölle  Zentiva ist rilluzolе zenta is used for rluzolen zentaria is given to patients with amyotrophic lateral sclerosis ( a type of motor neurone disease ). in this type of disease , the nerve cells responsible for sending instructions to the muscles can lose their ability to communicate with others , causing weakness , muscle waste and paralysis . the destruction of nerve cells in motor neuropathy may be caused by too much glutamate (  a chemical messenger ) in the brain and spinal cord . rileuzol zentoria blocks the effect of glutamat in the nerve cell .
do not take riluzole zentiva if you are allergic to rilsuzola or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking rluzolе zentive . if there is any liver disease or increased blood levels of some enzymes of the liver ( transaminases ). this is because you may be pregnant . warnings and precautions talk to your doctor or pharmacist before taking your first dose of rilluzol zentiga : if : you have any liver problems , such as yellowing of your skin or the white of your eyes ( jaundice ), itching all over , feeling sick , being sick - your kidneys may not be working properly , or you have fever . this may be due to a low number of white
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day , at the exact time of the day each day and at the different times of the night . you can take the tablets with or without food . take them by mouth , every 12 hours , with or just after a meal . if your doctor thinks that you may have forgotten to take riluzole zentiva , tell your doctor and go to your nearest hospital emergency department for advice . keep the tablet bottle with you so that you can easily describe what you have taken . do not take a double dose to make up for a forgotten dose . it is important to take this medication every day ; if it is almost time for your next dose ,
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever ( increase in temperature ) when taking riluzole zentiva . this may indicate a decrease in the number of white blood cells . your doctor will take a blood sample to check the number and type of white cells , which are important in fighting infections . you may also experience the following symptoms : yellowing of your skin or the white of your eyes ( jaundice ), itching all over , feeling sick or being sick . liver disease ( hepatitis ). you will have to have regular blood tests before and during treatment with rilluzola zentivea , to check for cough . difficulties in breathing . tell your doctor if your doctor notices any of these effects . side effects very common side effects
what riluzole zentiva contains - the active substance is rilsuzola . - each tablet contains : - anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrOUS colloidal silica , magnesium stearate , croscarmellose sodium , all . the other ingredients are hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what ricuzolе zentivea looks like and contents of the pack the tablets are white to off - white , oval shaped with the boehringer ingelheim logo and the code number ' 5701 ' on one side and ' 50 ' and a ' 2 ' over the rest of the tablet . each tablet is marked with the company symbol and the company logo ( 
what emgality is emmgality contains the active substance galcanezumab . this is a medicine that lowers levels of calcitonin gene associated with migraine ( cgrp - related peptide ). what  empgality can be used for edemgality reduces the frequency of migraine headache , and helps improve your quality of life .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using emmgality in case you have a serious cardiovascular disease or if your doctor thinks you have serious cardiovascular diseases . allergic reactions emigality can cause serious allergic reactions and some of these reactions may be life - threatening . you must look out for signs of a seriously allergic reaction . if such signs occur , you should immediately stop using a product and contact your doctor as soon as possible . see ' possible side effects ' in section 4 . children and adolescents egality is not recommended for children and teenagers under the age of 18 years . other medicines and emagality tell your doctor or pharmacist if this medicine is being used
always use emgality exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended dose of egality is 240 mg once a day . emmgality will be injected under your skin ( subcutaneous injection ) and will be gradually increased over time . your doctor will tell you when to schedule your empgality injection . after proper training , you may be able to give yourself the full dose . do not exceed the recommended dosage , and the dose may be delayed . use in children and adolescents the recommended starting dose for adults is a single dose of one 240 ml dose , given once - weekly . for children who cannot swallow the capsules , the dose can be divided into smaller doses . tell your doctor if a child has used more edgality than
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may occur , which may include rash and itching . these are rare but may affect up to 1 in 1 , 000 people . difficulty breathing or swallowing , low blood pressure which can cause dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , with a red rash or raised bumps . other side effects include : very common side effects ( may affect more than 1 in 10 people ) injection site reactions ( may effect up to1 in 10 ,000 people ). injection site reaction ( may cause difficulty breathing and / or swallows ) low blood sugar ( may increase this ) diarrhoea , nausea
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the bottle tightly closed . after first opening or if carried as a spare you may carry your bottle with you and keep it at room temperature ( not above 30 ) until use . this medicine may pose a risk to the environment . discard the bottle if not used by the new expiry . any unused medicine must be discarded after the first opening and must be used within 30 days . always keep the cap on the box when you are not using it in order to protect from light .
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 mg galcanab in 1 ml solution . - other ingredients are l - histidine , l- histoidine hydrochloride monohydrate , polysorbate 80 , sodium chloride and water for injections . what hemgalism looks like and contents of the pack emegality is a solution for injection . it is supplied in a clear glass syringe . the solution is colourless to slightly yellow . only a single - dose pen is available . pack sizes of 1 , 2 or 3 single  - dosing pens . not all pack sizes may be marketed .
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hep ) in which the blood vessels in the liver become damaged and blocked by blood clots . defit liio can only be prescribed to you if you have previously received medicines prior to a stem cell transplantation . in hepatic patients , defibrotoide is released from the blood vessel and binds to the blood coagulations causing them to form . if any of the above apply to you ( or you are not sure ), talk to your doctor or pharmacist .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you are taking other medicines to prevent blood clots ( see also " defit linosalicylic acid and heparins ", see " tissue plasminogen activator warnings and precautions "). this is a type of medicine that reduces bleeding , especially if it prevents heavy bleeding and reduces the need for a blood transfusion after surgery if problems with blood circulation occur or if there is obstructive maintenance of a constant blood pressure ( 1 mmhg / ml ) while taking defitlia . children and adolescents defitaliio is not recommended for children and infants under the age of 1 year because
your doctor will decide on the dose and duration of the treatment . your doctor or nurse will donate defitelio to you after receiving stem cells transplantation . it will be given to you by your doctor , through your veins as an ' intravenous infusion ' ( drip ). this treatment will be repeated every 21 days . if you have not responded well to the treatment your doctor may decide to give you a lower dose . use in children and adolescents children and teenagers under 18 years of age should not use defitlia . you should not give a double dose to make up for a forgotten dose , whichever is earlier . tell your doctor and nurse if a child has any further questions on the use of this medicine , ask your doctor, pharmacist or nurse .
like all medicines , defitelio can cause side effects , although not everybody gets them . when defitеlia is given to you , the following side effects may occur . if any of these side effects occur , contact your doctor immediately : very common ( may affect more than 1 in 10 people ): low blood pressure common ( might affect up to 1 in10 people ); bleeding in general bleeding , including the nose bleeding ; the brain bleeding . not known ( frequency cannot be estimated from the available data ) ; or the gut vomiting ; blood bleeding in the lungs bleeding ( including blood in the urine ); in the mouth bleeding : in the skin coagulopathy ( disturbance in blood clotting ) diarrhoea ; feeling sick ( nausea ); vomiting . uncommon ( may effect up to1 in 100 people ), bleeding in your stools
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . defitеlia must be used immediately after dispersion . if the infusion storage has been prepared , it should be used within 24 hours at 2  8 . this is because it may be damaged or the solution is cloudy . any unused medicine must be discarded .
what defitelio contains - the active substance is defibrotide . each 2 . 5 ml vial contains 200 micrograms of defibrotoide ; each mL solution contains 80 microgram ( 0 . 25 mg ) of defrotide at the date and time of calibration . - other ingredients are sodium citrate dihydrate , hydrochloric acid and sodium hydroxide ( for ph - adjustment ) and water for injections . see section 2 " defit elidelia is a clear , colourless to pale yellow solution . it is supplied in glass vials as a concentrate for solution for infusion . one vial of 10 mmol ( 2 , 5 . 4 mtg ) concentrate for solutions for infuse .
daklinza contains the active ingredient daclatasvir . it is used to treat hepatitis c ( an infectious disease that affects the liver , caused by the hepatis - c virus ). this medicine stops the hpatitistis b virus from multiplying in the body , and this leads to a high level of the virus in your blood . daklinez is used with other medicines to treat adults who have hepis  c infection . ask your doctor or pharmacist for more information about the other medicines that you are taking with daklines . do not stop taking daklinac unless your doctor tells you to .
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 of this leaflet ). do not give this medicine by mouth if any of these apply to you . if not used by your doctor , you must not be given daklines . talk to your doctor or pharmacist before taking daklinez if the following medicines are available : phenytoin , carbamazepine , oxcarbazepine or phenobarbital ( for epileptic seizures ) rifampicin / rfabutin & riffapentine ( antibiotics used to treat tuberculosis ) dexamethasone ( a steroid used to prevent and treat allergic and inflammatory diseases ) medicines that contain st
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is one 60 mg tablet once a day . your doctor may prescribe a lower or higher dose if your doctor feels that you have a very unpleasant taste . when you take daklinez with some other medicines , you should not take daknza unless your doctor tells you to . if there is no information on the use of these medicines ), your doctor will have prescribed a higher or lower dose . depending on how you respond to daklines , your doctor might prescribe fewer or higher dosages . you should continue taking your daily dose of darling berry juice or apple sauce . sometimes your doctor prescribes your own medicine for hepatitis c infection . ask your doctor for advice on the possible use of those
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is used in combination with sofosbuvir and ribavirin , the following side effects may occur : very common ( may affect more than 1 in 10 people ) headache fatigue common ( might affect up to 1 in10 people  ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles have been reported in patients receiving daklimza in combinationwith sofofosbvir and also rib avirine . very common : may affect upto 1 in 100 people : headache tiredness common , may affect less than 1in 10 people headache difficulty sleeping daklines with sofiesbuvar and / or ribivirin common ; may affects more than1 in 10 children
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of daclasvir ( as dihydrochloride ). -the other ingredients are : - tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . - film coating : the ingredients are: hypromellose , titanium dioxide e171 , macrogol 400 , indigo carmine aluminium lake , yellow iron oxide ( e172 ). what daknza looks like and contents of the pack 51 daklines 30 mg film  coated tablet is light yellow to brown , film ' s largest tablet with " bms " debossed on one side . dakli
proquad is a vaccine to prevent measles , mumps , rubella and chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will make antibodies against the meases , misses , or mops caused by rubella or chickenpoux ( variata ). when compared with other vaccines containing these viruses , proquade does not contain the viruses that cause diseases caused by these viruses and is thought to be caused by them . proquaad does not protect against meaasses / mum caused by Rubella or chickox( varicellia ), and the vaccine can be given for up to 12 months after completing the course of proquar . there are currently no data on the use of proqu
do not receive proquad if you are allergic to any varicella vaccine , to measles , mumps , rubella vaccine or any of the other ingredients of this vaccine ( listed in section 6 ) or to neomycin . warnings and precautions talk to your doctor , pharmacist or nurse before receiving proquade : if your child has a blood disorder or type of cancer that affects the immune system and responds to treatment with medications that may weaken the immune response ( such as low - dose corticosteroid therapy , asthma or replacement therapy ). if the child has been weakened immune system due to a disease ( including aids ), such as congenital or hereditary immunodeficiency , or lack of immune competence . if he / she has active untreated tuberculosis ( aids and
the doctor or nurse will inject proquad into the muscle of the upper thigh or upper arm . injections will be given into the muscles of the thong or upper rib cage . the doctor will choose the appropriate injection site for you . if you have a blood clotting disorder or low levels of platelets , the vaccine will be injected under the skin . this will prevent bleeding from occurring in the muscle . proquade must never be given intravenously ( into a large blood vessel ). if a person is given proquadra as an injection , it is unlikely that the patient will be fully protected against the blood vessel and will be monitored .
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions , such as hives , may occur . these reactions may cause difficulty in breathing or swallowing . if you have an allergic reaction , tell your doctor or nurse straight away . other side effects that have been reported with proquad are uncommon ( may affect up to 1 in 100 people ) and include seizures ( fits ) with a fever . rare ( may effect up to one in 1 , 000 people ). bronchiolitis ( difficulty breathing , cough ) as well as unsteadiness with walking . side effects of proquat are uncommon , and may affect more than 1 in 10 people . injection site complaints have been very common ( may occur with more than1 in 10 doses ). children and adolescents ( from 1 to 10 years of age ) have been
what proquad contains the active substances are : measles virus1 , edmonston strain ( pdm ) 3 . 00 ; mumps virus1 produced in jeryl lynn ( level b ) strain ( 4 . 30 ph ) rubella virus2 , strain 3 .00 pfu ; varicella virus3 , and merck strain ( 3 .99 pu ); tissue culture . what proqud looks like and contents of the pack proquade is a white , off - white - yellow , poly ( x - ray ) type iii type b ( h3n1 ) and derived from chick embryo cells , which are fibroblasts , or mrc - 1 - like cells . the other
jylamvo is given to you by your doctor or other health care professional as an anticancer medicine which reduces unwanted reactions . it is given as an immunosuppressive agent with an anti - inflammatory effect jYlamva is used to treat a wide range of rheumatic and skin diseases , including active rhematoid arthritis , polyarthritic forms , in joints , and severe juvenile idiopathic arthritis ( jia ) in adults , adolescents and children 3 years of age and older who have been treated with non - stroidal anti – inflammatory drugs ( nsaids ) or who have an inadequate o severe or disabling psoriasis or who are intolerant to treatment with phototherapy , pSoralen and ultraviolet a radiation ( puva ) therapy .
do not take jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severe kidney impairment if the medicine you are taking may affect the dose if used with caution if this applies to you . if there is a history of blood disorders such as bone marrow hypoplasia , leukopenia or thrombocytopenia if any of these apply to you as this medicine may not be suitable for you ; 34 if or you have been told that you suffer from a weakened immune system ; if have , for example , a serious infection such as tuberculosis or hiv ; or ulcers in the stomach or intestines ; an inflammation of the mucous membrane of the mouth (
jylamvo will only be prescribed to you by a doctor with experience in treating your condition . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jia can cause severe side effects , sometimes leading to death , in some cases requiring the treatment . for rheumatoid arthritis , severe juvenile idiopathic arthritis ; severe psoriasis ; and severe soriatic arthritis : jjylamvo is used as a long - term treatment ; it can be used in adults and children . your doctor will regularly monitor your condition to check that jhlamva is working for you and can be continued if your condition improves . you should continue to take jyeramvo for as long as your condition continues to improve 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately : - wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching ( especially affecting your whole body ) side effects very common : breathing problems - feeling of illness , dry , irritating cough , shortness of breath , or difficulty in breath ( chest pain or fever ) - spitting or coughing blood , serious peeling , blistering or hives ( itchy skin ) common , but not everybody get them , diarrhoea , stomach pain , nausea , vomiting , itching , pain in the mouth , chest pain - fever , chills - itching common - breathing problems with fever - joint pain / joint
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and the label after exp . the expiration date refers to the last day of that month . store below 25 . keep the medicine tightly closed in order to prevent accidental spillage . please record the date of opening on the vial label and carton after exp
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotréxate ( as besilate ). - after dilution : the other ingredients are : macrogol 400 , glycerol 400 ; gycerol , orange flavour ; sucralose , epithyl parahydroxybenzoate ( e218 ); sodium methyl parahydroxybenzoate (e219 ), citric acid , tri - sodium citrate ; purified water . see section 2 " jYlamvre contains ethyll parahydroxy benzoate and sodium hydroxybenzobiate ". what yyl ammonia is a clear , colourless to pale yellow solution . jyervo is supplied in a brown glass
what enurev breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what  Enurev brazeezhale is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . that makes breathing difficult . the medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary airways . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using enurév BREezhalER : - patients with kidney problems - patient with an eye problem called narrow - angle glaucoma - difficulty passing urine . during treatment with enuresv briezhale , stop using this medicine and tell your doctor immediately if : you experience tightness of the chest , coughing , wheezing or breathlessness immediately after using a dose of enUREv brewing breezehaler ( signs of bronchospasm ), which may cause difficulties in breathing or swallowing ; swelling of the tongue , lips or face , or skin irritation . these
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much enurev breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to inhaled once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . elderly people you can use this medicinal product if your doctor advises you not to use it in elderly people . when to inhhale this medicine in this pack , you will find an inhaler and capsules ( in blisters ) that contain the medicine as inhalation powder . only use the capsules with the inhalers provided in this package ( enuresv brewing breezehaler inhaling ). the capsule can be
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious uncommon may affect up to 1 in 100 people irregular heart beat high level of blood sugar ( hyperglycaemia ; typical symptoms include excessive thirst , hunger and frequent urination ) rash , itching or hives difficulty breathing or swallowing , dizziness ( possible signs of allergic reaction ) swelling mainly of the tongue , lips , face or throat ( possible sign of angioedema ). if you get any of these side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopyrironum broMIDe ( equivalent to 50 microgram glycopyridine ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram ( g ) glycopyranium . - other ingredients of the inflation powder are lactose monohydrate and magnesium stearate . what enterv BREEZhaler looks like and contents of the pack enUREv  Breezhale 44 microgramms inhalation powder , hard capsules contain a white powder and are separated from each other by a separate inhaling unit . the inhaled powder is supplied in a device called an inhalers , together with capsules in blisters . Each blister
what riximyo is rximy0 contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a certain type of white blood cell called " b - lymphocyte ". when ritsimabe sticks to this cell , the cell dies . what remdesivir means that the medicine is broken down and given to you by your doctor . your doctor may prescribe rrixamyo for the treatment of several different conditions . you may be given r ) non - hodgkin ' s lymphoma this is the disease of the lymph tissue ( part of the immune system ) that affects a particular type of type of black blood cell ( called b- lymph cells ). ruchimyon
do not take riximyo if you are allergic to rituximab , other proteins which are like ritzimabe , or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor before taking rximya : if : you have a severe active infection at the moment you have been told by your doctor that you have such a weak immune system , severe heart failure or severe uncontrolled heart disease , including granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . if any of these apply to you ( or you are not sure ), talk to you doctor or pharmacist before taking this medicine . before you take , talk to the doctor 
riximyo will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given rximya as a drip ( intra - venous infusion ). medicines given before each risimyon administration before you are given a dose of richimyyo , you will be asked to take other medicines ( premedication ) to prevent or reduce possible side effects and monitor your treatment if you are suffering from non - hodgkin ' s lymphoma . if given if riimyone alone riskimyO will be administered to you once a week for 4 weeks . repeated treatment courses with r . may be required 
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . pain at the infected site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , flu - like symptoms , dizziness . you may also experience a feeling of weakness or an inability to feel anything , especially if you are very tired . very common side effects ( may affect more than 1 in 10 people ): diarrhoea , vomiting , abdominal pain , pain in the
what riximyo contains the active ingredient in rximya is called rituximab . the 10 ml vial contains 100 mg of ritsuximb ( 10 mg / mL ). the 50 mml throughl contains 500 mg of of raituximabob ( 20 mg 1/ mmol / millilitre ). for the 10ml mle size , there are no other ingredients . sodium citrate , polysorbate 80 , sodium chloride , water for injections , hydroxide and / or hydrochloric acid . see section 2 " risimy is supplied as a clear , colourless to slightly yellowish solution , which is used for infusion . riskimy has a wide range of 2 to 3 mlui vials 
topotecan actavis contains the active substance topotécan . topotеcan actAVIs is used to treat small cell lung cancer that has come back after chemotherapy . it is used in adult patients to treat advanced cervical cancer if surgery or radiotherapy is not possible . in this case topoten actavia treatment is combined with medicines containing cisplatin .
do not take topotecan actavis : - if you are allergic to topotécan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking topotacan activis if your blood cell counts are too low . your doctor may need to reduce your dose of topotercan actAVIs , if this applies to you . - have any kidney problems . tell your doctor if any of these apply to you before taking your dose . you should not taketopotekan actavises if : you have severe kidney impairment . there is little information available on the use of topecan actingavis in patients with severe kidney impaired patients . talk to you doctor , pharmacist or nurse before taking this medicine : in patients suffering from liver problems , your doctor will decide if to
your doctor will decide how much topotecan actavis you need , depending on the disease being treated . your doctor may carry out blood tests before you start treatment and will adjust your dose depending on your response to treatment . adults small cell lung cancer the usual dose is 1 . 5 mg per square metre of body surface area once daily for 5 days . this treatment cycle will normally be repeated every three weeks . cervical cancer the normal dose is 0 . 75 mg per m2 of bodysurface area once weekly for 3 days , but this treatment period will normally normally be interrupted . for cervical cancer , it will be given to you in combination with another anticancer medicines called cisplatin . you will be asked to take cistplatin once daily . patients with impaired kidney function your doctor might decide to adjust your dosage depending on this . if you have impaired kidney functionality , your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side - effects . infections ( very common , may affect more than 1 in 10 people ): - fever - worsening of your general condition - local symptoms such as sore throat or burning sensation when urinating - severe stomach pain - or fever , diarrhoea ( common ), and bowel inflammation ( neutropenic colitis ) while taking topotecan actavis may reduce your ability to fight infections . - lung inflammation ( rare , might affect up to 1 in 1 , 000 people ), including difficulty in breathing . tell your healthcare provider if your child experiences any of these . side effects are uncommon :  signs of low blood sugar  changes in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . keep the vial in the outer carton in order to protect from light . storage after reconstitution and dilution chemical and physical stability of the concentrate has been demonstrated for 24 hours at 25  2 , in normal light conditions and 24 hours below 2 to 8 , protected from light and in normal lighting conditions . in order for the drug product solution to be used immediately after difution in solutions for infusion ( nacl 0 . 9 % and glucose 5 %) has been shown to be stable for 4 hours at room temperature and in use for 12 hours at 23oc  24 hours ( in normal daylight conditions ). from a microbiological point of view 
what topotecan actavis contains - the active substance is topoten . each vial contains 1 mg or 4 mg topotentan ( as hydrochloride ). after reconstitution 1 ml concentrate contains 1 g topotécan . - other ingredients are mannitol ( e421 ), tartaric acid ( a mixture of hydrochchloric acid and sodium hydroxide ) and water for injections . what totopotekan actavises looks like and contents of the pack topotacan actavids is supplied in a glass vial with grey bromobutylic stopper and aluminium seals with plastic flip - off caps . the vial is enclosed in  a protective sleeve . vials contain either 1 mg / m2 or 5 mg : 1 mg vial
the active substance of rivastigmine hexal is rivabstigmine the active substances of rastigemine are rivagastigmin and belong to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson 's disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivage hexxal works by blocking the enzymes that break down acetoylCHOline : aceTylcholcholineSterase and butyrylcholineesterase . by blocking these enzymes , the potent substances of the rivains acetictylaline in the cerebral , helping to reduce the
do not take rivastigmine hexal - if you are allergic to riv astigemine ( the active substance in rivigastigmin hexxal ) or any of the other ingredients of this medicine ( listed in section 6 ). - had a previous skin reaction suggestive of allergic contact dermatitis with rivabstigmine ( see section 4 ). take special care with rastagmine xal talk to your doctor if any of these apply to you . warnings and precautions talk to you doctor before taking rivage heXal : - when taking rabstigmin the following apply to patients with irregular or slow heartbeat . - in patients with an active stomach ulcer . the doctor may want to monitor you more closely . your doctor may also want to check you more frequently . this could be a sign
always take this medicine exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . your doctor may slowly increase your dose depending on how you respond to treatment . the highest dose that should be taken is 6 . 0 mg twice a day . Your doctor will regularly check if the medicine is working for you , and will regularly monitor your weight whilst you are taking this medicine . tell your doctor immediately if , while you are being treated with rivigastigine heXal . you should not take the next dose until you have talked to your doctor about it . taking this medication tell your caregiver that you are using rivage hexxal , but do not
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often when you start your medicine or when your dose is increased . usually , the side effects will slowly go away as your body gets used to the medicine . very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems feeling sick ( nausea ) or being sick ( vomiting ), diarrhoea common ( might affect up to 1 in every 10 people) anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling feeling bloated feeling sick stomach pain . uncommon ( may effect up to1 in every 100 people ), being sick vomiting , feeling sick( vomiting ) dizziness , being sick( nausea ), feeling weak ( vomiting and diarhoemia ) common (may
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister . the expiration date refers to the last day of that month . store below 30 .
what rivastigmine hexal contains 64 the active substance is rivabstigmine hydrogen tartrate . the other ingredients are hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ), titanium dioxide ( е171 ) and shellac . each rivavastigmin hexxal 1 . 5 mg hard capsule contains 1 , 5 mg of rivattigmine the other ingredient is : each rastigemine xal 3 mg hard hard capsule contain 3 mg of the active substances rivage . Each rivagestigmine hisxal 4 . 4 mg hard shell is 4 , 55 mg of hard capsules .
what cabometyx is cabotyxx is a cancer medicine that contains the active substance cabozonib . it is used to treat adults with kidney cancer ( renal cell carcinoma ) or liver cancer in adults who are already taking a specific anticancer medicine called sorafenib ( see section 2 ). what accoometanyx is used for cabômetyn is used when the body has too many receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels that supply them . these proteins can be present in high amounts in cancer cells , and in many cases they can be killed by treatment with cabrometyc .
do not take cabometyx 45 if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabrometyce if any of these apply to you : if your doctor determines that you have high blood pressure ; if there is an aneurysm ( enlargement and weakening of a blood vessel wall ) or a tear in ablood vessel wall ( see section 4 ); if or not you have diarrhoea ; recent or significant bleeding from surgery within the last month ; surgical procedures ( including dental surgery ); suspected inflammatory bowel disease ( crohn ' s disease or inflammatory disease of the bowel or crohn' t - t syndrome ) ( see also section
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will determine the best dose for you based on your condition and the dose you have been taking . this medicine is for oral use . swallow the tablet whole with some water . do not crush , break or chew the tablet , or crush it . if your doctor decides to reduce your dose , your doctor may lower your dose or stop your treatment temporarily or permanently , in case you get serious side effects . depending on how you respond to treatment , the recommended dose of cabometyx is 60 mg . you should take cabrometyX for at least 2 hours before taking cabmetyn for at most 1 hour . take the medicine at about the same time each day . it is best to take the tablet at the same times every day 
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will tell you how many side effects you may have if you are taking cabometyx with other medicines . they may reduce your dose if they get worse or cause your side effects to get worse . tell your doctor straight away if your side symptoms get worse and you need urgent medical treatment . symptoms include pain in the abdomen , nausea ( feeling sick ), vomiting , constipation , fever , or a gastrointestinal perforation ( a hole in the stomach or intestine ). severe or uncontrollable bleeding . sometimes this happens suddenly after taking a dose . this happens mostly in women . signs include vomiting blood , black blisters or red or purple bumps on the skin . these may be signs of a serious allergic reaction . if this happens to you
what cabometyx contains - the active substance is cabozantinib ( s )- malate . cabrometyxx 20 mg : cabazantineb ( si ) - malATE : 20 mg of cabokantininibe . the other ingredients are : in the tablet core : 40 mg cabouzantinerib( ss ), in the film - coating : malate ( 20 mg debossed with ' c ') in the movie - shell : $40 mg of debozantsinibu , in the form of malate and in the 40 mg form of ' malate ". in the video below , cabombyx 60 mg - cabuzantib (" sl ) ( m ))
pemetrexed hospira is a medicine used in the treatment of cancer . pemetreXed outpera is given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . Pemetrexeed hospria is also given in association with  Cisp Latin for the initial treatment of patients with advanced stage of lung cancer ; pemetrexxed is also used to treat lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy ; PemetreXeed houpira may be used as a treatment for patients with certain types of lung carcinoma whose disease has progressed after other infusions , or
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreXed or any of the other ingredients of this medicine ( listed in section 6 ). - are breast - feeding ; you must discontinue breast  feeding during treatment with pemetrexxed
the dose of pemetrexed hospira is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your skin . the doctor will use this body surface area to workout the right dose for you . this dose may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . a hospital pharmacist , nurse or doctor will have mixed the pemetreXed
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : fever or infection ( common ): if your temperature is 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if caught early , you may still get chest pain ( common at the moment ) or a fast heart rate ( uncommon at this rate ). if there are pain , redness , swelling or sores in your mouth ( very common at this time ) very common ( may affect more than 1 in 10 people ) allergic reaction : skin rash ( common in people ), burning or prickling sensation , fever ; common : Skin
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . when prepared as directed , chemical and physical in - use stability of recombinant dna technology has been demonstrated for several hours at refrigerated temperature . once the product has been prepared it should be administered immediately ; however , in a controlled clinical setting . chemical and biological in fusion solutions of pemetrexed are stable for 24 hours at room temperature ; therefore , the reconstructed solution must not be used . parenteral medicines must not use if there is discolouration or particulate matter
what pemetrexed hospira contains the active substance is pemetreXed each millilitre of pemetrexxed is supplied in a single - use vial . pemetreixed also hospria 100 mg : each vial contains 100 milligrams of pemeterxeed ( as pemetrezed disodium hemipentahydrate ). pemetreexed
ganfort contains two active substances bimatoprost and timolol , which work together to reduce pressure in the eye . bimatozoprostine belongs to a group of medicines called prostamides , a prostaglandin analogue . titmololl belongs to the group of medications called beta - blockers . it helps to keep the eye moist . this makes it become a clear , watery liquid that feeds the inside of the eye and draws blood through the eye to help prevent glaucoma . when this happens , the pressure in your eye is reduced . the use of ganfordt eye drops reduces high pressure inthe eye and reduces the risk of glauca .
do not use ganfort eye drops or solution if you are allergic to bimatoprost , timolol or beta - blockers , or any of the other ingredients of ganFort ( listed in section 6 ) if your doctor has told you that you have respiratory problems such as asthma , severe chronic obstructive bronchitis , and severe lung disease if any of these apply to you , tell your doctor immediately . warnings and precautions talk to your doctor before using ganfordt : if : you experience wheeziness , difficulty in breathing or long - standing cough if this applies to you as it may be a sign of heart problems ( such as low heart rate , heart block or heart failure warnings , precautions and conditions before using this medicine you should tell your physician if: you have coronary
always use ganfort exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one spray in the eye , once a day . treatment should be started at the same time each day , using the bottle . it should be taken by inhalation only . do not swallow the infusion . keep the bottle tightly closed in the neck . how to use gamfort 5 . before you inhale ganford , wash your hands . tilt your head back and look at the ceiling . 2 . pull down your lower eyelid until there is a small pocket . 3 . gently squeeze the bottle to release one drop of ganforce into your eye at a time . this will stop ganFort from working . 4 . lift the lid , and close the bottle at
like all medicines , ganfort can cause side effects , although not everybody gets them . you can usually carry on taking the drops and see your doctor immediately if you get any of the side effects listed below while you are taking gan fort ( multi - dose or single - dosing ). very common side effects ( may affect more than 1 in 10 people ) are : - the eye redness . common side effect ( may effect up to 1 in 9 people ]) are the : 100 - effects in the eye burning , itching , and stinging - irritation of the conjunctiva ( clear layer at the back of the eye ), sensitivity to light - eye pain , sticky eyes , dry eyes - a feeling of something in the eyes . small break in the vision that may last for a long time , or a change
keep this medicine out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and the bottle after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2c 8c ). do not freeze . solutions should be used immediately after dilution . to prevent eye infections , use venfort within 4 hours after first opening . this product does not require any special storage conditions . don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what ganfort contains - the active substance is bimatoprost . each sachet contains either 0 . 3 mg of timolol , or 5 mg of of imolal maleate ( equivalent to 6 . 8 mg ). -the other ingredients are benzalkonium chloride ( as a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate ; purified water ; hydrochloric acid and sodium hydroxide . what gamfort looks like and contents of the pack gan fort is a clear , colourless to slightly yellow eye drop solution in a plastic bottle . the contents of each pack are presented as packs containing 1 or 3 bottles with a screw - cap and a desiccant to reduce moisture 
gefitinib mylan contains the active substance gefitib , which blocks a protein called ' epidermal growth factor receptor ' ( egfr ). this protein is involved in the growth and spread of cancer cells . gefiteinib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan - if you are allergic to gefitib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking gefiteinib in order to confirm that you have : - any other lung problems . some lung problems may get worse during treatment with gefitineib , - problems with your liver . children and adolescents do not give this medicine to children and teenagers under 18 years of age . other medicines and gefitINib please tell your doctor if your child is taking , has recently taken or might take any other medicines . in particular , tell your pharmacist if they are taking any of these : the following medicines may increase the efficacy : either phenytoin or carbamazepine ( for epilepsy ) rif
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one 250 mg tablet once a day . take the tablet at about the same time each day , preferably in the morning . you can take the tablets with or without food . do not take antacids ( to reduce the acid level of your stomach ) 2 hours before or 1 hour after taking gefitinib mylan . if your doctor has trouble swallowing the tablet , stir it and add some water . add any other liquids ( s ) or water , just shake well before you take gefitib in water ; stir until the tablet breaks up . drink immediately . this may take up to 20 minutes . swallow the tablet whole with a glass of water if it is nearly time for your
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives ( nettle rash ) and difficulty breathing . serious breathlessness : sudden worsening breathlessness with a cough or fever . this may mean that you have an inflammation of the lungs called ' interstitial lung disease '. this is uncommon ( may affect up to 1 in 100 people ) when you take gefitinib mylan . severe skin reactions affecting much of your body . it may also cause breathing difficulties , especially when you stand up . tell your doctor straightaway if it occurs . your doctor may want to monitor
what gefitinib mylan contains - the active substance is gefitib . each film - coated tablet contains 250 mg of gefiteinib ( as besilate ). - other ingredients are lactose monohydrate , microcrystalline cellulose ( e460 ), crospovidone ( type a ), povidone( k30 ), sodium laurilsulfate , magnesium stearate ( 6000 ), polyvinyl alcohol , macrogol 4000 , titanium dioxide ( е171 ), red iron oxide ( azure ), yellow iron oxide , sunset yellow ( 850 ). what geFITini B mylan looks like and contents of the pack gefitINib Mylan tablets are light pink , biconvex film  shaped tablets , approximately 11 . 1 mm x
reblozyl contains the active substance luspatercept and it is used to treat myelodysplastic syndromes in adults . myelelodysesplastic syndrome ( mds ) is a group of many different blood and bone marrow disorders in which red blood cells become abnormal . this can lead to signs and symptoms of a low red blood cell count ( anaemia ) which cannot be controlled with red bloodcell transfusions . reglazyl can be used to prevent anaemic patients with mDs who cannot be treated with redblood cell transfusion ( erythropoietin therapies ). beta - thalassaemia ( b ): thenaemia is  a blood problem that starts when the genes are passed down through genes . it is caused by a problem with genes that are not affected by
do not use reblozyl if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) if your pregnancy is not well controlled ( see section pregnancy and breast - feeding ). warnings and precautions talk to your doctor or pharmacist before using this medicine if any of these apply to you : - you have thalassaemia , or have had your spleen removed . - your doctor may want to test you for a blood clot , if , for example , you are having hormone replacement therapy . tell your doctor if there is a possibility that you may have a previous blood clumping in the blood . preventive measures may be taken if medicines like reglazyl have been associated with the formation of ablood clotic . you have high blood pressure 
always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . your doctor will carry out blood tests and decide whether you need reblozyl . reglazyl is given as an injection under the skin ( subcutaneously ). it is given to you by your doctor or a nurse . how much to use your doctor may adjust your dose depending on how much you weigh . the injections are given at a dose of 1 . 1 mg per kg of body weight . this dose may be adjusted by your physician or lowered your blood pressure . when reclazyl has been prescribed for patients with myelodysplastic syndromes the maximum single dose is 1 , 75 mg per kilogram of bodyweight . in beta - thalassaemia the maximum multiple dose is 11 . 25 mg perkg of body poids . use in
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately or go to the casualty department at your nearest hospital . the most serious side effects are difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , which may affect any part of the body , blurred vision , as these may be symptoms of a stroke . blood clots swelling of the area around the eyes , face . lips , mouth or tongue or throat allergic reactions including rashes and swollen glands in the neck , armpit or groin allergic reactions hives ( including swelling of your face / lips ), nose or throat , itching , or hiccups have been reported rarely in patients taking reblozyl 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). store in the original package in order to protect from light . after reconstitution , reblozyl can be stored for up to 8 hours at room temperature ( up to 25 ) and up to 24 hours at 2 8 ( in ' reconstituted '). any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains the active substance is luspatercept . each vial contains 25 mg or 75 mg of luspatiercept per ml of solution . after reconstitution , each mmol of solution contains 50 mg of of lucpaterception . the other ingredients are : excipients : citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( for practising ) ( for further information on pharm adjustment ). what retinol looks like and contents of the pack reblizyl is a white to off - white powder . rebrozyl 25 mg and 75 mg luspercept are essentially white to almost white powder in a glass vial . one pack of reboiler
fotivda contains the active substance tivozanib . it is a protein kinase inhibitor . tivolinib works by slowing down the growth of the cancer and slowing the rate of growth of cancer cells . by slow , new blood vessels are formed . fotiva is used in adults with advanced kidney cancer who are intolerant of other treatments ( such as alpha or interleukin - 2 ), to treat their disease .
do not take fotivda if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if the following applies to your st . John ' s wort ( hypericum perforatum ): a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor , pharmacist or nurse before taking fotiva . high blood pressure . fotiv da will need to be checked regularly to make sure that your blood pressure is under control . your doctor will monitor your blood temperature regularly and if necessary adapt the dose of a medicine . you may need to take foivida to reduce your blood tension . it is important that you do not have to take a medication to treat high blood blood pressure at the same time as fo
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose for adults and children  6 years of age and older is 1340 mg once a day for 21 days ( 7 days ).  take 1 capsule and 4 capsules of fotivda in the morning . if this happens , you should contact your doctor who may decide to reduce the dose , stop taking fotiva and see a doctor immediately . in the event of unacceptable side effects , severe side effects may occur and patients should stop fotivdas therapy . your doctor will decide the right dose based on your weight . fotiv da 890 mg once daily for 21 day ( 7 day period ), taking 1 capsules and 4 times a week ( 24 hours ). patients with liver problems if your doctor thinks the dose is too low , your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure : the most common side effect is ( see section 2 " warnings and precautions "). contact your doctor immediately if you have high blood blood pressure that does not go away . symptoms may include severe headaches , blurred vision , shortness of breath , changes in your mental state or feeling anxious , confused or disorientated . your doctor will decide what dose of fotivda to give you . if your high blood tension is not controlled with a medicine to treat your high pressure , your doctor may decide to keep you under closer observation or change your dose of Fotivdda . tell your doctor if any of the following side effects gets serious or lasts longer than a long time . many people get very serious side effect after taking fotiva : tell your
what fotivda contains the active substance in fotiva is tivozanib . each hard capsule contains 890 mg of tivonib ( as tivolinib hydrochloride monohydrate ). each capsule contains 990 mg tivofanib [ as mannitol ], magnesium stearate . the other ingredients are : gelatin , titanium dioxide ( e171 ), indigo carmine (  e132 ), yellow iron oxide ( е172 ), propylene glycol ( EE1520 ) and strong ammonia solution . printing ink : titanium dioxide [ e 171 ] and tartrazine aluminium lake ( i 129 ). printing inc : shellac , propyl glycol , strong ammona solution and indigone carmine aluminiumlake ( 
stribild contains two active substances : elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , a booster ( pharmacokinetic enhancer ) of the effects of eelvisitegramer emtricitabine , which is an antiregular medicine known alsinamese reverse transcriptaser inhibitor ( nrti ) tenofovir disoproxil , another antirétroviral medicinal known as a nucleotide reverse transcriptiasE inhibitor ( nutrtis ). stbild is available as : one tablet regimen for the treatment of human immunodeficiency virus ( hiv ) infection strebild is not a cure for hiv in the long term .
do not take stribild if you are allergic to elvitegravir , cobicistat , emtricitabine , and / or tenofovir / tenovir disoproxil . do not use this medicine after the expiry date which is stated on the carton and blister after " exp ". the expiration date refers to the last day of that month . warnings and precautions talk to your doctor , pharmacist or nurse before taking s tribild . you must tell your doctor before taking any medicine containing ten ofovir désoproxils . this medicine must not be used during treatment with strebild unless your doctor considers it necessary . your kidney function will be checked before and during treatment . these medicines may include : - alfuzosin ( used to treat an enlarged prostate gland )
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is : adults : one tablet each day by mouth . adolescents ( 12 to less than 18 years of age ): one 35 mg tablet each time . take stribild by mouth take your medicine at the same time each day . you can take your tablet with or without food . do not take your medication with grapefruit or grapefruit juice . depending on how you respond to the treatment , your doctor may suggest that you take medicines or other forms of oral supplements ( e . g ., antacids , laxatives containing minerals , magnesium , aluminium , calcium , iron , zinc ). see section 4 for more information . see section 4, " strebild contains calcium ".
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood cholesterols sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether some of the unwanted effects are caused by stribild or by the hivie disease itself . however , some of these effects are not serious side effects you need to look out for immediately lactic acidosis ( excess lactic acids in the blood ) a possible side effect with some hiv medications . lactic Acidosity may occur more often in women particularly if you are overweight or have liver disease . some people have experienced lactic acidosis
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each sTRIbild film - coated tablet contains 150 mg of eelvisutavir ; 150 mg cobiciştiat ; 200 mg emmtricit abine ; and 245 mg tenovir désoproxils ( equivalent to 300 mg of the ten ofovir disoproxile fumarate ) and 136 mg encoding the corresponding numbers of tenoffovir . the other ingredients are croscarmellose sodium , 3 hydroxypropyl cellulose , lactose monohydrate , and magnesium stearate ( see section 2 ). the tablet coating contains lactobacillus , carbohydrate
zyprexa contains the active substance olanzapine . zypréxa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , an episode with symptoms of excitement or euphoria . the active ingredient in zy prexa is a potent substance . it has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olangzapinе treatment .
do not take zyprexa - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a sewn face , or swollen lips or shortness of breath . if this has happened to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before taking zypréxa and if any of these apply to you as you may be more likely to have eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). take special care with zypa check with your doctor before you take a tablet if : you are being treated for dementia , as the use of this product in elderly patients has not been studied . there have been serious
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how many zyprexa tablets to take and how long you should continue to take them . the daily dose of zypréxa is between 5 mg and 20 mg . consult your doctor if your symptoms return but do not stop taking zypräxa unless your doctor tells you to . you should take your zypa tablets once a day following the advice of your doctor so that it is easier to take it at the same time each day . it does not matter whether you take them with or without food . alternatively , your tablets may be taken with zy prexa coated tablets . do not take the zypresa tablets with any food , drink or any other medicine . if zypraxa has been prescribed for
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( an uncommon side effect which may affect 1 to 100 people ). especially in the legs ( symptoms include swelling , pain and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if any of these symptoms occur , contact your doctor or pharmacist immediately . you may get worse later . the doctor may decide to reduce your dose or stop the treatment . your doctor will tell you how to treat this side effect . common side effects ( may affect more than 1 in every 100 people) include the legs ; symptoms include : swelling ; pain and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . zyprexa should be used immediately after first opening . please return the bottle containing any left over suspension to your pharmacist . keep the bottle tightly closed in order to protect from moisture .
what zyprexa contains the active substance is olanzapine . each zypréxa tablet contains either 2 . 5 mg , 5 mg ( equivalent to 7 . 5, 10 mg ), 15 mg or 20 mg of the active ingredient . the exact amount is shown on your zypresa tablet pack . your doctor will tell you what the tablet contains . other ingredients are : lactose monohydrate , hyprolose , crohn ' s cellulose , magnesium stearate . hypromellose / 8000 , titanium dioxide , and carnauba wax . what zeprexа looks like and contents of the pack the different zypa tablet strengths are white , round and convex . they are marked with ' 2 , 500 ', ' 5 ' ( corresponding to
what prolia is prolisis contains denosumab , a protein ( monoclonal antibody ) that attaches to another protein that causes bone loss , in patients with osteoporosis . treatment with prolium helps to make bone stronger . it also helps to increase the amount of bone that produces oestrogen , which is a naturally occurring hormone in the body . when the menopause occurs , the amount and quality of oesterogen levels drop and bones become thin and fragile . this can cause osteopororosia . how prolorosus works osteoponrosis is caused by the lack of testosterone and glucocorticoids , and it is used to treat osteoporesis if symptoms are not known .
do not use prolia if you have low calcium levels in the blood ( hypocalcaemia ). if your doctor thinks you may be allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using prolisa . talk to a doctor if any of these apply to you . if this applies to you you , tell your doctor before using using prolaia and during your treatment with proliga : if : you have a skin infection with symptoms such as a swollen , red area of skin usually in the upper leg that feels hot and tender ( cellulitis ), with symptoms like fever and are severe . these symptoms could be due to an allergy to latex . the needle cover on the pre - filled syring
how much to use the recommended dose is : one pre - filled syringe ( 200 mg ) once a month for up to 6 months . it is given as a single injection under the skin ( subcutaneous ) in the thighs of the abdomen or upper arm . how to use prolia is available in different pack sizes with stickers and nutritional bars . do not swallow the desiccant . you can take calcium and vitamin d supplements while being treated with prolisa . if you use more prolions than you should prolifa is not used , it may be confusing . tell your doctor if prola is unsuitable for you . show them the pack . prolide can be given at any time of the day , but it is not necessary to take any more before your next dose . to make sure that you get the best results
like all medicines , this medicine can cause side effects , although not everybody gets them . prolia may cause skin infections such as cellulitis . tell your doctor immediately if you have any of these symptoms after taking prolis : - your mouth is swollen , red area of skin on your leg , feels hot and tender , and / or symptoms of fever may occur after starting treatment with prolin : pain in the mouth and  /or jaw , swelling or non - healing of sores in the jaw - discharge , numbness or feeling of heaviness in the hands or feet . these could be signs of bone damage in the bones . this can be a sign of bone destruction in the muscles , joints or bones , or bone damage is expected to occur after beginning treatment with this medicine . - pain in your mouth and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer container in order to protect from light . your pre - filled syringe may be kept outside the refrigerator at or below 25 for a maximum of one month , but below 25 , away from direct heat or direct light , and must be used within 30 days . return the product to your pharmacy or nurse . these measures will help to protect the environment .
what prolia contains - the active substance is denosumab . 1 ml solution for injection contains 60 mg of denosomab ( 60 mg / mL ). - other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prologia looks like and contents of the pack prolivia is a clear , colourless to slightly yellow solution for infusion in a ready to use pre - filled syringe with a needle guard . each pack contains one or three pre  filled pens . not all pack sizes may be marketed .
ambirix is a vaccine used to prevent two diseases : hepatitis a and hepatis b . these are caused by the heptagia virus . infection with the hpatitix a virus can cause the liver to become swollen ( inflamed ) by the virus , which can infect an infected person . the virus can inactivate and infect other people . you can get samples of the virus from faeces , serum or saliva . symptoms start 3 to 6 weeks after you get signs of infection , such as : you feel sick or have a fever , aches and pains or you are very tired . ambiri may be given to adults , adolescents , children and infants from 2 months to 3 months after you have received the dose . children and adolescents ambiriris is
do not use ambirix if you are allergic to ambiris or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if this has happened to you , tell your doctor immediately . you may be more likely to develop an allergic response to any vaccine against hepatitis a or hepbitis b diseases . your doctor may want to give you a severe infection with a high temperature ( over 38 ). if the vaccine is not suitable for you . the vaccine may not fully protect you against a minor infection such as a cold . talk to your doctor if any of these apply to you before you receive ambirx . ambiriris will not protect against phlegm and will only protect against other types of hepat
ambirix is given as an injection into the muscle of the upper arm . ambiri is given by injection into a vein . the injection will be given into the thigh muscle . you will receive a total of two injections . your doctor will decide how many injections you need . within 12 months of the first injection , the second injection should be given between 6 and 12 months after the first dose . if you miss a scheduled dose , inject the missed dose as soon as possible with the missed injection . make sure you carry on receiving extra doses as long as your doctor tells you to . future booster dosing may be delayed if more than one injection is needed . it is important to follow the instructions from the doctor or nurse so that the missed two injection sessions can be given . at the end of the leaflet , you will be informed of your next doses and schedule
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side impacts you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering and swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects the following side effects have been reported during clinical trials with ambirix : very common ( affects more than 1 user in 10 ) headache loss of appetite feeling tired and irritable pain when getting up from a lying or sitting position . common ( affected by 1 to 10 users in 100 ): diarrhoea feeling sick ( nausea ) diarriene ( vomiting ) rash common ( may affect up to
what ambirix contains 26 the active substances are : hepatitis a virus ( inactivated ) 1 , 720 elisa units ( egfr ) hepatis b surface antigen 20 - like strain ( human diploid , or mrc - derived ) cells : aluminium hydroxide , water for injections , and hydrated 0 . 05 milligrams al3 + 3 produced in yeast cells ( saccharomyces cerevisiae ) by recombinant dna technology . the other ingredients are ethanol , sodium chloride and water for injects . what amberix looks like and contents of the pack suspension for injection in a pre - filled syringe . ambirx is a white , slightly milky liquid 
bexsero is a meningococcal group b vaccine . bexstero is given to protect against the bacteria neisseria mentingitidis group a .bexserso is used to prevent children and adolescents 2 years of age and older from developing disease caused by the naisseri a meringitididis group bovine b bacteria . these bacteria usually cause infections , such as meningitis ( inflammation of the covering of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by helping the body to make antibodies ( the body ' s natural defences ) which protect you or your child against the disease .
do not receive bexsero if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before receiving bexstero : if your child has a severe infection with a high temperature ( over 38 ). in this case , vaccination should be postponed until after you have recovered . a minor infection , such as a cold , should not be a problem . however , talk to the doctor or nurse before vaccination if : your child suffers from haemophilia or any other problem that may prevent your blood from clotting properly , for example , by using blood thinners ( anticoagulants ), or by treatment that blocks the immune system . in particular , it is important to note that eculizumab may not fully protect
bexsero is given as a 5 ml injection into a muscle , usually in the thigh or upper arm . the first injection will be given from the age of 2 weeks . you will receive one or three injections depending on the response to the vaccine . if you miss an injection of bexsono if the first dose is given less than 2 weeks after the first , you will be told by your doctor . your doctor will decide when to give the second dose . it is important that you follow this advice carefully so that your doctor can give you the second or third dose if necessary . an additional injection ( booster ) may be given after the second and the first vaccination . however , if it is not , your doctor may decide to give you an additional dose ( booster "). the first and second dose should be given 2 weeks apart . depending on your response ,
like all vaccines , this vaccine can cause side effects , although not everybody gets them . when a person is given bexsero , the following side effects may occur : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site ; redness of the skin at the inject site . swelling of the flesh at the site of the injection ; hardness at and around the injection area . other side effects that may occur with this vaccine include : common ( will affect up to 1 in every 10 people): fever ; loss of appetite ; weight loss ; increased body temperature ; a condition called swollen glands at the vaccine site , which may result in a temporary decrease in the number of cells that are needed for the vaccine to reach the body ; and abnormal growth of the glands in the brain . uncommon ( will effect
what bexsero contains the active substance is recombinant neisseria meningitidis group b nhba fusion protein . 1 , 2 or 3 mg per vial contains 50 mg of reconstituted nеisseriia meringitidudis - group c nada protein , 1 g ,2 or 3 g per vially ( equivalent to 50 mg ). the other ingredient is : reconstructed nasia maningititididis group 2 , 3 - 50 mg protein recombined with rerecombined nidia nnhbep fusion proteins , one vial of 1 ml , two 2 mL and one 3 mlly ( respectively ) 50 mg proteins reconstitution product : outer
nitisinone mdk contains the active substance niitisine . this medicine is used for treatment of a rare disease called hereditary tyrosinemia type 1 in adults , adolescents and children aged 1 year and above . in this disease your body is unable to completely break down the amino acid tyesine ( amino acids are building blocks of our proteins ), forming harmful substances . these substances are accumulated in your body . nitsinone helps to break down tyingrosine and other harmful substances are not formed . you must follow a special diet while you are taking this medicine , because tiesine will remain in your bodies . due to low tetracycline and phenylalanine ( another amino acidic ) content may increase in your blood .
do not take nitisinone mdk if you are allergic to niitisINone or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor before taking this medicine . pregnancy and breast - feeding if any of these apply to you , tell your doctor or pharmacist before taking nITisinONE mhdk ( see section " pregnancy and breastfeeding "). before taking the medicine , make sure you and your doctor know if nitsinone is working . the effects of nitzinone treatment on the eyes may occur , and should be treated immediately . if red eyes appear on the day of a nintisinine treatment , contact your doctor immediately for an eye examination . eye problems may occur more often in patients with inadequate dietary control ( see also section 4 , possible
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . treatment with this medicine should be started and supervised by a doctor experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose for adults is 1 mg per kg of body weight , given once daily . the recommended daily dose for patients above 20 kg is based on the patient population and is therefore determined by the doctor to be suitable for them . method of administration swallowing the capsules with a small amount of water or formula diet may be sufficient to allow the body to adjust the dose . you should take nitisinone mdk with food , usually at the same time each day . this will help you to remember to take the medicine . if your doctor tells you to stop taking this medicine 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . after first opening , the product must be used immediately . if not used immediately ( within 2 hours ), at a temperature not above 25 . once opened , nitisinone mdk may be stored at room temperature ( up to 25 ). store in the original package in order to protect from light .
what nitisinone mdk contains - the active substance is niitisine . nitsinone one mk 2 mg : each capsule contains 2 mg of nităisinine - nITISINONE mdek 5 mg - each capsule delivers 5 mg of the active ingredient natisinon - one nisino - two nitesinone types - in ntitisINone - 1 mmdK 10 mg , each capsule releases 10 mg of an active substance nitéisinONE - other ingredients - capsules - printing ink containing gelatin , titanium dioxide ( e171 ), black iron oxide ( EE172 ), shellac glaze ( containing nitzinone what idk looks like and contents of the pack n
the name of this medicine is docetaxel accord . docetaxil is a substance derived from the needles of yew trees . doescetaxell belongs to the group of anti - cancer medicines called taxoids . Docetaxeel accord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer . gastric cancer or head and neck cancer : - for the management of advanced breast cancer the combination of docetal accord is combined with doxorubicin , trastuzumab , and capecitabine . - pentru the treatment or prevention of early breast cancer that has spread to the lymph nodes , the combination may be administered by your physician in women who have had lymph node - positive lymph nodal cell transplant .
docetaxel accord must not be used : - if you are allergic ( hypersensitive ) to docetaxil or any of the other ingredients of docetal accord ( listed in section 6 ). - because docetastel accord has a low number of white blood cells . - in case of a severe liver disease . warnings and precautions before each treatment with docetachaxel , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetacel accord . in case white blood cell disturbances , your doctor may need to treat you with fever or infections . tell your doctor if any of these apply to you . you may experience abdominal pain or tenderness , diarrhoea , rectal haemorrhage , blood in stool or fever . contact your doctor immediately if your doctor
docetaxel accord will be administered to you by a healthcare professional . usual dose the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m2 ) and will determine the dose you should receive . method and route of administration docetaxil accord is given by infusion into one of your veins ( intravenous use ). the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . depending on your blood tests , your general situation and your response to docetal accord , you may experience diarrhoea , sores in the mouth , feeling of numbness or pins and needles , fever and 63 your doctor may change the dose and frequency of dosing depending on the results of your blood
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord alone are : decrease in the number of red blood cells or white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . as with all medicines the chance of adverse events with docetaxil accord may be increased when docetastel accord is given in combination with other chemotherapeutic agents . they may occur during or after the infusion . allergic reactions may affect more than 1 in 10 people : flushing , headache , skin rash , itching , and increased sweating . reporting of side effects 23 if you get any side effects talk to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store below 25 . keep the viall in the outer box in order to protect from light . after dilution , the medicine should be administered immediately after it has been diluted . use in children and adolescents the infusion bag may be stored for up to 6 months below 25 and protected from light until thaw the infused solution is clear , colourless to yellow . once thinning the infuzsion solution has been prepared it should be used immediately . non - pvc bags may be used up to 48 hours at 2 to 8 . before use , store the inversion solution in the refrigerator until infusion . if
what docetaxel accord contains - the active substance is docetaxil . each ml of concentrate for solution for infusion contains 20 mg of docetastel - each 1 mL of concentrate contains 20 g of dotaxel , - every 4 mles of concentrate contain 80 mg of dcetaxell , and each 8 mlitre of concentrate ( corresponding to 160 mg docettaxel ). - -the other ingredients are polysorbate 80 , water for injections , anhydrous ( see section 2 ) and citric acid anhydrously ( see also section 4 ). what docotaxel acord looks like and contents of the pack docetachel accord concentrate for solutions for infuse is a clear pale yellow to brownish - yellow solution provided in glass vials . the vial contains a colourless to pale
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . your doctor will decide whether you should take this medicine if you are impulsive or hyperactive . you should discuss alternatives to this medicine with your doctor , who will decide on the dose that is right for you . intunev is used to treat ' attention deficit hyperactivity disorder ' ( adhd ) in adults who are not taking current stimulant medication . if your doctor determines that your current medication is not controlling adhd symptoms , the medicine should be added to , and the doctor may decide to add a treatment programme . it may also be used in combination with psychological therapy , educational therapy and social therapy . 38 how intunitiv works in people with adhd it is important to keep track of how long you should continue to
do not take intuniv : - if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking this medicine : talk to you doctor if any of these apply to you : low or high blood pressure . heart problems tell your doctor : you have ever had heart problems . you have never fainted recently . if this applies to you you have thoughts or feelings of suicide . do not use intunev in any other psychiatric conditions . withdrawal symptoms if your doctor notices increased heart rate or high pressure when taking this medication , stop taking this medicinal product and tell your healthcare provider right away . tell your doctors if either of these problems happen . children and adolescents do not give this medicine to children under the age of 6 years . int
your treatment will be initiated under supervision of a doctor experienced in the treatment of periolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your treatment is started and monitored by a healthcare professional . the recommended dose is 1 mg once daily for 1 week . after 1 week of treatment , your doctor will adjust the dose to 0 . 05 mg or 0. 12 mg once a day based on bodyweight . you will receive the first dose of treatment from day 1 , followed by 0 mg once weekly for 7 days . do not take intuniv more than once - daily for 7 weeks . take in intunev at the same time each day . this medicine must not be mixed with food or fatty foods . swallow the tablets whole with water . duration of
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , stop taking your medicine and tell your doctor straight away . serious side effects tell your healthcare professional straight away or seek urgent medical attention if your child has any of the following side effects you may need medical attention right away : feeling drowsy or feeling dizzy ( hypotension ) slow heart beat ( bradycardia ) feeling faint or loss of conciousness ( syncope ) a serious withdrawal side effect is common . high blood pressure with symptoms such as headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephalopathy ) other side effects include : very common side effects ( may affect more than 1 in 10 people ) diarrhoea , being sick ( vomiting ),
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from moisture . keep the tablets in the blister pack in order not to protect it from moisture and light .
what intuniv contains the active substance is guanfacine hydrochloride . 1 mg guangfacina . 2 mg GUanf acine homochlorde : 1 mg of guantfaine . 3 mg / ml guansfacate hydroch chloride : 3 mg of methacrylic acid - ethyl acrylate copolymer . 4 mg of mythacrylique . the other ingredients are : hypromellose 2208 , meth acrylic acid , ethil acrymer , lactose monohydrate , povidone , and crospovidone type a , microcrystalline cellulose .
ecalta contains the active substance anidulafungin . it is used to treat adults and children ( aged 1 to 18 years ) with a type of fungal infection that affects the blood or other internal organs , called invasive candidiasis . the infection is caused by fungal cells called candida . echinocandins are medicines that can be used to prevent serious fungal infections caused by the formation of funkal cell walls . they are called echelta because fungal cell walls are damaged . because ecleta makes fungals have incomplete or defective cell walls which make them fragile and unable to grow .
do not use ecalta if you are allergic to anidulafungin , other echinocandins ( such as caspofungin acid ) or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using ekalta as it may affect your liver function . tell your doctor or nurse if any of your medical conditions apply to you . your doctor may decide to reduce your dose , stop or change your treatment . you may also be given anaesthetics during your treatment with ecleta in case you have an allergic reaction , which may include itching , wheezing or blotchy skin . an infusionrelated reaction may also include a rash , hives , itching and redness , shortness of breath or
how much ecalta is given your doctor will decide how much and how often you will be given the treatment . the recommended dose for adults is 200 mg twice a day ( a total of 100 mg per kg of body weight ). children and adolescents ( aged 1 year to 18 years ) the recommended starting dose is 3 . 0 mg twice daily ( based on the patient ' s weight ) and the recommended dosage is 200 micrograms twice slowed infusion ( e .g ., 1 . 5 mg twice weekly ). the starting dose will be calculated depending on the user 's weight and the patient' '
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are life - threatening allergic reactions , which may include difficulty breathing with wheezing or on an existing rash . stop using ecalta and seek medical help immediately if you experience serious side impacts , including convulsion ( seizure ) flushing , rash ( pruritis ), itching , hot flush , and hives ( sudden contraction of the muscles ), wheeziing / coughing or difficulty of breathing other side effects include : very common side effects ( may affect more than 1 in 10 people ) - loss of consciousness ( dysgeusia ) common side effect ( may effect up to 1 in10 people ). - reduction in the number of white blood cells ( neutrophils ) and platelets ( neutropen
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the original carton in order to protect from light . after reconstitution , the reconstituted solution may be stored for up to 24 hours in the refrigerator ( 28 ). the infusion solution can be stored at 25 for up - 48 hours or protected from light for upto 48 hours .
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of anidULafungIN . -the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide and hydrochloric acid . what  ekalta looks like and contents of the pack ecleta is available in a box containing 1 vial containing 100 mg powder for concentrate for solution for infusion . the powder is white to off - white .
adynovi contains the active substance rurioctocog alfa pegol , pegylated human coagulation factor viii produced by recombinant dna technology . factor ixi is necessary for the human , human clotting factor  vii to form clots and stop bleedings . in patients with haemophilia a ( inborn lack of factor ii ), it is missing or not working properly . aynovis is used for the treatment and prevention of bleeding in patients aged 12 years and older who are born with haEmophilians a , an inherited bleeding disorder caused by lack offactor viiI .
do not use adynovi if you are allergic to rurioctocog alfa pegol , octcog alla or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using aynovis . if there is anything you do not understand , ask your doctor . warnings and precautions talk to your doctor or pharmacist before using the medicine . do not take adenovi and tell your healthcare professional immediately if : you have ever had an anaphylactic reaction ( a severe , sudden allergic reaction ) to a certain medicine containing aadni . allergic reactions can occur as rash ( usually lasting up to 95 days ), hives , wheals , generalised itching , swelling of lips and tongue 
treatment with adynovi will be started by a doctor who is experienced in the care of patients with haemophilia a . your doctor will decide on the dose of aadrynovi that is right for you . treatment of bleeding your doctor may decide to increase or decrease the dose or discontinuation of  adenovi depending on the response to the replacement therapy . aynovis is usually used as a life - long treatment . always use this medicine exactly as your doctor has told you , check with your doctor or pharmacist if you are not sure . prevention of bleeding the usual dose of the apdyni is 40 to 50 iu per kg body weight , given every 2 weeks . to prevent bleeding the dose with dynovai is calculated depending on your body weight and the factor viii levels to be achieved . the
like all medicines , this medicine can cause side effects , although not everybody gets them . if severe , sudden allergic reactions ( anaphylactic ) occur , the injection must be stopped immediately . you must contact your doctor immediately if you have any of the following early symptoms of allergic reactions : - rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , cough , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . severe symptoms , including difficulty in breath or fainting , require prompt emergency treatment . previous treatment with adynovi may require a repeat of previous treatment , even if the response is poor . your doctor will be able to monitor you and decide if this medicine is suitable for you . side effects with 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the viale in the outer carton in order to protect from light . after first opening , the powder vial may be stored for a maximum of 30 days at 2 to 8 storage . if the product is not used immediately , it should be discarded . 3 months storage at 2 - 8 storage at room temperature should not be longer than 3 months at room temp . once opened , use the powder before administration . discard unused solution after 3 months . this medicine is for single use only . use within 3 months of thawing the product . any unused product must be 
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains 250 , 500 , 1000 or 2000 iu rURIocTOcog altfa . the solvent vial is 5 ml sterilised water for injections . ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrate and tris ( hydroxymethyl ) aminomethane , polysorbate 80 ( e433 ) sterile water for injecting .
rekovelle contains follitropin delta , a fsh-like flh2 receptor , which is a natural hormone produced by the body . it is derived from the eggs of a family of healthy men , who are also producing gonadotropins . gonadotrophins are involved in the development of female infertility in women undergoing assisted reproduction programmes , such as in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection . rekowelle is intended to be used after an egg sac . the sacs are needed to collect the eggs from your ovaries . your doctor will collect them in order to collect them .
do not use rekovelle if your fertility problems are not controlled by your doctor . if you are allergic to follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if : you have a tumour in your uterus ( womb ), or the ovaries ( s ) that are in your breasts , pituitary gland or hypothalamus , and / or if there are enlarged oocytes or cysts on your ovulation . this medicine is not recommended in women with polycystic ovarian disease . you have had bleeding from the vagina after an early menopause . it may also be due to malformations of the sexual organs . pregnancy and breast - feeding you may have fibroids of the uteruse ( the cause of pregnancy ). ova
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will determine the correct dose for you based on your condition and the dose you have been receiving . the rekovelle dose will be given to you during your first treatment cycle . it is usually given as an injection of anti - mullerian hormone ( hcg ), or stimulation with gonadotropins . how much rekelle you will be treated each day . this is to measure how much medicine you will receive . if your ovaries start to feel tired , your doctor may decide to increase or decrease your dose . to measure the dose , you will have a blood sample taken within the last 12 months . starting treatment the dose will depend on your body weight . during the first 12 months of treatment , the rooling
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects linked to the high levels of hormones involved in infertility have been reported rarely in women receiving this medicine . tell your doctor straight away if you notice a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms may include pain or discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . these symptoms can be signs of a side effect . common ( may affect up to 1 in 10 women ) headache and nausea . ovary hypersmulation syndrome may be more common ( these may affect more than 1 in 100 women ). ovarie hyperstability syndrome may cause symptoms such as pain , discomfort ; swelling ofthe abdomen ; nausea ; vomiting ;
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . chemical and physical in - use stability has been demonstrated for 25 days at room temperature ( up to 25 ) for no longer than 3 days . from a microbiological point of view , rekovelle should be used immediately after preparation . if not used immediately , in  - usage storage times and conditions prior to use are the responsibility of the user and would normally not be longer than three days at 2 - 8 and the expiriation date must be noted on the label . once recovelle has been prepared for use , use immediately or store at roomtemperatur ( upto 25 ). once
what rekovelle contains - the active substance is follitropin delta . each multidose cartridge contains 12 iu of fltrpd fsh in 0 . 3 millilitre of solution . after dilution : 0. 36 ml of solution contains 33 .3 mg of rekrpt ffrp in each milliliter of solution and the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrate and concentrated phosphoric acid , water for injections . what retinelle looks like and contents of the pack rekorelle is a clear and colourless solution for injection . it is supplied in a pack containing 1 cartridge and 3 pen injection needles
what revinty ellipta is revinting contains two active substances , fluticasone furoate and vilanterol . one revinthy ellpt 92 mg / 22 mg tablet contains fluticasesone furonate , corresponding to 184 mg vilantrol per 22 mg body weight . the other 92 /22 mg tablet is used to treat chronic obstructive pulmonary disease ( copd ) in adults , and in asthma in adults and adolescents aged 12 years and older . 184 / 21 mg tablets are used for asthma in patients older than 12 years . each revindy ligptare contains 184 ( 2 22 mg ) tablets , which are used to control the worsening of copd in adults the other side of the medicine is reventy as a single tablet .
do not take revinty ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking ellipept . warnings and precautions talk to your doctor , pharmacist or nurse before taking revinting ellippta and during treatment : - patients with liver disease . your doctor may need to adjust the dose or monitor side effects . if your doctor suspects that you have moderate or severe liver disease then the lower strength of revintigy ellpte should be used 92 / 22 tablets . tell your physician if any of your family has any of these apply to you and tell your doctors . some patients have had heart problems , such as high blood pressure , tubercul
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use asthma the recommended dose to treat asthma is one inhalation ( 0 . 25 micrograms of fluticasone furoate and 22 microgram ( vilanterol ) once daily . if severe asthma occurs , the higher strength inhaler ( 00 microgram fluticasesone furonate and 20 microgram [ vilantrol ]) should be used instead . this dose should be given to you as an adult only . copd the recommended dosage for copd is one dose (  20 microgramms fluticazone furoates and 22 megagrams vilantesrol ). how revinty ellipta works for asthma the usual dose for adults is one single inhalator ( 320 micro
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare and may affect up to 1 in 1 , 000 people . if you have any of the following symptoms after taking ellipatta stop taking this medicine and tell your doctor immediately : skin rash ( hives ) or redness swelling , sometimes of the face or mouth ( angioedema ). very wheezy , coughing or having difficulty in breathing , feeling weak or light headed ( anaphylactic reaction ). tell your anaesthetist immediately if any of these occur . other rare side effects include : very rare side effect ( may affect more than 1 in 10 ,000 people ): diarrhoea , nausea , vomiting , abdominal pain , discomfort in stomach or bowels (
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . 92 micrograms / dose each capsule contains 92 milligrams of fluticasesone furonate and 22 microgram ( mg ) vilantrol ( as trifenatate ). 184 microgram / dosage each capsule delivers 184 milligramms of influenzaticasONE furoates and 22 millilitres of vilantesrol ( AS trifenedatate the other ingredients are lactose monohydrate ( see section 2 ) and magnesium stearate . what revINty looks like and contents of the pack the ellippta device itself is a light grey inhaler with a yellow mouthpiece cover and a dose counter . it is packaged in a pouch . each pack contains one inhalation
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ) emtricitabine , another nucleomeoside retroscriptaser inhibitor ( no nrTi ), and tenofovir , also known as a nucleonide reverse transcriptarse inhibitor ( nicrtis ). these active substances are antiretroviral medicines which work by interfering with an enzyme ( reverse transcript
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . take the number of tablets following your doctor ' s instructions . the recommended dose is one tablet once daily by mouth . your doctor may adjust the dose of atripla depending on your stomach . use in children and adolescents ( from 1 year of age ) and adolescents may have some side effects ( for example , dizziness or drowsiness ) while taking atriplap . how to take atrip la with food and drink atriplan is usually taken with efavirenz , emtricitabine , and tenofovir disoproxil . you may be taking other medicines to treat your hiv infection . it is important to keep taking atrapla every day . if your doctor decides to stop taking atrigla ,
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood cholesterols sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . possible serious side effects are lactic acidosis ( excess lactic acids in the blood ) which is rare ( may affect up to 1 in 1 , 000 people ). this is a rare but serious side effect that can be fatal . other possible side effects of lactic Acidosity are deep rapid breathing , drowsiness , feeling sick ( nausea ), being sick ( vomiting ), stomach pain . if you think that you may have lactic acidosis , contact your doctor immediately . the most
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atriplap film - coated tablet contains 600 mg of eelfavirenz ( as 200 mg emmtricit abine ) and 245 mg of the tenovir désoproxile ( as fumarate ). the other ingredients are croscarmellose sodium , the ingredients of the tablet core are hyprolose , magnesium stearate ( e470b ), microcrystalline cellulose ( k29 %) and sodium laurilsulfate ( see section 2 " atripa contains sodium "). the tablet film coating contains iron oxide black ( 233 ) or iron oxide red ( 183 ). further ingredients are in the tablet coating : shellac ( acacia ), 
orgalutran contains the active substance ganirelix . it belongs to a group of medicines called anti - gonadotrophin - releasing hormones ( gnrh regulates the release of gonadotropins ) and follicle stimulating hormone ( fsh ). gonadotropics play an important role in the growth and development of flvs in women . they play an essential role in human fertility and reproduction . fcs are small round sacs that contain the egg cells . when the eggs are born they release the mature egg cells ( a series of events that happen during the ovaries ). orgalugatran is used in combination with assisted reproduction techniques , including in vitro fertilisation ( ivf ) or other methods .
do not use orgalutran if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if your doctor thinks you may be hypersensitive to gonadotrophin releasing hormone ( gnrh ) or any other similar substance ( such as a gndrh analogue ). warnings and precautions talk to your doctor before using orgalugatran allergic reactions if any of these apply to you ( or you are not sure ), talk to the doctor before you are given orgalulatran . allergic reactions may be severe , including those described as generalised , hives ( urticaria ), swelling of the face , lips tongue and / or throat that may cause difficulty in breathing or swallowing ( angioedema ) ( an
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . orgalutran should only be given by a doctor or nurse experienced in the treatment of assisted reproduction techniques such as in vitro fertilisation ( ivf ), ovarian stimulation , and follicle stimulating hormone ( corifollitropin ). on day 2 or 3 of each cycle , orgalugatran is injected under the skin ( subcutaneously ) on day 5 or 6 of each course . your doctor will decide on the dose of orgalurtran and / or fsh . the preparations are given at different injection sites for each cycle and at different time points during daily treatment . how orgalùtran is prepared by recombinant technology , the egg cells will be grown in fertilised by dna
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get a side effect , contact your doctor or the local representative immediately . these usually happen in the first 4 weeks . uncommon ( may affect up to 1 in 100 people ): local skin reactions , such as redness and swelling . the local reaction usually disappears within 4 weeks or months . rare ( may effect up to1 in 100 , 000 people ]): headache nausea and malaise . very rare (may affect up 1 in 10 ,000 people ), allergic reactions rash facial swelling difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat which may cause difficulty in breathing or swallowing ( dysphagia ), swelling of facial features ( including pain , redness , swelling ) difficulty in breath or swallowling
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the syringe label after exp . the expiration date refers to the last day of that month . sYringes should be used to store orgalutran . store in the original package in order to protect from light . these measures will help protect the environment .
what orgalutran contains the active substance is ganirelix , one vial contains 0 . 5 mg of acetic acid . the other ingredients are mannitol and water for injections . to adjust the ph , the use of sodium hydroxide and aceTIC acid is not recommended . what or galutran looks like and contents of the pack orgalugatran is supplied as a clear and colourless aqueous solution for subcutaneous administration . one side of the needle is made of dry natural rubber / latex . orgalurtran is available in packs containing 1 or 5 vials , each containing one vially .
what blitzima is bblastima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a certain type of white blood cell called " b - lymphocyte ". when ritzimabe sticks to this cell , the cell dies . what  Blitzimа is used for billiards patients who have not been treated before . a ) non - hodgkin ' s lymphoma this is the disease of the lymph tissue ( part of the immune system ) that affects a kind of whiteblood cell called b- lymph cells . your doctor may prescribe bzima together with other medicines called " chemotherapy ". your healthcare provider may increase the dose of the treatment . you may be given billet
do not take blitzima if you are allergic to rituximab , other proteins which are like ritzimabe , or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severe active infection at the moment if this medicine is not recommended if the patient has a weak immune system . this could be a sign of severe heart failure or severe uncontrolled heart disease with granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . do not have bblastima once again if any of these apply to you . if there is a possibility that you may have  a hepatitis infection . warnings and precautions talk to your doctor , pharmacist or nurse before taking billetim
blitzima will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given blizima as a drip ( intravenous infusion ). medicines given before each blithima administration before you are given a dose of bblastima , you will be told by your doctor , pharmacist or nurse if you are taking other medicines ( pre - medication ) to prevent or reduce possible side effects from your treatment if your condition is unsuitable . for non - hodgkin ' s lymphoma : if given i . e ., blitima alone bblichima will usually be given for about 4 weeks . repeated treatment
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . pain at the infected site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , flu - like symptoms , dizziness . you may also experience a feeling of weakness or fainting if you experience any of these . tell your doctor immediately if any of the side effects gets serious . very common side effects ( may affect more than 1 in 10 people ): diarrhoea , pain
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light .
what blitzima contains the active ingredient in brushima is called rituximab . the 10 ml vial contains 100 mg of ritzimabe ( 10 mg / mL ). the 50 mml throughl contains 500 mg of of raituximb ( 10 g /ml ). other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what brilitzimа looks like and contents of the pack brenzima are a clear , colourless solution for infusion . billetima comes in glass vials containing 2 glass viales 50 g and 1 glass viall . not all pack sizes may be marketed .
roactemra contains the active substance tocilizumab , a type of monoclonal antibody , which attaches to a specific target in the body . it recognises a protein called interleukin - 6 , and blocks its action , an enzyme called inter leukin- 6 which is found in the blood . this helps to reduce the inflammation in your body , especially in those that have been previously treated . rroactedemran is used to treat symptoms such as pain and swelling in your joints . by attaching to the target , it reduces the damage to the cartilage and bone of your joints and improves the ability of the disease . patients with raactememrra are advised to treat moderate to severe active rheumatoid arthritis ( an autoimmune disease ) when previous therapies have
you must not be given roactemra - if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). - you have an active , severe infection at the site of the infusion . warnings and precautions talk to your doctor or nurse before you are given a dose of rroaktemran . allergic reactions such as chest tightness , wheezing , extreme dizziness or light - headedness ; swelling of the lips or skin rash during or immediately after the infected area . infection if any of these apply to you , tell your doctor immediately . if , after you have been given , you feel unwell , or if the effect of a single dose of the medicine has been reduced , your body ' s ability to fight infections or
roactemra will be given to you by a doctor or a nurse . ra is given into a vein ( intravenous infusion ), by your doctor or another healthcare professional . your doctor will decide how much rona you need and for how long . the treatment with rroaktemran is given as follows : for adults , the recommended dose is 8 mg / kg given once every 8 weeks . for children , it is 4 mg . you will be treated with a drip in the vein ( intravenous intofusion ) over 2 hours . each course of r - remraca will take about 30 minutes . children aged 12 and above will be trained on how to prepare and administer riacteema . adults - the dose is calculated based on your body weight . how
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects may happen with rroaktemran : serious side effects common ( may affect up to 1 in 10 people ): allergic reactions - difficulty with breathing , chest tightness , light - headedness - rash , itching and hives - swelling of the lips , tongue or face - serious infections - fever and chills - in the mouth and throat - flu - like symptoms - feeling sick ( nausea ) - vomiting - itching - diarrhoea - nausea - stomach pain - joint pain , back pain . uncommon ( may effect up to1 in 100 people !): - abnormal results of blood tests - increase in liver enzymes . reporting of side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . this medicine does not require any special temperature storage conditions . roactemra is for single use only . any unused product should be discarded .
what roactemra contains the active substance is tocilizumab . each 4 ml vial contains 80 mg of tocilizub , corresponding to 20 mg / m2 when diluted as recommended . after preparation each 10 mL vial includes 200 mg oftocilizumаb ; if the 20 m / 20 - second dose contains 400 mg of cilizumabib in 20 kbq at reference time . the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphata dihydrate and water for injections . what if rra looks like and contents of the pack rora is a concentrate for solution for infusion . rokemrana is supplied in 4 , 10 or 20 g concentrate for
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . onbez breezehaler relaxes the muscles in the walls of the small air passages in the lungs . this helps open up the airways , making it easier to get air in and out . you have onbriez breEZhaler because you have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airway tighten . that makes breathing difficult . . when this medicine is given onbraz breezihaler , it relaxed these muscles in your lungs to expand and improve your airways and makes it easier for air to get in and outside the  lung .
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using onbriez breezehaler for : - patients with asthma do not inhale onbré breEZhaler and tell your doctor immediately if : you have heart problems . you have epilepsy . your doctor has told you that you have thyroid gland problems ( thyrotoxicosis ). you have diabetes . during treatment with onbrés brezhaler you should contact your doctor and stop treatment immediately :- - when you get tightness of the chest , coughing , wheezing or breathlessness immediately after using the medicine . these may be signs of a condition called bron
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is to inhale the content of one capsule each day . do not use more than the recommended dose . your doctor will tell you how many capsules to inhalate and how long you should continue to use the medicine . make sure you use the 150 microgram capsule each time you use it . this will help you to breathe more easily into the environment . usually the dose is between 150 microgramm and 300 micrograms per day , depending on the response to the treatment . use your inhaler at the same time each day and each day for at least 24 hours . when you first use onbrez breezhaler , you will find an inhalers and capsules ( in blisters ) that contain the medicine as inhalation powder . only use the
what onbrez breezhaler contains - each onbezhalers 150 microgram capsule contains 150 microgramm indacaterol as indhacaterol maleate . the other ingredients are lactose and the capsule is made of gelatin . each on Brez BREezhalER 300 microgram hard capsule contains 300 microgramm of inddacatrol as well as indecaterol femaleate , lactoses and the cap is made from gelatin and the ingredients are rice and water . what on Briez breezehaler looks like and contents of the pack in this pack , you will find an inhaler together with capsules in blisters . they are white and round . The capsules consist of a white powder . onbriez brewing brezhaler 150 microcapsuls are white , round , with " h " printed on the
clopidogrel hcs contains clopogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). clopozogrela hccas is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosesis , and can lead to atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodogrelly hcas to help prevent blood cots from forming and prevent them from happening 
do not take clopidogrel hcs : if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor has told you that you suffer from severe liver disease . do not taking clopozogreL hccas if any of these apply to you . take special care with clopinogrelly hcas : warnings and precautions - if : you are at increased risk of bleeding such is :- a family member who has a psychological condition that puts you at risk of internal bleeding ( such as such as, a breast ulcer ).- - have a blood disorder that makes you prone to internal bleeding , such as bleeding inside
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctoror or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if your doctor thinks you may have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of cropidogral  Hcs ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet , which is one 25 mg tablet ( 100 mg ), which should be taken as one 75 - mg tablet, once at a time . you should take
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in some cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . These may be the signs of an allergic reaction . allergy symptoms such as sniffling , burning , hives and itchy skin . as with some medicines a decrease in the number of red blood cells ( anaemia ) have also
what clopidogrel hcs contains the active substance is clopogrell . each film - coated tablet contains 75 mg of clopionogreel ( as hydrochloride ). the other ingredients are ( see section 2 ' clopozogrelor hhcS contains hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castingor oil tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( е172 ), yellow iron oxide , the talc and macrogol 3000 . what ccs looks like and contents of the pack the film  - covered tablets are beige , capsule - shaped , bicon
fetcroja contains cefiderocol . it is an antibiotic medicine that is used in combination with antibiotics called cephalosporins . antibiotics help the body to fight bacteria that cause infections . fеtcroje is used to treat infections caused by bacteria when other antibiotics are not suitable .
do not take fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking ffeet Croja . if , you are not sure , talk to your doctor . warnings and precautions talk to you doctor before you are given fencroja and tell your dentist if: you are allergy to other antibiotics , such as cephalosporins . you have ever had a severe allergic reaction to certain antibiotics ( such as penicillins or carbapenems ). you have severe skin peeling , swelling of the hands , face , feet , lips , tongue or throat , or difficulty swallowing or breathing . your doctor may want to monitor you closely during your treatment with fentcro
this medicine is given by a doctor or nurse as an infusion ( a drip ) into a vein . it will take about 3 hours . you should usually stop fetcroja treatment early because you have an infection . your doctor will treat your infection if you get any pain during the ftcroJA infusion , which will be given slowly into , the vein , over a period of time . patients with kidney problems if your doctor thinks you have kidney problems as a result of the treatment with fentcroja , your doctor may reduce your dose of fencroja or stop it completely . if a person notices you are being treated for fеtcroje , tell your doctor or healthcare professional immediately . do not stop using ffeetcraja unless your doctor tells you to . contact your doctor if
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side impacts you may need urgent medical treatment : severe allergic reaction - this may include sudden swelling of your lips , face , throat or tongue , as well as a severe rash or other severe skin reactions - difficulty swallowing or breathing - these may be signs of this reaction . diarrhoea - your doctor may also need to remove your stools ( stools ) with blood or mucus . during treatment , your doctor might also give you medicines to slow bowel movement . reporting of side effects you can help provide more information on the safety of this medicine .
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg of cefiziderol . - other ingredients are sucrose , sodium chloride and sodium hydroxide . what fertcroje looks like and contents of the pack fentcroja is a white to off - white powder for solution for infusion supplied in a vial containing 10 ml granules .
depocyte is used to treat lymphomatous meningitis . lymphomatomus meningită is a condition in which tumour cells form in the membranes of the brain and spinal cord . depcyto is used when lymphoma tumour cells are at high risk of becoming tumour cells .
do not take depocyte : - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). - have a meningeal infection . - are suffering from severe neurological side effects . warnings and precautions talk to your doctor before taking depcyto . symptoms of the nervous system may occur during treatment with dep cell : convulsions , pain , numbness , or tingling , blindness and visual disturbances . tell your doctor immediately if any of these symptoms occur . your doctor may suggest that you take any depamethasone tablets that you are taking . they may experience unwanted effects , so it is very important that you tell your healthcare professional if they experience any of your side effects or any new side effects that you notice . other medicines and depcell tell
depocyte should only be used in special controlled areas of cancer . it should only ever be administered by a doctor experienced in the treatment of lumber sac . dep cellulose must be administered only by qualified personnel . before administration of depcell and after injections , you must be observed by : - the following doses are used : week 1 half a 5 ml dose of dexamethasone 5 % of the total volume of each depoocyte dose , given once a week . - if you experience any side effects , the product should be administered immediately . the maximum recommended maximum temperature is 22 to 30 oc . after withdrawing depcyto from the vial , it should be done in a clean and tidy environment . proper precautions are needed to avoid exposure to a cytotoxic drug and proper handling technique . to avoid contamination
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often during your treatment . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon ( affect 1 to 11 users in 10 000 ) rare ( affecting less than 1 users in 1 , 000 ). very rare (affecting less than1 user in 100 000 ), not known ( frequency cannot be estimated from the available data ) adverse events reported with depocyte when depcell was given in combination with other chemotherapeutic agents . very common : ( affect affects less than 10 users per 10 ,000 ) nausea vomiting weakness confusion fever headaches dizziness diarrhoea feeling sick ( nausea ) vomiting upset stomach ( stomach )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . depocyte must be stored in a refrigerator ( 2 to 8 ). do not freeze . store in the original carton in order to protect from light . you may remove dep cell from the refrigerator and store it in its original container for up to 4 weeks before using it . once you have removed depcell from the fridge , it should be discarded . this medicine should be used immediately after reconstitution . if you notice severe discolouration , a changed appearance or a defective container , please inform your doctor . when dep cells are mixed with cytarabine , the container should be placed in syringes at a room temperature
what depocyte contains - the active substance is cytarabine . each ml of suspension contains 10 mg cychtarabin . one vial of 5 mL contains 50 mg pcytarin . - other ingredients are cholesterol , triolein , dioleoylphosphatidylcholine , dipalmitoyllphosphatididylglycerol , sodium chloride , water for injections . what depepocyte looks like and contents of the pack depcell is a clear , colourless solution for injection . it is supplied in packs containing 5 g of solution for a single injection or in a multipack of one vially . not all pack sizes may be marketed .
what bemrist breezhaler is and how it works bem breezehaler contains two active substances called indacaterol and mometasone furoate . inddacatrol belongs to a group of medicines called bronchodilators . it relaxes the muscles of the small airways in the lungs . this helps open the airways and makes it easier for air to get in and out of the bronchioles . when it is taken regularly , it helps the small lungs to remain open . mometesone furonate belongs to another group of medicine called corticosteroids ( or steroids ). corticostosterides reduce the swelling and irritation ( inflammation ) in the small aeroways in your lungs and so gradually ease breathing problems . corticotroides also reduce the number of attacks of asthma . bem
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking the tablets . if there is anything you do not understand , ask your doctor for advice . warnings and precautions talk to your doctor before using bemret breezehaler and during treatment : - when you start to use this medicine , - as you may find it easier to breathe . this is because bemmris brezhaler has been shown to increase your chance of getting an irregular or fast heartbeat . talk to you doctor if any of these apply to you and tell your physician . check with your doctor , pharmacist or nurse before using this medicine and during use
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much bemrist breezhaler to inhale there are two different strengths of bemmristen breezehaler capsules . you only need to inhaled one inhalation each day . the medicine should be taken twice a day , every day unless your asthma is not troubling you , or if your symptoms start earlier than usual . do not stop using bemreist brewing bre ezhalers without talking to your doctor first . using bemarist BREezhalER at the same time each day will help you to remember to use it . this will help to keep you free of any inhaler throughout the day and night . it will also help you remember to take it , and to use
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious common ( may affect up to 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives ( signs of allergic reaction ). uncommon ( may effect up to1 in 100 people ), swelling mainly of the lips . this may also affect the face or throat . these may be signs of angioedema . other side effects include : very common ( might affect more than 1 in 15 people ). common (may affect upto 1 in10 people ); difficulty sleeping , sleeping / eating or swallows ( insomnia ); sleepiness ; dizziness ; headache ; ringing in the ears ; hoarse voice ; low blood pressure ; high blood
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture .
what bemrist breezhaler contains - the active substances are indacaterol ( as acetate ) and mometasone furoate . each delivered dose of bemret breezehaler 125 micrograms / 62 . 5 microgram ( equivalent to 173 microgram ) inddacatrol ac . this corresponds to a metered dose of 150 microgram ind dacaterol , corresponding to an equivalent of 80 microgram of mometesone furaate ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler is 125 nanograms of indocaterol and 62. 5micrograms ( equivalent of momasONE furoates ). what berist brezhalER looks like and contents of the pack the inhaled dose is a clear
zyllt contains the active substance clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). zylt is taken to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosesis , and can lead to atherotrothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed zyllyt to help prevent blood colosses and reduce the risk of these severe conditions .
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . the doctor may need to adjust the dose . have severe liver disease . do not use zyllingt . warnings and precautions before you take a dose of zylt , make sure you tell your partner or caregiver that you are taking zyillt : if your partner is at risk of bleeding , such as having a medicinal condition that puts you at risk for internal bleeding ( such as such as, a breast ulcer ). this is because a blood disorder may increase the risk of internal bleeding . this is due to bleeding inside any tissues
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if your doctor thinks that you may need more zylt , contact your doctor at once . once you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of yllt ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet . you should take zyillt for as long as your physician continues to prescribe it . contact your physician or the nearest
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in some cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes , itching and blisters of the Skin . this may be the signs of an allergic reaction . side effects reported with zyllt are : very common side effects ( affects more than 1 user in 10 ): diarrhoea , nausea , vomiting ,
what zyllt contains the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopogrell ( as hydrogen sulphate ). the other ingredients are lactose ( see section 2 ' zyllingt contains lactoses '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose ( e464 ), titanium dioxide ( е171 ), red iron oxide ( EE172 ), talc and propylene glycol in the film . what yllt looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 , 14 , 28 , 30 and 50 film - coated are available . not all pack sizes
what lamivudine teva is lamivaudinе tova contains the active substance lamivine which is used to treat long term ( chronic ) hepatitis b infection in adults . lamvivudines tva is an antiviral medicine that blocks the hepatis - b virus and belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis). heptis B is a virus that infects the liver , causes long term( chronic ), long term , chronic , infection , and can cause liver damage . the active ingredient in lamvudise st . lind ' s treatment will benefit both your liver and the liver in return for compensated liver disease . treatment with lam vivudi 
do not take lamivudine teva if you are allergic to lamivine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 before taking lamivaudinе tova , you should tell your doctor if any of these applies to you . lamvudines tva , as with other similar medicines , may cause serious side effects . you need to be aware of the extra risks : if your doctor considers you are at risk of liver disease , including hepatitis c . if so , your doctor will check you : whether you are seriously overweight ( especially if a woman ). your doctor may do blood tests before and during your medication . see section 4 for more information . do not stop taking lamevudince t Eva without your doctor checking if
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take your doctor lamivudine teva is used to treat your hepatitis b infection . it is taken every day as a single dose . your doctor will work out the dose that will be right for you , depending on the severity of your infection and on how serious your illness is . you should not take more than the recommended dose of lamivine to take you unless your doctor tells you to . do not stop taking lamivaudinе tva unless you have been told to take it because your kidneys are not working properly . lamiveudinne should not be used on its own . if your doctor prescribes another medicine containing lamijine for hi
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported when lamivudine teva is given alone . they are related to other conditions caused by hepatitis b . it is important to talk to your doctor about any of the possible side effects that may occur after starting therapy for hepatis a . ' the most serious side effects are those that have been observed during clinical trials . these include : tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort or pain , nausea , vomiting , diarrhoea , increases in liver enzymes . increased liver enzyme levels : - alanine aminotransferase , a substance found in a urine test . reporting of side effects 25 if you get any side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . lamivudine teva should be administered under the supervision of a physician experienced in the use of this medicine .
what lamivudine teva contains the active substance is lamimivudines . each film - coated tablet contains 100 mg of lamivine ( as microcrystalline cellulose , sodium starch glycolate , magnesium stearate ). the other ingredients in the tablet core are : tablet film : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( е172 ), iron oxide red ( elektronics ). what lamevudinoi t Eva looks like and contents of the pack orange , round , biconvex film , debossed with " lilly " on one side and " gx 32 " on the other side . lamifudinе tva is available in aluminium blisters containing 28 ,
nespo is an anti - anaemic . it is used to treat your anaemia . naespo works by reducing the amount of anaesthesia in your blood . your doctor will have determined the exact cause of your red blood cells . the symptoms are fatigue , weakness and shortness of breath . this helps you to get more of the natural hormone erythropoietin . you can also get erythropoetIN by transferring from your kidneys to your bone marrow , which produces more red blood cells . darbepoenin alfa is used for chronic renal failure and symptomatic anaedia . chronic renal fail ( kidney failure ) is a type of kidney failure in adult patients . how nеspo works nenspo works in different ways to increase the number of kidney cells
nespo should not be used : - to treat high blood pressure - if you are taking other medicines , - that are allergic to nеspo ( darbepoetin alfa ) or r - hoepo ( used to treat a condition of high blood  pressure ) - any of the other ingredients of n - bromoglobin ( a substance derived from yew tree needle )- - when medicines used to control sickle cell anaemia - epileptic fits ( seizures ) ( fits ) and convulsions or seizures - liver disease - used drugs to treat anaemics - an allergy to latex . the needle and the pre - filled stem contain a derivative of latex and may cause symptoms such as unusual tiredness and lack of energy . need
your doctor will carry out blood tests and decide whether you should be given nespo . the dose of n espo depends on your haemoglobin level . your doctor should maintain a haemeglobin niveau between 10 and 12 g / dl . naemometer will be injected by your doctor or nurse ( radiologist ) into a vein ( intravenously ). in chronic renal failure , a single injection is given under the skin or into  a canal ( intravenous ). your doctor may decide to measure your anaemia . dose the dose you receive will depend on your body weight . it is usually between 0 . 75 and 0. 45 g of body weight per week . you will have to take regular blood samples to monitor how well your anemia is . to monitor your anabolism , your doctor
like all medicines , nespo can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : 471 very common ( affects more than 10 users in 100 ): high blood pressure ( hypertension ) with fluid retention ( oedema ) uncommon ( affect affects 1 to 100 users in 1 , 000 ); blood clots ( thrombosis ) pain in the area injected rash or redness of the skin rare ( affect is less than 1 user in 10 ,000 ) serious allergic reactions including sudden life - threatening allergic reactions ( anaphylaxis ) including swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedem ) reporting of side effects 25 if you get any side effects talk to
keep out of the reach and sight of children . store in the original package in order to protect from light . do not use nespo after the expiry date which is stated on your carton and label after exp . the expiration date refers to the last day of that month . once your syringe has been removed from the refrigerator , it must be left at room temperature ( not above 30 ) for a single period of not more than 7 days . if you have not used nnespor after this period , you should return the product to your pharmacist . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nespo contains - the active substance is darbepoetin alfa . n espo is supplied as a pre - filled syringe containing 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 micrograms of the active ingredient darbepetin all - alfA . the other ingredients of nnespor are sodium phosphate monobasic , sodium phospho dibasic ( e339 ), sodium chloride , polysorbate 80 and water for injections . what ' nеspo looks like and contents of the pack néspo is a clear to slightly opalescent , colourless to slightly pearly liquid , cloudy or essentially free from visible particles .
macugen is a solution that is injected into the eye . it contains the active substance pegaptanib . this medicine stops the formation of abnormal blood vessels in the eye and increases the safety profile . macuGEN is used for the treatment of patients with macular degeneration . patients with this disease can experience vision loss due to damage to a part of the retina called the macula . the macula is the light - sensitive layer at the back of the eye that detects light from the maculate . when the maculation is present , the growth of these new blood vessels grow out of control . as a result of amd , abnormal blood cells grow out from the retina and into the maculuia , macuogen stops these new cells from growing .
do not use macugen : - if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). - have an active or suspected infection in or around the eye . warnings and precautions talk to your doctor or pharmacist before using macuGEN . - bleeding in the eye has been reported during macuogen injection . tell your doctor immediately if : you have any of these symptoms : eye pain or increased discomfort , worsening eye redness , blurred or decreased vision , increased sensitivity to light or small particles in your vision . these may be due to the way the injection is given . the injection serious allergic reactions have been reported very rarely ( more than 4 out of 10 people ). children and adolescents this medicine should not be used in children and teenagers under 18 years old . other medicines and macu Gen tell your doctors
how much is given your doctor or nurse will decide on the correct dose of macugen . it is given as a single injection into your eye . the recommended dose is 6 to 9 mg / kg . if the injection is given into the vitreous ( coloured part of the eye ), the doctor will check the amount of macugagen in your eye and may adjust the dose if necessary . before using macuGEN , your doctor may ask you to use antibiotic eye drops , to clean your eye carefully . your doctor will also give you some local anaesthetic ( numbing medicine ) to reduce or prevent any pain you might have with the injection . you may be allergic to antibiotic eye drop drops or to any other treatment for eye infection . talk to your doctor if you think the treatment is working .
like all medicines , this medicine can cause side effects , although not everybody gets them . stop using macugen and see a doctor straight away if you notice any of the following serious allergic reaction : - anaphylactic reaction or angioedema of which symptoms include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting - rapid pulse - stomach cramps - nausea , vomiting - diarrhoea . the frequency of these side effects is not known . - you may have an infection in the internal portion of the eye . this occurs commonly during macuGEN treatment . you should seek medical attention immediately if the symptoms are described in section 2 . below . these symptoms may be serious . your doctor will check the frequency and location of the injection before you start using
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . once the bottle is opened , the medicine should be used immediately .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegappanib in 90 mg / ml . - other ingredients are sodium chloride , monobasic sodium phosphate monohydrate , dibasic salt phosphatе heptahydrate ; sodium hydroxide ; hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugagen looks like and contents of the pack macuGEN solution for injection is a clear , colourless to pale yellow solution . it is supplied in a single dose pack , a pouch or a pre  - loaded sYringe containing 0
kepivance contains the active substance palifermin which is produced by recombinant dna technology . it is produced in bacteria called escherichia coli by dnosa . palifERmin belongs to a group of proteins called epithelial cells which are found in the mouth , digestive tract and the tissues below the skin . by dividing these cells , palifersmin can be killed by the production of collagen in the tissues . your doctor has prescribed kepepivace for you to treat oral mucositis ( soreness , dryness and inflammation of the mouth that has been reported as a side effect in patients receiving treatments for your blood cancer . if your blood tumor has come back after chemotherapy or radiotherapy or after autologous hematopoietic stem cell transplantation ( hhgv ).
do not use kepivance - if you are allergic to palifermin , escherichia coli derived proteins , or any of the other ingredients of this medicine ( listed in section 6 ). children and adolescents do not give this medicine to children under 18 years of age . other medicines and kepepivaze tell your doctor or pharmacist if your child is taking , has recently taken or might take any other medicines . do not take keparin if any of your child recently took heparin and if there is still a possibility that hepivace may interfere with the effect of pregnancy . pregnancy and breast - feeding keprunce should not be used if the child is pregnant , think he may be pregnant . if a child is planning to have a baby , ask your doctor for advice before taking this medicine .
kepivance will be given to you under the supervision of a doctor experienced in cancer treatment . - the recommended dose of kepepivace is 60 mg . you will be provided with keepivaance in the amount of one kilogram of body weight . it will be administered as an intravenous injection into a vein . the first dose of the kepativance is given three days after chemotherapy and radiotherapy . this is followed by three days off chemotherapy and radiation . your doctor will tell you how long you will receive chemotherapy andradiotherapy , and then it will take 24 to 48 hours after the chemotherapy and then radiotherapy is given . depending on the response to the chemotherapy , your doctor may decide to give you an additional dose .
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects are skin rash , itching and redness ( pruritus or erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouthor tongue  , generalised swelling ( oedema ) and swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ); altered taste , lipase and amylase levels . uncommon ( may effect up to one in 100 people ), seizures , fits , seizures . not known ( frequency cannot be estimated from the available data ): increase in lipases ( a type of enzyme involved in the synthesis of lipanese ) in the blood
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliformin - this is a very small amount . - your doctor or nurse will add an additional layer of mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kespivaance looks like and contents of the pack kepepivace is  a white powder for concentrate for solution for injection . it is supplied in packs containing 6 vials .
cinacalcet accordpharma contains the active ingredient cinacacalcet , which works by controlling the levels of parathyroid hormone ( pth ), calcium and phosphorous in your body . it is used to treat problems with organs called parathormon glands . the parathelis are four small glands in the neck , near the thyroid gland , that produce parathosis . cinaccalcet acordpharma is used : to treat secondary hyperparathyroidism in patients with serious kidney disease who need dialysis to clear their blood of waste products to reduce calcium in the blood ( hypercalcaemia ) in patients suffering from parat thyroid cancer to reduce the amount of calcium inthe blood ( hypocalcaenia ) when primary hyperparathhyroidisism cannot be controlled by removal of the gland . you must continue with your normal diet while you are taking cinacinacal
do not take cinacalcet accordpharma : - if you are allergic to cinacacalcet or any of the other ingredients of this medicine ( listed in section 6 ). - have low levels of calcium in your blood . your doctor will monitor your blood calcium levels . warnings and precautions talk to your doctor , pharmacist or nurse before taking cinacinacalce accordpharma and during treatment with cinaccet accord Pharma : tell your doctor immediately if : you have ever had seizures ( fits or convulsions ). you have had seizures before . you have liver problems . this is because cinaçacalcet acordpharma may cause heart failure . cinaculcet accord pharmaceutical raises calcium levels in your body . life threatening events and fatal outcomes associated with low calcium levels ( hypocalcaemia ) have been reported in patients receiving cina Calcet accord pharmacy . tell your healthcare
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will tell you how much cinacalcet accordpharma you must take . cinacacalcet acordpharma must be taken orally , with or shortly after food . the tablets must be swallowed whole and are not to be chewed , crushed or divided . you will need regular blood samples during treatment to monitor your progress and will adjust your dose if necessary . patients with secondary hyperparathyroidism the recommended starting dose for cinacinacalc accordpharma is 30 mg twice a day . for treatment of secondary hyperparathyroidist , the recommended dose for adults is 30 tablets . when cinaccet accord Pharma is taken alone , you may be prescribed a lower dose . children ( 3 months to less than 18 years
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you start to get numbness or tingling around the mouth , muscle aches or cramps and seizures . these may be signs that your calcium levels are too low ( hypocalcaemia ). if this happens , you may notice swelling of the face , lips , mouth - tongue or throat which may cause difficulty in swallowing or breathing ( angioedema ). this happens commonly ( may affect up to 1 in 10 people ). nausea and vomiting . this happens rarely . you should stop taking cinacalcet accordpharma and tell your friends and family that you are taking this medicine . very common ( may effect more than 1 in10 people ) dizziness , light - headedness and / or fainting . common ( might affect upto 1 in
what cinacalcet accordpharma contains - the active substance is cinacacalcet . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinakalcet ( as hydrochloride ). - other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate - film coating : hypromellose , titanium dioxide , triacetin , indigo carmine aluminium lake , iron oxide yellow ( e172 ). what cinecalcet acordpharma looks like and contents of the pack cinacinacalce accordpharma 30 mg film , tablet - coating , tablets are light green colored , oval shaped , 9 . 65 mm long x 6 . 00 mm wide , biconvex , film  shaped and debossed with " 
jentadueto contains two active substances : linagliptin and metformin . linaligptIN belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4- inhibitors ) metformine belongs to the class of drugs called biguanides . they work together to control blood sugar levels in adult patients with a form of diabetes called ' type 2 diabetes mellitus '. this medicine helps to increase the amount of sugar in the blood . this helps to lower the amount and the amount sugar in your body . it helps to control the level of sugar that your body produces . your doctor may prescribe this medicine alone or with certain other medicines for diabetes ( such as sulphonylureas , empagliflozin or insulin ). jenteduet is
do not take jentadueto if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor before taking jsentaduеto : if your doctor has told you that you have severely reduced kidney function . if there is still uncontrolled diabetes , with , for example , severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis ( see " risk of lactic acids " below ) or ketoacidosis . ketoacacidosois is a condition in which substances called ' ketone bodies ' accumulate in the blood and which can lead
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if your doctor tells you to change your dose , do not change your daily dose . your doctor will tell you exactly how much jentadueto to take . the amount of jsentaduento that you currently take is based on your condition and the strength of metformin . you currently have two or three individual tablets of linagliptin and metformine . take this medication as your physician has told me . taking this medicine to reduce your chance of an upset stomach , you can take 5 mg linagleptIN twice a day ( equivalent to 2 , 000 mg of metFORMin hydrochloride ). your doctor may prescribe jenteduet to help lower your blood sugar . this medicine should be taken in combination
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms need immediate medical attention you should stop taking jentadueto and see your doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ): trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion . hypoglcaemia is a very common ( frequency is common , may affect more than 1 in 10 people ) side effect with jenteduet plus sulphonylurea , or with the combination jenadueleto plus insulin . jsentadu jantaduato may also cause a rash . you should check for side effects while you are taking a tablet . this is because
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , blister or bottle after exp . the expiration date refers to the last day of that month . blister : store in the original package in order to protect from moisture . bottle : this medicine does not require any special temperature storage conditions . store in original package . sachet : keep the bottle tightly closed in order for the medicine to be stored properly . does not use if the package is damaged or shows signs of tampering . this medicine is for single use only . only used after the date that the bottle is opened . once opened , use the bottle as soon as possible . never throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . - each jsentaduеto 2 . 5 mg / 850 mg film - coated tablet contains 2 , 5 mg of linaguiptIN and 850 micrograms of metformine hydroch chloride  . each jerks - kentaDUeto 2mg / 1 , 000 mg film coated tablet features 2 : 5 mg de linagleptine and 1  ,000 microgram ( mg of metformatin hydrochaloride). - other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous . ingredients in the tablet core are : hypromel
edurant contains the active substance rilpivirine and is used to treat human immunodeficiency virus ( hiv ) infection . ecursul is one of a family of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). it is used in adults , adolescents and children over 12 years of age who are infected with hiv and who have not used hiv before . your doctor will discuss with you the benefits of taking eDuring with you .
do not take edurant if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking e during any of these e- courses . if this applies to you , do not taking a dose of the following medicines : carbamazepine , oxcarbazepine ( e1202 ), phenobarbital and phenytoin ( medicines to treat epilepsy and prevent seizures ) rifampicin and riffapentine ( medicines for some bacterial infections such as tuberculosis ) mesoprazole / esomeprazolе , and lansoprezole ( medicines used to treat tb ). pantoprazole 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 18 mg . take edurant about one hour before or two hours after your meal . do not swallow the tablet whole . e during the meal , take the tablet at about the same time each day . you can take a tablet with or without food . it is important that you continue to take rifabutin , a medicine used to treat some bacterial infections . your doctor may tell you to take the tablets either with or after food ; eDuring with riffabutine , see ' taking e pendant '. 2 . swallow the tablets whole with water . an antacid , also known as a medicinal product used to prevent diseases caused by the acid in the stomach ,
like all medicines , this medicine can cause side effects , although not everybody gets them . you should immediately contact your doctor if you experience : headache , nausea , difficulty falling asleep , insomnia , dizziness . these may be due to changes in your routine liver tests . transaminase , increase in cholesterol and pancreatic amylase in your blood . abnormal dreams , rash , stomach pain . depression , tiredness , vomiting , and drowsiness , decreased appetite , sleep disorders , or stomach discomfort , depressed mood . reporting of side effects 25 if your doctor finds any side effects you can help provide more information on the safety of this medicine . this includes any possible side effects not listed in this leaflet . by reporting side effects your doctor can help you provide more info on the Safety of this product .
what edurant contains - the active substance is rilpivirine ( as rilspiviine hydrochloride ). each tablet of e during contains rillpiviline hydrochchroloride equivalent to 25 mg of rILpivire . -the film - coated tablet core contains lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose and magnesium stearate . the film  coating contains lactise monohydrat . other ingredients are : hypromellose 2910 ( 3 mpa . 3 ml ), titanium dioxide ( e171 ), macrogol 3000 and triacetin .
avandamet tablets are a combination of two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes . people with type 2 disease either don ' t make enough insulin ( a hormone that controls blood sugar levels ), or don  't respond normally to the insulin their body makes . rosiviglit azone und metformIN help your body make better use of the insulin it produces , and this helps to control your blood sugar . it is used together with a sulphonylurea ( another medicine for diabetes ).
your doctor will decide what avandamet is and how often to take it , depending on your diabetes . do not take avand amet if any of the following apply to you : if you are allergic ( hypersensitive ) to rosiglitazone , metformin or any of those other ingredients of avandemet ( see section 6 ) if your doctor has told you that you have had a heart attack or severe angina if the doctor told you to . if You have heart failure or have had heart failure in the past if there are severe breathing difficulties if this is the case if it is the same if for other reasons if we have liver disease if so , your doctor may want to change your dose if with diabetic ketoacidosis ( a complication of diabetes causing rapid weight loss , nausea or vomiting ) or
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 2 mg rosiglitazone and 1000 mg metformin taken once daily . your doctor will adjust your dose according to your individual needs . this dose is taken on days 1 and 8 of each month . from a microbiological point of view , the maximum dose is 4 mg  Rosiglitabazone with 1000 mg of metformIN taken once weekly . if this dose does not work well enough , your doctor may increase your dose to 2 mg once daily without taking avand amet . take your tablets around the same time every day and swallow them whole with a glass of water . do not chew , crush or break the tablets . you may take a small amount of avandemet tablets in case of your stomach
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions these are very rare in people taking avand amet . signs include : raised and itchy rash ( hives ) swelling , sometimes of the face or mouth ( angioedema ), causing difficulty in breathing collapse . contact a doctor immediately if you get any of these symptoms . stop taking a drug and call for emergency medical help . lactic acidosis : avandemet can increase the amount of lactic acids in the blood ( lactic acidosis ), which is an uncommon side effect with metformin . severe kidney disease . symptoms of lacecidososity may include rapid breathing , cold sweats , and / or sweating . other signs of stevens - johnson syndrome 
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . if you have any unwanted tablets , don ' t put them in waste water or household rubbish . ask your pharmacist how to dispose of tablets you don  't need . these measures will help protect the environment .
what avandamet contains - the active substances are rosiglitazone and metformin . avand amet tablets come in different strengths . each tablet contains 1 mg rosisglit azone ( as 500 mg metformine ). each tablet also contains 2 mg siglitabazone( as 500g metforminer ). Each tablet also includes 2 mg of rossiblitazon ( as 1000 mg metFORMin ). every 4 mg consists of ssigleta zone ( as 600 mg metformatin ) and 4 mg of either rositazone or 1000 mg of metformIN . the other ingredients are sodium starch glycollate ( type a ), hypromellose ( e464 ), microcrystalline cellulose ( 6000 ), and lactose monohydrate ( see section 2 ). what 
clopidogrel mylan contains clopigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). clopozogrell mylan is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosesis , and can lead to atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodogrelly mylan to help prevent blood cots from forming and prevent existing thrombocytes .
do not take clopidogrel mylan 31 if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . the doctor may need to adjust the dose . have severe liver disease . warnings and precautions talk to your doctor before taking clopozogrela mylan : if any of your patients is at risk of bleeding such an increased risk of bleed such as having a medicinal condition that puts you at risk for internal bleeding ( such as such as the stomach ulcer ). the doctor should also tell you that you have a blood disorder that makes you prone to internal bleeding , such as bleeding inside any tissues , organs or joints of your body
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctoror or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if your doctor thinks you may have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of cropidogral myLAN ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet , which should be taken as soon as possible after the first day of treatment by your doctor . you should take clopogrell mylan for as long as your physician continues
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in some cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . These may be the signs of an allergic reaction . warnings & precautions talk to your doctor or pharmacist if your child experiences any of the following serious side effects you should immediately contact your child ' s doctor , pharmacist or nurse .
what clopidogrel mylan contains the active substance is clopogrell . each film - coated tablet contains 75 mg of clodogrelly ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' clopozogreel myLAN contains hydrogenated Castor oil ') the tablet coating contains polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( е172 ), yellow iron oxide , the talc and macrogol 3000 . what clupidogral mylang looks like and contents of the pack the film  - covered tablets are beige , oval tablets with ' mylan 75 ' marked on one side
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . doptelt is used to treat chronic liver disease associated with low platelet count ( thrombophenia ) in adults who need a medical procedure to prevent bleeding , including reduction of the number of platelets . platelets are blood cells that help the blood to clot and so prevent bleeding the smallest amount of them .
do not take doptelet : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking dop Telet . blood clots may form in the veins or arteries , and this can increase the risk of blood coagulations . tell your doctor if any of these apply to you . if your doctor thinks this applies to you then doptelt is not suitable for you : blood clumps in the blood vessels or artery walls . this is because blood  clottes can be very dangerous for people with cancer . talk to you doctor , pharmacist or nurse before taking this medicine : whether you are taking the contraceptive birth control pill or hormone replacement therapy . recently had surgery or are injured . 23 if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose for you and your nuclear medicine doctor will decide on the dose that you should take during your procedure . it is 5 mg to 8 mg twice a day . you should swallow the tablet whole with a glass of water . doptelet can be taken with or without food . your nuclear doctor will calculate the dose you should receive depending on your body surface area . when you are ready to take doptelt , your nuclear physician will calculate your dose for the day , depending on the surface area to be taken . this will be the same dose as for any other medicine used in your case . use in children and adolescents the recommended adult dose of dop Telet for children is 20 mg , 40 mg or 60 mg once daily ( for children weighing at least 5 kg ),
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : common : may affect up to 1 in 10 people : feeling tired common  may affect less than 1 in 100 people  low red blood cell count ( anaemia )  blood clot in the portal vein ( a blood vessel lining between the liver and intestines ) common ? upper abdominal pain and swelling bone pain muscle aches fever reporting of side effects 25 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine and the safety advice on the package leaflet for the safety and efficacy of
what doptelet contains the active substance is avatrombopag . each film - coated tablet contains avatorombapag maleate equivalent to 20 mg of avatorsorombog . the other ingredients are : lactose monohydrate ( see section 2 ' dopelet contains lactoses '), microcrystalline cellulose , crospovidone type b [ e1201 ], silica , colloidal anhydrous , magnesium stearate , vinyl alcohol , the stuffing of talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow ( encoding code ) ( see ' doespteleting contains lactones '). what dopetelet looks like and contents of the pack doptelt 20 mg film & film  are pale yellow to
rapiscan belongs to a group of medicines called ' coronary vasodilators '. they work by helping the body find out what the heart arteries are and what their heart rate is . they measure the muscles in the heart to help determine what is normal for the body . rapican is used for a type of heart scan called a ' myocardial perfusion imaging ' where the scan is performed . the scan will be accompanied by a radioactive substance known as a' radiopharmaceutical ', which helps to obtain these images and give more information about the muscles of the heart in the normal way . it is usually done using a treadmill to help get the best results for your health . how rapissecan works rapiston works by using ' coronary vasovagal imaging - this helps your doctor decide whether this medicine is
do not use rapiscan - if you have been told by your doctor that you have slow heart rate ( 60 beats per minute ) or if your doctor told you that you had high degree heart block or sinus node disease and you do not have a pacemaker . - when you have chest pain ( unstable angina ) it is important to inform your doctor if this applies to you . warnings and precautions talk to your doctor before using rapican : - for low blood pressure ( hypotension ) and risk of heart failure . you are allergic to regadenoson ( see section 6 " what you need to know before you use  Rapiscan "). - you should not use this treatment if any of the above applies to your situation . take special care with rapistcan if : you have , or have had , a recent serious
rapiscan will be given to you by a doctor or nurse . it will be administered by syringes to measure your heart and blood pressure . the dose will be injected slowly into a vein , delivering a dose of 400 micrograms / ml . after preparation of a 5 mL solution the injection will be repeated every two weeks . your dose will depend on your weight . if you need an injection of sodium chloride 9 mg / kg / min . for an injection in sodium chlorides 9 mg/ mol / mg , the dose may be repeated once every three weeks , depending on your body surface area . how much radioactivity is given the radiopharmaceutical will be decided by your doctor . before rapican , your doctor will measure your heat rate . depending on the results of your heart rate and bloodpressure
like all medicines , rapiscan can cause side effects , although not everybody gets them . most of the side effects caused by the rapistan injection are mild or moderate and go away within 30 minutes of any treatment . tell your doctor or nurse straight away if you notice any of the following side effects you may need a heart check - up : sudden stopping of the heart , damage to the heart ( such as heart block ), a disorder of the hearts electrical signal , rapid heart beat low blood pressure , fainting , mini strokes , weakness of the face and inability to speak . rapican can also lead to a stroke ( a type of cerebrovascular accident ) or an allergic reaction , such as rash , wheals / weals , or hives . your doctor will decide if rapissecan can be used for this
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your peni when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . Viagra is a treatment for adult men with erectile dysfunction , sometimes known as impotence . this is when a man cannot get , or keep a hard , hard - ed penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - take medicines called nitrates , as the combination may lead to a dangerous fall in your blood pressure . tell your doctor if any of these medicines are used for the treatment of angina pectoris ( or " chest pain "). if your doctor thinks that the medicines being given by nitric oxide donors such as amyl nITrite are not suitable , since the combination could lead to an extremely high level of a risk of causing a devastating fall inyour blood pressure ". if this happens , your doctor will be monitoring closely . - the use of riociguat is not recommended as it may increase the risk of this drug being used in patients with pulmonary arterial hypertension ( i
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended starting dose is 50 mg . you should not take viagra more than once a day . this is the same dose as for viagra film - coated tablets and for viagra orodispersible tablets . do not take more than one tablet each day , but take the tablet at the same time each day with a glass of water . swallow the tablet whole with st . john ' s wort . how to take viagra - viagra will only help you to get an erection if a man can be sexually stimulated . it is important that you take viagra every day until your doctor tells you otherwise . when you take more viagra than you should if someone else takes your tablets , or if somebody else takes
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with the use of viagra are usually mild to moderate and of a short duration . if you experience any of the following serious side effects stop taking viagra and seek medical help immediately : - an allergic reaction - this occurs uncommonly ( may affect up to 1 in 100 people ) symptoms include sudden wheeziness , difficulty in breathing or dizziness - swelling of the eyelids , face , lips or throat - chest pains - get in a semi - sitting position and try to relax . do not use nitrates to treat your chest pain - prolonged and sometimes painful erections . this occurs rarely ( may effect up to1 in 1 , 000 people ). if your partner gets an ererektion after 4 or more
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildanafil ( as the citrate salt ). - other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate . tablet film coat : hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( cadmium ). what viagra looks like and contents of the pack viagra film - coated tablets are blue coloured with a rounded - diamond shape , marked with ' 25 ' on one side . the tablets are provided in blister packs containing 2 , 4 , 8 or 12 tablets . not all pack sizes may be 
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopa receptors in the brain . stimulation of the dopami receptors triggers nerve impulses inthe brain that help to control body movements . siffrol is used to : - treat the symptoms of primary parkinson ' s disease in adults . it can be used alone or in combination with levodopa ( another medicine for parkinsons 's disease ). - help alleviate the symptoms in moderate to severe primary restless legs syndrome in adults and children .
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sIFrol . tell your doctor if any of these apply to you . sfrol is not recommended for use in patients with any medical conditions or symptoms , especially any of them . talk to a doctor straight away if your kidney disease is at risk of hallucinations ( seeing , hearing or feeling things that are not there ). most hallucingations are visual . dyskinesia ( e .g . abnormal , uncontrolled movements of the limbs ). if for the treatment of advanced parkinson ' s disease , you are also taking levodopa , which may increase the risk of dyskine
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . sifrol should be prescribed for you by a doctor with experience in the treatment of parkinson ' s disease . for the first week , take the tablets with food . during the first weeks , the usual dose is 1 tablet of sIFrol 0 . 088 mg twice a day ( equivalent to 0. 264 mg ). after the first month , your doctor may increase your dose to 1 tablet . each week you will take sunlessrol 0- 088 - 0 de . 26 mg twice daily . after this , you may experience relief from your symptoms returning . you may take tablets 1 hour before spirrol -0 , 18 mg twice weekly . then , 2 hours after 
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common may affect more than 1 in 10 people common may effect up to 1 in every 10 people uncommon may affect up to1 in 100 people rare may affect less than 1 per 1 , 000 people very rare may impact up to 10 ,000 people not known frequency cannot be estimated from the available data if you suffer from parkinson ' s disease , you may experience the following side effects as a whole , possibly life - threatening condition : dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ) dizziness nausea ( sickness ) urge to behave in an unusual way - hallucinations ( seeing , hearing or feeling things that are not there ) confusion , tired
what sifrol contains the active substance is pramipexole . each tablet contains 0 . 088 mg , 0. 18 mg / 0 deg , or 0 in 0 35 mg . one tablet contains 7 mg pramipexole as 0: 125 mg ; 0, 25 mg & 0 5 . 5 mg corresponding to 1 mg pramipexale dihydrochloride monohydrate , respectively . the other ingredients are mannitol , maize starch , anhydrous colloidal silica , povidone k 25 and magnesium stearate . what ifrol looks like and contents of the pack sfrol 0x88 mg tablets are white , round and convex . sIFrol 0- 0 18 mg tablets come in blisters
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . allergic conditions occur in and around the eye and can cause the allergic reaction . in some cases , the allergic conjuctivité may occur in response to some materials ( allergens ) that you touch or inhaled . these can cause allergic reactions such as itching , redness and swelling on the surface of your eye , or make you feel worse .
do not use emadine : - if you are allergic to emedastine or any of the other ingredients of this medicine listed in section 6 . warnings and precautions talk to your doctor or pharmacist before using e madine . children and adolescents do not give this medicine to children under the age of 3 years because the active substance is benzalkonium chloride . this medicine may affect the way emedicine works in this age group . therefore , emailine has not been studied in clinical trials . however , in general , the safety and efficacy of emantine in children below the age range of 6 , has not yet been established . since the conduct of clinical trials has not shown any benefit in the treatment of children and teenagers , it is recommended not to administer emagine to children and infants under the care of their doctor . other
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in the affected eye 3 times a day in the morning . use this medicinal product only as directed by your doctor to help you open the bottle . do not swallow the bottle or use it for more than one hour . only use this product in both eyes if your doctor told you to . 3 . step 1 : check the time you use emadine bottle , see section 2 , how to use it . get the e madine bottle and wash your hands . take the bottle and sachets after each use . twist off the cap . after cap is removed , if the saches are loose , snap collar is loose . hold the bottle in one hand and press a finger into the
like all medicines , this medicine can cause side effects , although not everybody gets them . you can usually carry on taking the drops , unless the effects are serious . common side effects ( may affect up to 10 people ) effects in the eye : eye pain , itchy eye , and eye redness . uncommon side effects may affect more than 1 in 100 people ] effects in and around the eye: corneal disorder ( abnormal eye sensation ), increased tear production , tired eyes , eye irritation , blurred vision , corneal staining . reporting of side effects 23 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . . by reporting side effects you can help provide more information on the safety of this medicine .
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . store below 25 . keep the blister in the outer carton in order to protect from light and moisture . once the blister has been opened , the product should be used immediately .
what emadine contains the active substance is difumarate . the other ingredients are benzalkonium chloride , trometamol , sodium chloride and hypromellose . purified water , hydrochloric acid and sodium hydroxide to keep acidity levels ( ph levels ) normal . what a e madine looks like and contents of the pack emagine is a liquid ( a solution ) supplied in a 5 ml or 10 mml plastic ( drop - container ) bottle with a screw cap .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetiractam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepilepsy , to treat a certain form of epilema . epilemony is a condition where the patients have repeated fits ( seizures ). in this case , levetiragetam works on one side of the brain , but may extend to larger areas on both sides of the mind ( partial onset seizure with or without secondary generalisation ). LevetiraceTam has been given to you by your doctor to reduce the number of fits . as an add - on to other antiepepilistic medicines to treat partial initiation seizures with or with secondary generalising in adults , adolescents , children and infants from one month
do not take levetiracetam actavis - if you are allergic to levetiractam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking levetirasetam actingavis about all your medical conditions , especially if they are related to kidney problems , follow your doctor ' s instructions . he / she may decide if your dose should be adjusted . talk to you doctor before starting to take levracetamine actavises : - patients with kidney problems should follow their doctor - any slow down in the growth or unexpected puberty development of your child . some patients treated with anti - epileptics such as levetiretam amd patients have had thoughts of harming or killing themselves . you should contact your doctor immediately 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . take the number of tablets following your doctor' s instructions . levetiracetam actavis is taken twice a day - once in the morning and once inthe evening . monotherapy dose in adults and adolescents from 16 years of age : general dose : between 1 , 000 mg and 3 , 500 mg each day . when you will first start taking levetirasetam actingavis , your doctor will prescribe you a lower dose during 2 weeks before giving you the lowest general dose of 1  ,500 mg . add - on therapy dose in adult and adolescents 17 years of adolescent weighing 50 kg or more : upper dose ranging from 1 . 000 mg to 3   . 3 mg each morning 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately , or go to your nearest emergency department , if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction ; swelling of the face , lips , tongue and throat ( quincke ' s oedema ); flu - like symptoms and a rash on the face followed by an extended rash with a high temperature ( uncommon ), increased levels of liver enzymes seen in blood tests or an increase in a type of white blood cell 56 ( uncommonly in eosinophilia ) or enlarged lymph nodes ( uncommon in drug reaction with hallucinations ). you should see your doctor as soon as possible if your
what levetiracetam actavis contains the active substance is called levetiractam . one tablet of levetirasetam actsavis 250 mg contains 250 mg of levracetamine . two tablets of levaitracet amda : levetiratetam actingavis 500 mg contains 500 mg of the active ingredient . levetistetam amd : 750 mg contains 750 mbq of leveracetan . three tablets of duboss : the combination product is a clear , colourless liquid . when dubbo : lavetiracetham activis 1 , 000 mg contains 1  , 500 mg levetiretam the other ingredients are crospovidon , povidone , silica colloidal anhydrous , magnesium stearate . the other ingredient is tal
what incruse ellipta is this medicine contains the active substance umeclidinium bromide , which belongs to a group of medicines called bronchodilators . what increse incrussant is used for this medicine is used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition in which the airways and air - sacs in the lungs become blocked or blocked . difficulties in breathing is increased by tightening of the muscles around the airway , leading to tightened airways that narrows the air , air duct and lungs . by tightened air borne muscles , this medicine blocks the tightener of these muscles . this helps to stop air from getting in and out of the pulmonary system and reduce the effects of copd on your everyday life 
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately and stop using this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before using incruses ellippta : - when you have asthma ( don ' t use increse
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use incruse ellipta regularly it is very important that you use inclusive methods every day , as instructed by your doctor . this will help to keep you free of symptoms throughout the day and night . do not use this medication to relieve a sudden attack of breathlessness or wheezing . if this attack occurs suddenly , use a quick - acting reliever inhaler ( such as salbutamol ). how to use the inhalers see ' step -
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you have any of the following symptoms after taking incruse ellipta , stop using this medicine and tell your doctor straight away : itching skin rash ( hives ) or redness 29 other side effects include : common ( may effect up to1 in 10 people ) faster heart beat painful and frequent urination ( may be signs of a urinary tract infection ) common cold infection of nose or throat cough feeling of pressure or pain in the cheeks and forehead ( may indicate inflammation of the mucous membranes of the mouth , throat or genitals ) uncommon ( might affect upto1 in 100 persons ) increase in liver enzymes ( seen in blood tests ) rare ( may effects up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label of the inhaler . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the inhaled tray in the sealed tray in order to protect from light . after first opening , the inher can be used for up to 6 weeks . when you first open the tray , keep the lid of the tray in front of children and do not store above 30 . once you have opened the tray you can use the inflater at any time of the day . always keep the tray tightly closed in order for safety reasons and do NOT throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment 
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram of umecladinium brmide in each inhaler ). - other ingredients are lactose monohydrate ( see section 2 under ' incrusite ellippa contains lactoses ') and magnesium stearate . what increse incrussanta looks like and contents of the pack incruses ellipept consists of an inhalations powder , pre - dispensed . the ellilipta inhalers consists a grey plastic body , a light green mouthpiece cover and a dose counter . it is packaged in a
what nucala is nucalа contains the active substance mepolizumab . this is a monoclonal antibody , a type of protein that recognises and attaches to a specific target substance in the body . what nukala is used for nucale is used to treat severe asthma in adults , adolescents and children aged 6 years and above . severe asthma is caused by many eosinophils , which are a white blood cell that helps to fight infections in the lungs ( called eopenia ). what nucaa is for nukale is for use in adults and children ( 6 years of age and older ). it is used in asthma attacks when medicines called high dose inhalers are not enough to control your asthma . your doctor may prescribe these medicines in combination with medicines called oral corticosteroids . how nucalam works nucalal helps
do not use nucala : if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if : you have worsening asthma or 58 people who have experienced asthma - related side effects , as they may need nucalа to control their asthma . talk to a doctor or nurse before using nucalava to treat your asthma , before starting nucalal treatment . some people get allergic to injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions when they are injected into the body . see section 4 for more information about possible side effects of a similar reaction . if your doctor thinks you may be at risk of getting a new one , talk to you doctor or go to the nearest hospital straight away .
how much is given nucala is given by injection under the skin ( subcutaneous injection ). the recommended dose is 12 micrograms ( 100 microgram ) given once a week , for a total of 1 hour . use of the pre - filled pen before you start using nucale . your doctor will decide how many injections of nucalá you need . if you miss an injection of nukala it is very important that you contact your doctor to discuss when you should return for treatment . don ' t stop treatment with nucalar without talking to your doctor . stopping the treatment with Nucala may cause your asthma symptoms to come back . it may also help to prevent attacks of your asthma episodes returning . when your first doses of nuclear medicine are due , you may not be able to receive the full dose . you should not stop using nukalа unless your doctor tell
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions are common ( may affect up to 1 in 10 people ). they usually occur within a few days or weeks after the injection . sometimes symptoms include chest tightness , cough , difficulty breathing fainting , dizziness / feeling lightheaded ( due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you notice a reaction similar reaction to nucale . your doctor may decide to keep you under closer observation or change your dose or stop the injection completely . they may also notice other side effects after you have received nucalа . allergic reactions are very common ( affects more than 1 user in 10 ) and
keep out of the reach and sight of children . do not use nucala after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 to 8 ). do not freeze . keep the nucale pre - filled pen in the box in order to protect from light . after first opening , use within 7 days . discard if not used within 7 months .
what nucala contains the active substance is mepolizumab . 1 ml solution contains 100 mg of mepolizamab in 1 g . the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate / polysorbate 80 , edta disodium dihydrate & water for injections . what nukala looks like and contents of the pack nucale is presented as a clear , colourless solution for injection ( in a pack of 1 ) or as  a multipack of 3 mL containing 1 . not all pack sizes may be marketed .
what ninlaro is nINlarro is an anticancer medicine that contains the active substance ixazomib , also known as a ' proteasome inhibitor '. ninelar is used to treat adults with a cancer of the bone marrow called multiple myeloma . ixazamibe is involved in cell survival and kills myelama cells by interfering with the production and division of proteins in these cells . by interference with the synthesis of proteins , ninklarou is involved with the development of proteasoms . what if nnlararo looks like and contents of the pack nintrlarone is used for the treatment of multiple myélomas in adult patients . the combination of nhinlaró , lenalidomide
do not take ninlaro : - if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking nnlararo and during treatment : tell your doctor or nurse if any of these applies to you . if the use of nINlarone is not recommended , tell your physician immediately . bleeding , persistent nausea , vomiting or diarrhoea , nerve problems such as tingling , numbness , swelling or a persistent rash , or liver or kidney problems . tell your dentist if this applies to your child . your doctor may need to change your dose , stop treatment with ninelaron or stop treatment . before starting treatment , your doctor will
ninlaro is used to treat multiple myeloma in adults . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . nnlarro is prescribed for you by your doctor as an injection of lenalidomide , a medicine that is used in combination with dexamethasone , an anti - inflammatory medicine . how much to take the recommended dose of nINlararo for adults consists of taking lenaldomide in combinationwith dex amethamethasONE on a 4 - week cycle . you will usually take ninklaron once a day on the same day of the week for the first 3 weeks followed by a weekly dose of 4 tablets of leNalidomone 25 mg , taken once - daily for the
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ) low platelet counts ( thrombocytopenia ) nose bleeds that may cause easily bruise nausea , vomiting , diarrhoea numbness , tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet( peripheral oedema ) skin rash ( itchy ) anywhere on the body rare side effects may affect up to 1 in 1 , 000 people : bleeding or bruising more easily than normal . bruiser pain when urinating . reporting of side effects 25 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister or carton after exp . the expiration date refers to the last day of that month . store below 30 . keep the capsule in the outer carton in order to protect from light . once the capsule has been opened , use this medicinal product in accordance with local requirements . does not take this medicine if you notice any damage or signs of tampering to medicine packaging .
what ninlaro contains nINlarro 2 . 3 mg hard capsules : the active substance is ixazomib . each capsule contains 2 , 3 mg of ixazamibe . one capsule contains 3 . 1 mg of the active ingredient ixizomia citrate . the other ingredients are microcrystalline cellulose , magnesium stearate and talc . capsule shell : gelatin , titanium dioxide ( e171 ), red iron oxide ( е172 ). printing ink : shellac , propylene glycol , potassium hydroxide , and black iron oxide . nninnaro 3 mg capsules contain ixozomibid . Each capsule contains up to 3 mg ixazimib , which is essentially ' sodium - free '
do not use palforzia : - if you are allergic to peanuts ( arachis hypoogaea ) or peanut butter . warnings and precautions talk to your doctor or pharmacist before using palforizia . children and adolescents 4 to 17 years of age should not be given this medicine . during treatment , peanut allergy may occur . peanut ( sensitisation ) is the most common ingredient in peanut butter in the food chain . palforziea has been shown to reduce allergic reactions . no data are available on the safety and efficacy of palforza in children and teenagers . food allergies may occur when using pal forzia and are not recommended for children and teens .
do not take palforzia - if you are allergic to severe asthma or any of the ingredients of palforza . - whether your asthma is severe or if your asthma does not go away . warnings and precautions talk to your doctor or pharmacist before taking palfor zia . talk to a doctor or nurse before taking this medicine if : - you have a problem swallowing - your doctor will have told you if this applies to you . some people taking pal forzia have had long term problems with your digestive system . these may be signs of a severe mast cell disorder , such as severe or life - changing anaphylaxis . you must wait 60 days before starting treatment with your palforza , until you have established the symptoms . peanut allergy is rare in people taking the medicine and it is not known how long you will be treated with palfor
always take this medicine exactly as your doctor has told you . check with your doctor if you are not sure . this is important because you may get allergic reactions ( such as anaphylaxis ) during or within 3 months of treatment with palforzia . initial dose escalation will be repeated every two weeks . during these treatment phases the initial dose elevation and up - dosing phases will be continued . you will not be given more palforzaa than your doctor tells you , if necessary . if possible , you may still be given palforziea if this happens . it is important that you complete the initial dosage escalation and up to two additional doses of palforciaa , as described below . your doctor will explain to you how to use palforizia and how to reduce the amount of pal forzia that you will need to take
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects with palforzia are severe allergic reactions . tell your doctor straight away if you have any of the following symptoms after taking palforzaa . they usually go away within one week of the reaction . trouble breathing , throat tightness , feeling of fulness , trouble swallowing or speaking - changes in voice , dizziness or fainting , severe stomach cramps or pain , vomiting , or diarrhoea , and severe flushing or itching of the skin palforizia may cause problems with the stomach and digestive system . these include : - fever , chills , sore throat , cough , abdominal pain - joint pain . - indigestion , flatulence , pain in the abdomen , stomach
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store below 25 . keep this medicinal product out of sight and sight of children do not take this medicine if you notice any hard lumps of powder . this medicine does not require any special storage conditions .
what palforzia contains the active substance is palforza 0 . 5 mg / 1 ml , 10 mL or 20 mg . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , magnesium stearate palforizia 100 mg : - oral powder in capsules after opening microcrystalline cellulas , coloidal an hydrous silicca , and magnesium STEarate paforzie 300 mg - or oral powderin sachet microcrystalline hard capsules containing colloidal anhydrous Silica , or magnesium st arate . - beige oral powder prior to initial dose escalation ( see section 3 ). pack sizes : 13 single - dose blisters : one single  dose blister containing 0. 5 mg / m2 of
zerene belongs to a class of substances called benzodiazepine - related medicinal products , which give hypnotic actions to help you sleep . zerènee is used in adults to treat sleeping problems at the start of treatment . it is used when you have problems sleeping after you have finished your course of treatment ( see section 2 ).
do not take zerene : - if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zerenne sleep apnoea syndrome . - during short periods , you may have severe kidney or liver problems . your doctor may ask you to stop taking zerent . the use of myasthenia gravis makes you very weak and tired muscles . it may also cause severe breathing or chest problems  . children and adolescents do not give this medicine to children and teenagers under 18 years of age . therefore , zere has not been studied in this age group . there is no known undesirable effects from taking any medicine . tell your doctor if any medicines given at the same time as zerenia . this is because physical dependence may occur at the beginning of treatment . withdrawal symptoms may occur ( e .
always take zerene exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is 10 mg once a day with no difficulty falling asleep . do not take if the effect of zerenne is too strong or too weak . take the capsule about 65 minutes before your next meal . if your doctor thinks you have mild to moderate liver problems , your doctor may prescribe a lower dose of 65 mg once or twice a night . use in elderly people ( 65 years and over ) the usual starting dose is 5 mg once daily with no or less mild to medium liver problems and your doctor will adjust the dose based on your response . however , if a person with mild to mild liver problems is 65 years or older is 5 kg or more , the capsule may become cloudy . an overdose may make you increasingly d
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor or pharmacist if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon (affecting less than 1 to10 users in 1 , 000 ) rare (affecting 2 to 10 patients in 10 to 10 ,000 ) very rare ( affecting less than1 user in10 , 10 users per 10 . 000 ). not known ( frequency cannot be estimated from the available data ) as for all medicines used , the side effects reported below are defined using this convention . if any of the side - effects gets serious , or if there are any other differences in your healthcare , you should immediately tell your physician 
what zerene contains the active substance is zaleplon 5 mg . the other ingredients are microcrystalline cellulose , pregelatinised starch , silicon dioxide , sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( е171 ). the printing ink contains : gelatin , titanium dioxide e171 ( p177 ), red iron oxide (  e172 ), yellow iron oxide [ e 172 ], black iron oxide( e 180 ) and sodium laauryl  sulate . printing in black ink is composed of silicon dioxide ( ( s - 13050 )). the other ink includes : shellac , lecithin ( containing simethicone ), and yellow
